"","idChemical","strName","strCAS","strMF","Source","Type","numValue","RfDConsistent","dateAssessed","strHyperlink","strDateAssessed","strReference","POD type","numPOD","strUnitsPOD","BMR Type","strCriticalEffect","Adjusted","Route to Route","Animal to Human","strDR","numUF","numUFa","numUFh","numUFs","numUFl","numUFd","numUFother","UFsConsistent","strUFother","strRelatedCompound","Species","Strain","Sex","Route","intHoursPerDay","intDaysPerWeek","strDuration","Duration type","Organ","tblOrgan_strSex","strMOA","idEffect","Effect","tblEffect_strSex","DR Type","strEffectPOD","CV Type","strDoseUnits","strResponseUnits","strDoseConvertedUnits","strDoseHEqUnits","strComment","intDoseOrder","numDose","numDoseConverted","numDoseHEq","intAnimals","intAnimalsEffected","numMeanResponse","numSDResponse"
"1",514,"2,4,5-Trichlorophenol","95954","C6H3Cl3O","IRIS","RfD (mg/kg/day)",0.1,1,1988-03-01,"http://www.epa.gov/iris/subst/0121.htm","3/1/1988","McCollister, D.D., D.T. Lockwood and V.K. Rowe. 1961. Toxicologic information on 2,4,5-trichlorophenol. Toxicol. Appl. Pharmacol. 3: 63-70.","NOEL",100,"mg/kg/day","NA","Liver and kidney pathology","No","None","None","No",1000,10,10,10,NA,NA,NA,TRUE,NA,NA,"Rat","Unspecified","M/F","Oral diet",NA,NA,"98","Days","kidneys","Both","None",1416,"nonneoplastic histopathology","Both","Dichotomous","kidney pathology",NA,NA,NA,NA,NA,"slight degenerative changes in the kidneys; incidence data were not presented in primary report",NA,NA,NA,NA,NA,NA,NA,NA
"2",514,"2,4,5-Trichlorophenol","95954","C6H3Cl3O","IRIS","RfD (mg/kg/day)",0.1,1,1988-03-01,"http://www.epa.gov/iris/subst/0121.htm","3/1/1988","McCollister, D.D., D.T. Lockwood and V.K. Rowe. 1961. Toxicologic information on 2,4,5-trichlorophenol. Toxicol. Appl. Pharmacol. 3: 63-70.","NOEL",100,"mg/kg/day","NA","Liver and kidney pathology","No","None","None","No",1000,10,10,10,NA,NA,NA,TRUE,NA,NA,"Rat","Unspecified","M/F","Oral diet",NA,NA,"98","Days","liver","Both","None",1414,"nonneoplastic histopathology","Both","Dichotomous","liver pathology",NA,NA,NA,NA,NA,"slight degenerative changes in the liver; incidence data were not presented in primary report",NA,NA,NA,NA,NA,NA,NA,NA
"3",482,"2,4,6-Trichlorophenol","88062","C6H3Cl3O","PPRTV","RfD (mg/kg/day)",0.001,1,NA,"http://hhpprtv.ornl.gov/issue_papers/Trichlorophenol246.pdf","3/21/2007","Exon, J.H. and L.D. Koller. 1985. Toxicity of 2-chlorophenol, 2,4-dichlorophenol, and 2,4,6-
trichlorophenol. In: Water Chlorination: Chemistry, Environmental Impact and Health Effects,
R.L. Jolley et al., Ed. Proceedings Fifth Conference Williamsburg, Chelsea, MI. Lewis Publishers. P. 307-330.","NOAEL",3,"mg/kg/day","NA","Decreased litter size","NA","None","None","No",3000,10,10,10,NA,3,NA,TRUE,NA,NA,"Rat","Sprague-Dawley","F","Oral drinking water",NA,NA,"13","Weeks","female repro","Both","None",3255,"reproduction","Both","Continuous","Decreased litter size","SE","ppm water","pups/litter","mg/kg-day",NA,"Dose-response data are from Table 5 of the primary report; calculated doses are reported in the PPRTV document.  Mean pups per litter included stillborn pups; percent stillborn were 0, 2, 3, and 3% in control through high dose groups.",NA,0,0,NA,NA,NA,12.1,1.1
"4",482,"2,4,6-Trichlorophenol","88062","C6H3Cl3O","CalEPA","Oral Slope Factor (mg/kg-day)-1",0.07,NA,NA,NA,"1988","National Cancer Institute (NCI). 1979. Bioassay of 2,4,6-Trichlorophenol for Possible Carcinogenicity. National Cancer Institute, National Institutes of Health, Bethesda, MD.",NA,NA,NA,"10% ER","hepatoma","NA","None","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Oral diet",NA,NA,"105","Weeks","liver","Both","None",2647,"neoplasia","M","Dichotomous","hepatoma",NA,"ppm",NA,"mg/kg/day",NA,"OSF is the geometric mean of slope factors calculated from four data sets.  The OSF calculated for this dataset 0.021 per mg/kg/day.",NA,0,0,NA,20,4,NA,NA
"5",482,"2,4,6-Trichlorophenol","88062","C6H3Cl3O","CalEPA","Oral Slope Factor (mg/kg-day)-1",0.07,NA,NA,NA,"1988","National Cancer Institute (NCI). 1979. Bioassay of 2,4,6-Trichlorophenol for Possible Carcinogenicity. National Cancer Institute, National Institutes of Health, Bethesda, MD.",NA,NA,NA,"10% ER","hepatoma","NA","None","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Oral diet",NA,NA,"105","Weeks","liver","Both","None",2648,"neoplasia","F","Dichotomous","hepatoma",NA,"ppm",NA,"mg/kg/day",NA,"OSF is the geometric mean of slope factors calculated from four data sets.  The OSF calculated for this dataset 0.008 per mg/kg/day.",NA,0,0,NA,20,1,NA,NA
"6",482,"2,4,6-Trichlorophenol","88062","C6H3Cl3O","CalEPA","Oral Slope Factor (mg/kg-day)-1",0.07,NA,NA,NA,"1988","Innes JRM, Ulland BM, Valerio MG, Petrucelli L, Fishbein L, Hart ER, Pallotta AJ, Bates RR, Falk HL, Gart JJ, Klein M, Mitchell I and Peters J. 1969. Bioassay of pesticides and industrial chemicals for tumorigenicity in mice: a preliminary note. J Natl Cancer Inst 42:1101-1114.",NA,NA,NA,"10% ER","reticulum cell sarcoma (males); hepatoma (female)","Yes","None","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Oral gavage",NA,NA,"78","Weeks","liver","F","None",2649,"neoplasia","F","Dichotomous","hepatoma",NA,"mg/kg/day (TWA)",NA,NA,NA,"Animals were treated with 100 mg/kg/day by oral gavage from day 7 to 28 of life, then fed diet containing 260 ppm for 74 weeks.  OSF is the geometric mean of slope factors calculated from four data sets.  The OSF calculated for this dataset 0.28 per mg/kg/day.",NA,0,NA,NA,87,0,NA,NA
"7",482,"2,4,6-Trichlorophenol","88062","C6H3Cl3O","CalEPA","Oral Slope Factor (mg/kg-day)-1",0.07,NA,NA,NA,"1988","Innes JRM, Ulland BM, Valerio MG, Petrucelli L, Fishbein L, Hart ER, Pallotta AJ, Bates RR, Falk HL, Gart JJ, Klein M, Mitchell I and Peters J. 1969. Bioassay of pesticides and industrial chemicals for tumorigenicity in mice: a preliminary note. J Natl Cancer Inst 42:1101-1114.",NA,NA,NA,"10% ER","reticulum cell sarcoma (males); hepatoma (female)","Yes","None","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Oral gavage",NA,NA,"78","Weeks","systemic","M","None",2650,"neoplasia","M","Dichotomous","reticulum cell sarcoma",NA,"mg/kg/day (TWA)",NA,NA,NA,"Animals were treated with 100 mg/kg/day by oral gavage from day 7 to 28 of life, then fed diet containing 260 ppm for 74 weeks.  OSF is the geometric mean of slope factors calculated from four data sets.  The OSF calculated for this dataset 0.47 per mg/kg/day.",NA,0,NA,NA,79,3,NA,NA
"8",482,"2,4,6-Trichlorophenol","88062","C6H3Cl3O","IRIS","Oral Slope Factor (1/mg/kg-day)",0.011,NA,1994-02-01,"http://www.epa.gov/iris/subst/0122.htm","2/1/1994","NCI (National Cancer Institute). 1979. Bioassay of 2,4,6-Trichlorophenol for Possible Carcinogenicity. U.S. DHEW Publ. No. NCI-CG-TR-155.",NA,NA,NA,"Other","leukemia","No","None","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Rat","Fischer 344","M/F","Oral diet",NA,NA,"106-107","Weeks","blood","M","MOA Data",1425,"neoplasia","M","Dichotomous","leukemia",NA,"ppm","incidence","mg/kg/day","mg/kg/day",NA,NA,0,0,0,20,3,NA,NA
"9",482,"2,4,6-Trichlorophenol","88062","C6H3Cl3O","IRIS","Inhalation Unit Risk (1/μg/m3)",3.1e-06,NA,1994-02-01,"http://www.epa.gov/iris/subst/0122.htm","2/1/1994","NCI (National Cancer Institute). 1979. Bioassay of 2,4,6-Trichlorophenol for Possible Carcinogenicity. U.S. DHEW Publ. No. NCI-CG-TR-155.",NA,NA,NA,"Other","leukemia (derived from oral data)","No","Other","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Rat","Fischer 344","M/F","Oral diet",NA,NA,"106-107","Weeks","blood","M","MOA Data",1428,"neoplasia","M","Dichotomous","leukemia",NA,NA,NA,NA,NA,"Calculated from the oral data in the ORF section.  Method for route-to-route extrapolation was not reported.",NA,NA,NA,NA,NA,NA,NA,NA
"10",254,"2,4-Dinitrophenol","51285","C6H4N2O5","IRIS","RfD (mg/kg/day)",0.002,1,1991-07-01,"http://www.epa.gov/iris/subst/0152.htm","7/1/1991","Horner, W.D. 1942. Dinitrophenol and its relation to formation of cataracts. Arch. Ophthal. 27: 1097.","LOAEL",2,"mg/kg/day","NA","Cataract formation","No","None","NA","No",1000,NA,10,10,10,NA,NA,TRUE,NA,NA,"Human",NA,"Unspecified","Oral - other",NA,NA,NA,"Duration","eyes/ocular","Both","None",619,"nonneoplastic histopathology","Both","Dichotomous","Cataract formation",NA,NA,NA,NA,NA,"Over 100 anecdotal cases of cataracts resulting from therapeutic use of 2,4- dinitrophenol were reviewed. The length of time and amount of drug taken varied among the population.  Cataracts were observed in patients receiving as little as 2 mg/kg/day, the lower range of the recommended therapeutic dose.",NA,NA,NA,NA,NA,NA,NA,NA
"11",80,"2,4-Dinitrotoluene","121142","C7H6N2O4","CalEPA","Oral Slope Factor (1/mg/kg-day)",0.31,NA,NA,"http://www.oehha.ca.gov/air/hot_spots/2009/AppendixB.pdf","6/1/2009","Lee CC, Ellis HV, Kowalski JJ, Hodgson JR, Short RD, Jagdis BC, Reddig TW and Minor JL. 1978. Mammalian toxicity of munition compounds. Phase II. Effects of multiple doses and Phase III. Effects of lifetime exposure. Part II. 2,4-Dinitrotoluene. US Army Medical Bioengineering Research and Development Laboratory. Contract No. DAMD-17-74-C-4073. Midwest Research Institute, Kansas City, MO. NTIS ADA 061715.

US Environmental Protection Agency (US EPA). May, 1987. Health Effects Assessment for 2,4- and 2,6-Dinitrotoluene. Prepared by the Environmental Criteria and Assessment Office. Office of Health and Environmental Assessment. Office of Research and Development. Cincinnati, OH 45268. EPA/600/8-88/032.",NA,NA,NA,"10% ER","combined liver and mamary gland tumors","NA","None","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Rat","CD","M/F","Oral diet",NA,NA,"720","Days","combined","Both","None",2670,"neoplasia","F","Dichotomous","combined liver and mamary gland tumors",NA,"ppm",NA,"mg/kg/day",NA,NA,NA,0,0,NA,31,11,NA,NA
"12",80,"2,4-Dinitrotoluene","121142","C7H6N2O4","ATSDR","Chronic Oral MRL (mg/kg/day)",0.002,1,NA,"http://www.atsdr.cdc.gov/ToxProfiles/tp109.pdf","12/1998","Ellis HV, Hagensen JH, Hodgson JR, et al. 1979. Mammalian toxicity of munitions compounds. Phase BI:
Effects of lifetime exposure. Part I. 2,4-Dinitrotoluene. Final report no. 7. Midwest Research Institute,
Kansas City, MO. Contract no. DAMD 17-74-C-4073, ADA077 692.
Ellis HV, Hong CB, Lee CC, et al. 1985. Subchronic and chronic toxicity studies of 2,4-dinitrotoluene.
Part I. Beagle dog. J Am Co11 Toxicol 4:233-242.","NOAEL",0.2,"mg/kg","NA","hematological effects","NA","None","None","No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral - other",NA,NA,"24","Months","blood","Both","MOA Determination",4429,"hematology","Both","Continuous","Hematological effects: Heinz bodies and methemoglobinemia",NA,NA,NA,NA,NA,"Individual animal data were reported in the primary reference (Ellis et al. 1979, Table 2, page 31).  Group means and SDs were not given.",NA,NA,NA,NA,NA,NA,NA,NA
"13",80,"2,4-Dinitrotoluene","121142","C7H6N2O4","IRIS","RfD (mg/kg/day)",0.002,1,1993-02-01,"http://www.epa.gov/iris/subst/0524.htm","2/1/1993","Ellis, H.V., C.B. Hong, C.C. Lee, J.C. Dacre and J.P. Glennon. 1985. Subchronic and chronic toxicity studies of 2,4-dinitrotoluene. Part I. Beagle dogs. J. Am. College Toxicol. 4(4): 233-242.","NOAEL",0.2,"mg/kg/day","NA","Neurotoxicity, Heinz bodies and biliary tract hyperplasia","No","None","None","Yes",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral - other",NA,NA,"2","Years","CNS","Both","None",477,"neurobehavior","Both","Dichotomous","Neurotoxicity",NA,"mg/kg/day",NA,NA,NA,"2,4-DNT was administered daily in gelatin capsules; dose-response data are from the primary report.",NA,0,NA,NA,12,0,NA,NA
"14",80,"2,4-Dinitrotoluene","121142","C7H6N2O4","IRIS","RfD (mg/kg/day)",0.002,1,1993-02-01,"http://www.epa.gov/iris/subst/0524.htm","2/1/1993","Ellis, H.V., C.B. Hong, C.C. Lee, J.C. Dacre and J.P. Glennon. 1985. Subchronic and chronic toxicity studies of 2,4-dinitrotoluene. Part I. Beagle dogs. J. Am. College Toxicol. 4(4): 233-242.","NOAEL",0.2,"mg/kg/day","NA","Neurotoxicity, Heinz bodies and biliary tract hyperplasia","No","None","None","Yes",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral - other",NA,NA,"2","Years","blood","Both","None",2152,"hematology","F",NA,"Heinz bodies","SE","mg/kg/day","%",NA,NA,"2,4-DNT was administered daily in gelatin capsules; dose-response data following 2 years of exposure were not reported, data below are measurements taken after 3 months of exposure (from Table 2 of the primary report).",NA,0,NA,NA,6,NA,0,0
"15",80,"2,4-Dinitrotoluene","121142","C7H6N2O4","CalEPA","Inhalation Unit Risk (1/μg/m3)",8.9e-05,NA,NA,"http://www.oehha.ca.gov/air/hot_spots/2009/AppendixB.pdf","6/1/2009","Lee CC, Ellis HV, Kowalski JJ, Hodgson JR, Short RD, Jagdis BC, Reddig TW and Minor JL. 1978. Mammalian toxicity of munition compounds. Phase II. Effects of multiple doses and Phase III. Effects of lifetime exposure. Part II. 2,4-Dinitrotoluene. US Army Medical Bioengineering Research and Development Laboratory. Contract No. DAMD-17-74-C-4073. Midwest Research Institute, Kansas City, MO. NTIS ADA 061715.

US Environmental Protection Agency (US EPA). May, 1987. Health Effects Assessment for 2,4- and 2,6-Dinitrotoluene. Prepared by the Environmental Criteria and Assessment Office. Office of Health and Environmental Assessment. Office of Research and Development. Cincinnati, OH 45268. EPA/600/8-88/032.",NA,NA,NA,"10% ER","combined liver and mamary gland tumors","NA","Simple","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Rat","CD","M/F","Oral diet",NA,NA,"720","Days","combined","Both","None",2673,"neoplasia","F","Dichotomous","combined liver and mamary gland tumors",NA,NA,NA,NA,NA,"IUR was calculated from the cancer slope factor (see accompanying record) using an assumed human breathing rate of 20 m3/day, 70 kg human body weight, and 100% fractional absorption after inhalation exposure.",NA,NA,NA,NA,NA,NA,NA,NA
"16",80,"2,4-Dinitrotoluene","121142","C7H6N2O4","IRIS","RfD (mg/kg/day)",0.002,1,1993-02-01,"http://www.epa.gov/iris/subst/0524.htm","2/1/1993","Ellis, H.V., C.B. Hong, C.C. Lee, J.C. Dacre and J.P. Glennon. 1985. Subchronic and chronic toxicity studies of 2,4-dinitrotoluene. Part I. Beagle dogs. J. Am. College Toxicol. 4(4): 233-242.","NOAEL",0.2,"mg/kg/day","NA","Neurotoxicity, Heinz bodies and biliary tract hyperplasia","No","None","None","Yes",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral - other",NA,NA,"2","Years","blood","Both","None",432,"hematology","M","Continuous","Heinz bodies","SE","mg/kg/day","%",NA,NA,"2,4-DNT was administered daily in gelatin capsules; dose-response data following 2 years of exposure were not reported, data below are measurements taken after 3 months of exposure (from Table 2 of the primary report).",NA,0,NA,NA,6,NA,0,0
"17",80,"2,4-Dinitrotoluene","121142","C7H6N2O4","IRIS","RfD (mg/kg/day)",0.002,1,1993-02-01,"http://www.epa.gov/iris/subst/0524.htm","2/1/1993","Ellis, H.V., C.B. Hong, C.C. Lee, J.C. Dacre and J.P. Glennon. 1985. Subchronic and chronic toxicity studies of 2,4-dinitrotoluene. Part I. Beagle dogs. J. Am. College Toxicol. 4(4): 233-242.","NOAEL",0.2,"mg/kg/day","NA","Neurotoxicity, Heinz bodies and biliary tract hyperplasia","No","None","None","Yes",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral - other",NA,NA,"2","Years","CNS","Both","None",478,"nonneoplastic histopathology","Both","Dichotomous","Neurotoxicity",NA,NA,NA,NA,NA,"2,4-DNT was administered daily in gelatin capsules and lesions including gliosis, edema, and demyelination of the cerebellum, spinal cord, and brain stem were observed.  Incidence not provided in primary reporte.",NA,NA,NA,NA,NA,NA,NA,NA
"18",80,"2,4-Dinitrotoluene","121142","C7H6N2O4","IRIS","RfD (mg/kg/day)",0.002,1,1993-02-01,"http://www.epa.gov/iris/subst/0524.htm","2/1/1993","Ellis, H.V., C.B. Hong, C.C. Lee, J.C. Dacre and J.P. Glennon. 1985. Subchronic and chronic toxicity studies of 2,4-dinitrotoluene. Part I. Beagle dogs. J. Am. College Toxicol. 4(4): 233-242.","NOAEL",0.2,"mg/kg/day","NA","Neurotoxicity, Heinz bodies and biliary tract hyperplasia","No","None","None","Yes",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral - other",NA,NA,"2","Years","liver","Both","None",431,"nonneoplastic histopathology","Both","Dichotomous","biliary tract hyperplasia",NA,NA,NA,NA,NA,"2,4-DNT was administered daily in gelatin capsules",NA,NA,NA,NA,NA,NA,NA,NA
"19",80,"2,4-Dinitrotoluene","121142","C7H6N2O4","IRIS","RfD (mg/kg/day)",0.002,1,1993-02-01,"http://www.epa.gov/iris/subst/0524.htm","2/1/1993","Ellis, H.V., C.B. Hong, C.C. Lee, J.C. Dacre and J.P. Glennon. 1985. Subchronic and chronic toxicity studies of 2,4-dinitrotoluene. Part I. Beagle dogs. J. Am. College Toxicol. 4(4): 233-242.","NOAEL",0.2,"mg/kg/day","NA","Neurotoxicity, Heinz bodies and biliary tract hyperplasia","No","None","None","Yes",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral - other",NA,NA,"2","Years","liver","Both","None",431,"nonneoplastic histopathology","Both","Dichotomous","biliary tract hyperplasia",NA,NA,NA,NA,NA,"2,4-DNT was administered daily in gelatin capsules.  Primary report states that ""most dogs given 10 mg/kg/day and some dogs given 1.5 mg/kg/day in the chronic study had hyperplasia of the biliary tract."" Incidence data were not reported.",NA,NA,NA,NA,NA,NA,NA,NA
"20",465,"Acenaphthene","83329","C12H10","IRIS","RfD (mg/kg/day)",0.06,0.97,1994-04-01,"http://www.epa.gov/iris/subst/0442.htm","4/1/1994","U.S. EPA. 1989. Mouse oral subchronic study with acenaphthene. Study conducted by Hazelton Laboratories, Inc., for the Office of Solid Waste, Washington, DC.","NOAEL",175,"mg/kg/day","NA","Hepatotoxicity","No","None","None","No",3000,10,10,10,NA,3,NA,TRUE,NA,NA,"Mouse","CD-1","M/F","Oral gavage",NA,7,"90","Days","liver","Both","None",1256,"nonneoplastic histopathology","M","Dichotomous","Hepatotoxicity; hepatocellular hypertrophy",NA,"mg/kg-day",NA,NA,NA,"Minimal or slight",NA,0,NA,NA,20,2,NA,NA
"21",465,"Acenaphthene","83329","C12H10","IRIS","RfD (mg/kg/day)",0.06,0.97,1994-04-01,"http://www.epa.gov/iris/subst/0442.htm","4/1/1994","U.S. EPA. 1989. Mouse oral subchronic study with acenaphthene. Study conducted by Hazelton Laboratories, Inc., for the Office of Solid Waste, Washington, DC.","NOAEL",175,"mg/kg/day","NA","Hepatotoxicity","No","None","None","No",3000,10,10,10,NA,3,NA,TRUE,NA,NA,"Mouse","CD-1","M/F","Oral gavage",NA,7,"90","Days","liver","Both","None",4051,"nonneoplastic histopathology","F","Dichotomous","Hepatotoxicity; hepatocellular hypertrophy",NA,"mg/kg-day",NA,NA,NA,"Minimal or slight",NA,0,NA,NA,20,0,NA,NA
"22",211,"Aldrin","309002","C12H8Cl6","CalEPA","Oral Slope Factor (mg/kg-day)-1",17,NA,NA,"http://oehha.ca.gov/risk/ChemicalDB/index.asp","1993","NCI (National Cancer Institute). 1978. Bioassays of aldrin and dieldrin for possible carcinogenicity. DHE",NA,NA,NA,NA,"liver carcinoma",NA,NA,NA,"Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Oral diet",NA,NA,"80","Weeks","liver","M","None",2761,"neoplasia","M","Dichotomous","liver carcinoma",NA,"ppm",NA,NA,"mg/kg-day",NA,NA,0,NA,0,20,3,NA,NA
"23",211,"Aldrin","309002","C12H8Cl6","CalEPA","Oral Slope Factor (mg/kg-day)-1",17,NA,NA,"http://oehha.ca.gov/risk/ChemicalDB/index.asp","1993","Davis, K.J. 1965. Pathology report on mice fed dieldrin, aldrin, heptachlor, or heptachlor epoxide for two years. Internal FDA memorandum to Dr. A.J. Lehrman, July 19.

NCI (National Cancer Institute). 1978. Bioassays of aldrin and dieldrin for possible
carcinogenicity. DHE",NA,NA,NA,"Other","liver carcinoma","No","None","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","C3H","M/F","Oral diet",NA,NA,"2","Years","liver","Both","None",4381,"neoplasia","M","Dichotomous","liver carcinoma",NA,"ppm",NA,NA,"mg/kg/day",NA,NA,0,NA,0,73,22,NA,NA
"24",211,"Aldrin","309002","C12H8Cl6","CalEPA","Oral Slope Factor (mg/kg-day)-1",17,NA,NA,"http://oehha.ca.gov/risk/ChemicalDB/index.asp","1993","Davis, K.J. 1965. Pathology report on mice fed dieldrin, aldrin, heptachlor, or heptachlor epoxide for two years. Internal FDA memorandum to Dr. A.J. Lehrman, July 19.

NCI (National Cancer Institute). 1978. Bioassays of aldrin and dieldrin for possible
carcinogenicity. DHE",NA,NA,NA,"Other","liver carcinoma","No","None","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","C3H","M/F","Oral diet",NA,NA,"2","Years","liver","Both","None",2754,"neoplasia","F","Dichotomous","liver carcinoma",NA,"ppm",NA,NA,"mg/kg-day","From USEPA IRIS database, 1988",NA,0,NA,0,53,2,NA,NA
"25",211,"Aldrin","309002","C12H8Cl6","ATSDR","Chronic Oral MRL (mg/kg/day)",3e-05,0.83,NA,"http://www.atsdr.cdc.gov/ToxProfiles/tp1.pdf","9/2002","Fitzhugh OG, Nelson AA, Quaife ML. 1964. Chronic oral toxicity of aldrin and dieldrin in rats and dogs. Food Cosmet Toxicol 2:551-562.","LOAEL",0.025,"mg/kg/day","NA","enlarged hepatocyte, increase in cytoplasmic eosinophilia with peripheral migration of basophilic granules, and possible increases in vacuolation and bile duct proliferation","No","None","None","No",1000,10,10,NA,10,NA,NA,TRUE,NA,NA,"Rat","Osborne-Mendel","M/F","Oral diet",NA,NA,"2","Years","liver","Both","None",4408,"nonneoplastic histopathology","Both","Dichotomous","enlarged hepatocyte, increase in cytoplasmic eosinophilia with peripheral migration of basophilic granules, and possible increases in vacuolation and bile duct proliferation",NA,NA,NA,NA,NA,"Based on same study and endpoint as IRIS RfD (see IRIS RfD record)",NA,NA,NA,NA,NA,NA,NA,NA
"26",211,"Aldrin","309002","C12H8Cl6","IRIS","RfD (mg/kg/day)",3e-05,0.83,1988-03-01,"http://www.epa.gov/iris/subst/0130.htm","3/1/1988","Fitzhugh, O.G., A.A. Nelson, and M.L. Quaife. 1964. Chronic oral toxicity of aldrin and dieldrin in rats and dogs. Food Cosmet. Toxicol. 2: 551-562.","LOAEL",0.025,"mg/kg/day",NA,"Liver toxicity","No","None","None","No",1000,10,10,NA,10,NA,NA,TRUE,NA,NA,"Rat",NA,"M/F","Oral diet",NA,NA,"2","Years","liver","Both","None",144,"nonneoplastic histopathology","Both","Dichotomous","Liver toxicity",NA,"ppm",NA,NA,NA,"Microscopic liver changes primarily characterized by enlarged centrilobular hepatic cells, with increased cytoplasmic oxyphilia, and perpheral migration of basophilic granules; sum of incidences across all severity categories; severity increased with dose",NA,0,NA,NA,17,1,NA,NA
"27",211,"Aldrin","309002","C12H8Cl6","IRIS","Oral Slope Factor (1/mg/kg-day)",17,NA,1993-07-01,"http://www.epa.gov/iris/subst/0130.htm","7/1/1993","Davis, K.J. 1965. Pathology report on mice fed dieldrin, aldrin, heptachlor, or heptachlor epoxide for two years. Internal FDA memorandum to Dr. A.J. Lehrman, July 19.",NA,NA,NA,"Other","liver carcinoma","No","None","NA","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","C3H","M/F","Oral diet",NA,NA,"2","Years","liver","Both","MOA Data",148,"neoplasia","F","Dichotomous","liver carcinoma",NA,"ppm",NA,NA,"mg/kg-day","Incidence data referenced in source as ""Davis, 1965 reevaluated by Reuber (cited in Epstein, 1975).",NA,0,NA,0,53,2,NA,NA
"28",211,"Aldrin","309002","C12H8Cl6","IRIS","Oral Slope Factor (1/mg/kg-day)",17,NA,1993-07-01,"http://www.epa.gov/iris/subst/0130.htm","7/1/1993","Davis, K.J. 1965. Pathology report on mice fed dieldrin, aldrin, heptachlor, or heptachlor epoxide for two years. Internal FDA memorandum to Dr. A.J. Lehrman, July 19.",NA,NA,NA,"Other","liver carcinoma","No","None","NA","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","C3H","M/F","Oral diet",NA,NA,"2","Years","liver","Both","MOA Data",148,"neoplasia","F","Continuous","liver carcinoma: incidence in Davis 1965",NA,"ppm",NA,NA,"mg/kg-day",NA,NA,0,NA,0,53,2,NA,NA
"29",211,"Aldrin","309002","C12H8Cl6","IRIS","Oral Slope Factor (1/mg/kg-day)",17,NA,1993-07-01,"http://www.epa.gov/iris/subst/0130.htm","7/1/1993","Davis, K.J. 1965. Pathology report on mice fed dieldrin, aldrin, heptachlor, or heptachlor epoxide for two years. Internal FDA memorandum to Dr. A.J. Lehrman, July 19.",NA,NA,NA,"Other","liver carcinoma","No","None","NA","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","C3H","M/F","Oral diet",NA,NA,"2","Years","liver","Both","MOA Data",4063,"neoplasia","M","Dichotomous","liver carcinoma: incidence in NCI 1978",NA,"ppm",NA,NA,"mg/kg-day",NA,NA,0,NA,0,20,3,NA,NA
"30",211,"Aldrin","309002","C12H8Cl6","IRIS","Oral Slope Factor (1/mg/kg-day)",17,NA,1993-07-01,"http://www.epa.gov/iris/subst/0130.htm","7/1/1993","Davis, K.J. 1965. Pathology report on mice fed dieldrin, aldrin, heptachlor, or heptachlor epoxide for two years. Internal FDA memorandum to Dr. A.J. Lehrman, July 19.",NA,NA,NA,"Other","liver carcinoma","No","None","NA","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","C3H","M/F","Oral diet",NA,NA,"2","Years","liver","Both","MOA Data",149,"neoplasia","M","Dichotomous","liver carcinoma",NA,"ppm",NA,NA,"mg/kg-day","Incidence data referenced in source as ""Davis, 1965 reevaluated by Reuber (cited in Epstein, 1975).",NA,0,NA,0,73,22,NA,NA
"31",211,"Aldrin","309002","C12H8Cl6","IRIS","Oral Slope Factor (1/mg/kg-day)",17,NA,1993-07-01,"http://www.epa.gov/iris/subst/0130.htm","7/1/1993","Davis, K.J. 1965. Pathology report on mice fed dieldrin, aldrin, heptachlor, or heptachlor epoxide for two years. Internal FDA memorandum to Dr. A.J. Lehrman, July 19.",NA,NA,NA,"Other","liver carcinoma","No","None","NA","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","C3H","M/F","Oral diet",NA,NA,"2","Years","liver","Both","MOA Data",149,"neoplasia","M","Continuous","liver carcinoma: incidence in Davis 1965",NA,NA,NA,NA,"mg/kg/day",NA,NA,0,NA,0,NA,NA,73,22
"32",211,"Aldrin","309002","C12H8Cl6","IRIS","Oral Slope Factor (1/mg/kg-day)",17,NA,1993-07-01,"http://www.epa.gov/iris/subst/0130.htm","7/1/1993","NCI (National Cancer Institute). 1978. Bioassays of aldrin and dieldrin for possible carcinogenicity. DHEW Publication No. (NIH) 78-821. NCI Carcinogenesis Tech. Rep. Ser. No. 21. NCI-C6-TR-21.",NA,NA,NA,"Other","liver carcinoma","No","None","NA","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Oral diet",NA,NA,"80","Weeks","liver","M","MOA Data",152,"neoplasia","M","Dichotomous","liver carcinoma",NA,"ppm",NA,NA,"mg/kg-day",NA,NA,0,NA,0,20,3,NA,NA
"33",211,"Aldrin","309002","C12H8Cl6","IRIS","RfD (mg/kg/day)",3e-05,0.83,1988-03-01,"http://www.epa.gov/iris/subst/0130.htm","3/1/1988","Fitzhugh, O.G., A.A. Nelson, and M.L. Quaife. 1964. Chronic oral toxicity of aldrin and dieldrin in rats and dogs. Food Cosmet. Toxicol. 2: 551-562.","LOAEL",0.025,"mg/kg/day",NA,"Liver toxicity","No","None","None","No",1000,10,10,NA,10,NA,NA,TRUE,NA,NA,"Rat",NA,"M/F","Oral diet",NA,NA,"2","Years","liver","Both","None",144,"nonneoplastic histopathology","Both","Dichotomous","Liver toxicity (liver lesions were characterized by enlarged centrilobular hepatic cells, with increased cytoplasmic oxyphilia, and peripheral migration of basophilic granules)",NA,"ppm",NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA
"34",211,"Aldrin","309002","C12H8Cl6","IRIS","Inhalation Unit Risk (1/μg/m3)",0.0049,NA,1993-07-01,"http://www.epa.gov/iris/subst/0130.htm","7/1/1993","Davis, K.J. 1965. Pathology report on mice fed dieldrin, aldrin, heptachlor, or heptachlor epoxide for two years. Internal FDA memorandum to Dr. A.J. Lehrman, July 19.",NA,NA,NA,NA,"Liver carcinomas (unit risk was calculated from the oral data used to derive the OSF).",NA,"Other",NA,"Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","C3H","M/F","Oral diet",NA,NA,"2","Years","liver","Both","MOA Data",1383,"neoplasia","Both",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"35",211,"Aldrin","309002","C12H8Cl6","IRIS","Inhalation Unit Risk (1/μg/m3)",0.0049,NA,1993-07-01,"http://www.epa.gov/iris/subst/0130.htm","7/1/1993","NCI (National Cancer Institute). 1978. Bioassays of aldrin and dieldrin for possible carcinogenicity. DHEW Publication No. (NIH) 78-821. NCI Carcinogenesis Tech. Rep. Ser. No. 21. NCI-C6-TR-21.",NA,NA,NA,"Other","Liver carcinomas (unit risk was calculated from the oral data used to derive the OSF).",NA,"Other",NA,"Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Oral diet",NA,NA,"80","Weeks","liver","Both","MOA Data",1388,"neoplasia","M",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"36",211,"Aldrin","309002","C12H8Cl6","IRIS","RfD (mg/kg/day)",3e-05,0.83,1988-03-01,"http://www.epa.gov/iris/subst/0130.htm","3/1/1988","Fitzhugh, O.G., A.A. Nelson, and M.L. Quaife. 1964. Chronic oral toxicity of aldrin and dieldrin in rats and dogs. Food Cosmet. Toxicol. 2: 551-562.","LOAEL",0.025,"mg/kg/day",NA,"Liver toxicity","No","None","None","No",1000,10,10,NA,10,NA,NA,TRUE,NA,NA,"Rat",NA,"M/F","Oral diet",NA,NA,"2","Years","liver","Both","None",145,"organ weight","Both","Continuous","Liver toxicity (increased liver-to-body weight ratio)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"37",211,"Aldrin","309002","C12H8Cl6","IRIS","RfD (mg/kg/day)",3e-05,0.83,1988-03-01,"http://www.epa.gov/iris/subst/0130.htm","3/1/1988","Fitzhugh, O.G., A.A. Nelson, and M.L. Quaife. 1964. Chronic oral toxicity of aldrin and dieldrin in rats and dogs. Food Cosmet. Toxicol. 2: 551-562.","LOAEL",0.025,"mg/kg/day",NA,"Liver toxicity","No","None","None","No",1000,10,10,NA,10,NA,NA,TRUE,NA,NA,"Rat",NA,"M/F","Oral diet",NA,NA,"2","Years","liver","Both","None",145,"organ weight","Both","Dichotomous",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"38",495,"Benzidine","92875","C12H12N2","IRIS","RfD (mg/kg/day)",0.003,0.9,1995-02-01,"http://www.epa.gov/iris/subst/0135.htm","2/1/1995","Littlefield, N.A., C.J. Nelson and C.H. Frith. 1983. Benzidine dihydrochloride: Toxicological assessments in mice during chronic exposures. J. Toxicol. Environ. Health. 12: 671-685.","LOAEL",2.7,"mg/kg/day","NA","Brain cell vacuolization; liver cell alterations in females","No","None","None","Yes",1000,10,10,NA,10,NA,NA,TRUE,NA,NA,"Mouse","C57/B1","M/F","Oral drinking water",NA,NA,"33","Months","liver","Both","None",2526,"nonneoplastic histopathology","M","Dichotomous","liver cell alterations (MC strain)",NA,"ppm",NA,NA,NA,"72-120 mice per group",NA,0,NA,NA,NA,1,NA,NA
"39",495,"Benzidine","92875","C12H12N2","IRIS","RfD (mg/kg/day)",0.003,0.9,1995-02-01,"http://www.epa.gov/iris/subst/0135.htm","2/1/1995","Littlefield, N.A., C.J. Nelson and C.H. Frith. 1983. Benzidine dihydrochloride: Toxicological assessments in mice during chronic exposures. J. Toxicol. Environ. Health. 12: 671-685.","LOAEL",2.7,"mg/kg/day","NA","Brain cell vacuolization; liver cell alterations in females","No","None","None","Yes",1000,10,10,NA,10,NA,NA,TRUE,NA,NA,"Mouse","C57/B1","M/F","Oral drinking water",NA,NA,"33","Months","liver","Both","None",2524,"nonneoplastic histopathology","F","Dichotomous","liver cell alterations (F1 strain)",NA,"ppm",NA,NA,NA,"72-120 mice per group",NA,0,NA,NA,NA,2,NA,NA
"40",495,"Benzidine","92875","C12H12N2","IRIS","RfD (mg/kg/day)",0.003,0.9,1995-02-01,"http://www.epa.gov/iris/subst/0135.htm","2/1/1995","Littlefield, N.A., C.J. Nelson and C.H. Frith. 1983. Benzidine dihydrochloride: Toxicological assessments in mice during chronic exposures. J. Toxicol. Environ. Health. 12: 671-685.","LOAEL",2.7,"mg/kg/day","NA","Brain cell vacuolization; liver cell alterations in females","No","None","None","Yes",1000,10,10,NA,10,NA,NA,TRUE,NA,NA,"Mouse","C57/B1","M/F","Oral drinking water",NA,NA,"33","Months","brain","Both","None",2523,"nonneoplastic histopathology","F","Dichotomous","Brain cell vacuolization (MC strain)",NA,"ppm",NA,NA,NA,"72-120 mice per group",NA,0,NA,NA,NA,1,NA,NA
"41",495,"Benzidine","92875","C12H12N2","IRIS","Inhalation Unit Risk (1/μg/m3)",0.067,NA,1993-07-01,"http://www.epa.gov/iris/subst/0135.htm","7/1/1993","Zavon, M.R. 1973. Benzidine exposure as a cause of bladder tumors. Arch. Environ. Health. 27: 1-7.",NA,NA,NA,NA,"bladder tumors","Yes","None","NA","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Human",NA,"M","Inhalation",NA,NA,"<13","Years","bladder","Both","None",1445,"neoplasia","M","Dichotomous","bladder tumors",NA,NA,NA,NA,NA,"The slope factor (B) was calculated using the model  P = 1-exp [-Bdt **3] or
 B = [-ln (1-13/25)] / [0.0063 x (56.5/71.3) **3] = 234.13 per mg/kg-day where:  13/25 = observed bladder tumor incidence; 0.0063 mg/kg/day = daily lifetime exposure calculated from a mean urine benzidine level of 0.04 mg/L at the end of workshift, 1.2 L/day average urine output, a 1.45% recovery factor in urine, 70 kg bw, 240 work days/ year, 11.46 average exposure duration, and 56.5 years average cohort age at the end of the study; and 71.3 years = average life span in U.S.",NA,NA,NA,NA,NA,NA,NA,NA
"42",495,"Benzidine","92875","C12H12N2","IRIS","Oral Slope Factor (1/mg/kg-day)",230,NA,1993-07-01,"http://www.epa.gov/iris/subst/0135.htm","7/1/1993","Zavon, M.R. 1973. Benzidine exposure as a cause of bladder tumors. Arch. Environ. Health. 27: 1-7.",NA,NA,NA,"NA","bladder tumors","NA","Other","NA","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Human","C57/B1","M","Inhalation",NA,NA,"<13","Years","bladder","Both","None",2522,"neoplasia","Both",NA,"bladder tumors",NA,NA,NA,NA,NA,"The oral risk estimates were calculated from the inhalation exposure data",NA,NA,NA,NA,NA,NA,NA,NA
"43",495,"Benzidine","92875","C12H12N2","CalEPA","Oral Slope Factor (mg/kg-day)-1",500,NA,NA,"http://www.oehha.ca.gov/air/hot_spots/2009/AppendixB.pdf","1988","Zavon MR, Hoegg U and Bingham E. 1973. Benzidine exposure as a cause of bladder tumors. Arch Environ Health 27:1-7.

Allen RC, Ship AM, Crump KS, et al. 1987. Investigation of Cancer Risk Assessment Methods: Vol. 1. Introduction and Epidemiology. Office of Health and Carcinoma Assessment, EPA, Washington DC, EPA/600/6-87/0516 (NHS PB88-127113).

US Environmental Protection Agency (US EPA). 1986. Health and Environmental Effects Profile for Benzidine. EPA/600/8-86/157. NHS PB88-219431. Environmental Assessment Office of Research and Development, Cincinnati, OH.

US Environmental Protection Agency (US EPA). 1987. Health Effects Assessment for Benzidine. EPA/600/8-88/019. Prepared by the Office of Health and Environmental Assessment for the Office of Research and Development, Cincinnati, OH.

US Environmental Protection Agency (US EPA). 1988. Integrated Risk Information System: Benzidine. EPA Environmental Criteria and Assessment Office, Cincinnati, OH.",NA,NA,NA,"10% ER","bladder and kidney tumors","Yes","Other","NA","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Human",NA,"Unspecified","Inhalation",8,5,"3-28","Years","combined","Both","None",2803,"neoplasia","Both",NA,"bladder and kidney tumors",NA,NA,NA,NA,NA,"Exposure levels were established using the daily urine concentration estimation of 0.023 mg/l (Allen et al 1987).  Assuming 1.5 L/day urinary output, 70 kg body weight, 240 work days per year, and average duration of exposure 11.46 yrs in a cohort of 56.5 yrs average age, lifetime average exposure is 0.0044 mg/kg-day. Using the US EPA (1986, 1987, 1988) methodology and the upper 95% confidence bound on incidence [p(t) = 0.68], the cancer potency is 5.0 E+2 (mg/kg-day)-1.",NA,NA,NA,NA,NA,NA,NA,NA
"44",495,"Benzidine","92875","C12H12N2","IRIS","RfD (mg/kg/day)",0.003,0.9,1995-02-01,"http://www.epa.gov/iris/subst/0135.htm","2/1/1995","Littlefield, N.A., C.J. Nelson and C.H. Frith. 1983. Benzidine dihydrochloride: Toxicological assessments in mice during chronic exposures. J. Toxicol. Environ. Health. 12: 671-685.","LOAEL",2.7,"mg/kg/day","NA","Brain cell vacuolization; liver cell alterations in females","No","None","None","Yes",1000,10,10,NA,10,NA,NA,TRUE,NA,NA,"Mouse","C57/B1","M/F","Oral drinking water",NA,NA,"33","Months","brain","Both","None",1444,"nonneoplastic histopathology","F","Dichotomous","Brain cell vacuolization (F1 strain)",NA,NA,NA,NA,NA,"Primary reference gives percentage of mice affected but not number of mice surviving or evaluated for this endpoint; data not entered in database.",NA,NA,NA,NA,NA,NA,NA,NA
"45",176,"Benzo(b)Fluoranthene","205992","C20H12","CalEPA","Inhalation Unit Risk (1/μg/m3)",0.00011,NA,NA,"http://www.oehha.ca.gov/air/hot_spots/2009/AppendixB.pdf","1993","Thyssen J, Althoff J, Kimmerle G and Mohr U. 1981. Inhalation studies with benzo[a]pyrene in Syrian Golden hamsters. JNCI 66:575-577.

U.S. Environmental Protection Agency (US EPA). 1984. Health Effects Assessment for Benzo[a]pyrene. EPA 540/1-86-022. Environmental Criteria and Assessment Office, Cincinnati, OH.",NA,NA,NA,"10% ER","respiratory tract tumors","Yes","None","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,"benzo(a)pyrene","Hamster","Golden Syrian","M","Inhalation",NA,NA,"96","Weeks","tracheobronchial","Both","MOA Evaluation",2575,"neoplasia","Both","Dichotomous","respiratory tract tumors",NA,NA,NA,NA,NA,"Inhalation unit risk was extrapolated from BaP inhalation study (see BaP database entry for dose-response data and methodology) using a potency equivalency factor of 0.1.",NA,NA,NA,NA,NA,NA,NA,NA
"46",176,"Benzo(b)Fluoranthene","205992","C20H12","CalEPA","Oral Slope Factor (mg/kg-day)-1",1.2,NA,NA,"http://www.oehha.ca.gov/air/hot_spots/2009/AppendixB.pdf","1993","Neal J and Rigdon RH. 1967. Gastric tumors in mice fed benzo[a]pyrene: a quantitative study. Texas Reports Biol Med 25:553-557.

U.S. Environmental Protection Agency (US EPA). 1984. Health Effects Assessment for Benzo[a]pyrene. EPA 540/1-86-022. Environmental Criteria and Assessment Office, Cincinnati, OH.",NA,NA,NA,"10% ER","gastric tumors","NA","None","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,"benzo(a)pyrene","Mouse","CFW","M/F","Oral diet",NA,NA,"4-6","Months","stomach/forestomach","Both","MOA Evaluation",2576,"neoplasia","Both","Dichotomous","gastric tumors",NA,NA,NA,NA,NA,"Oral slope factor was extrapolated from BaP feeding study (see BaP database entry for dose-response data and methodology) using a potency equivalency factor of 0.1.",NA,NA,NA,NA,NA,NA,NA,NA
"47",71,"Bis(2-Ethylhexyl)Phthalate","117817","C24H38O4","CalEPA","Oral Slope Factor (mg/kg-day)-1",0.0084,NA,NA,"http://www.oehha.ca.gov/air/hot_spots/2009/AppendixB.pdf","1988","National Toxicology Program (NTP). 1982. Carcinogenesis bioassay of di-(2-ethylhexyl)phthalate (CAS No. 117-81-7) in F344 rats and B6C3F1 mice (feed study). NTP Tech Rep Ser TR No. 217, NTP, Research Triangle Park, NC.

US Environmental Protection Agency (US EPA). 1987. Health and environmental effects profile for phthalilc acid alkyl, aryl and alkyl/aryl esters. Draft document dated September 1987. ECAO/OHEA, US EPA, Cincinnati, OH.",NA,NA,NA,"10% ER","hepatocellular carcinoma","NA","None","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Oral diet",NA,NA,"103","Weeks","liver","Both","None",2823,"neoplasia","M","Dichotomous","hepatocellular carcinoma",NA,"ppm diet",NA,"mg/kg/day",NA,"Dose conversions were conducted by the U.S. EPA (1987).",NA,0,0,NA,50,9,NA,NA
"48",71,"Bis(2-Ethylhexyl)Phthalate","117817","C24H38O4","ATSDR","Chronic Oral MRL (mg/kg/day)",0.06,0.97,NA,"http://www.atsdr.cdc.gov/ToxProfiles/tp9.pdf","9/2002","David RM, Moore MR, Finney DC, et al. 2000a. Chronic toxicity of di(2-ethylhexyl)phthalate in rats. Toxicol Sci 55:433-443.","NOAEL",5.8,"mg/kg/day","NA","testicular toxicity","NA","None","None","Yes",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Rat","Fischer 344","M/F","Oral diet",NA,NA,"104","Weeks","male repro","M","MOA Evaluation",3596,"organ weight","M","Dichotomous","bilateral aspermatogenesis",NA,"ppm diet",NA,"mg/kg-day",NA,NA,NA,0,0,NA,64,37,NA,NA
"49",71,"Bis(2-Ethylhexyl)Phthalate","117817","C24H38O4","CalEPA","Inhalation Unit Risk (1/μg/m3)",2.4e-06,NA,NA,"http://www.oehha.ca.gov/air/hot_spots/2009/AppendixB.pdf","1988","National Toxicology Program (NTP). 1982. Carcinogenesis bioassay of di-(2-ethylhexyl)phthalate (CAS No. 117-81-7) in F344 rats and B6C3F1 mice (feed study). NTP Tech Rep Ser TR No. 217, NTP, Research Triangle Park, NC.

US Environmental Protection Agency (US EPA). 1987. Health and environmental effects profile for phthalilc acid alkyl, aryl and alkyl/aryl esters. Draft document dated September 1987. ECAO/OHEA, US EPA, Cincinnati, OH.",NA,NA,NA,"10% ER","hepatocellular carcinoma","NA","Simple","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Oral diet",NA,NA,"103","Weeks","liver","Both","None",2824,"neoplasia","M",NA,NA,NA,NA,NA,NA,NA,"IUR was calculated from the cancer slope factor (see accompanying record) assuming a 70 kg average human body weight, 20 m3/day human breathing rate, and 100% fractional absorption.",NA,NA,NA,NA,NA,NA,NA,NA
"50",71,"Bis(2-Ethylhexyl)Phthalate","117817","C24H38O4","IRIS","RfD (mg/kg/day)",0.02,0.95,1991-05-01,"http://www.epa.gov/iris/subst/0014.htm","5/1/1991","Carpenter, C.P., C.S. Weil and H.F. Smyth. 1953. Chronic oral toxicity of di(2-ethylhexyl)phthalate for rats and guinea pigs. Arch. Indust. Hyg. Occup. Med. 8: 219-226.","LOAEL",19,"mg/kg/day","NA","Increased relative liver weight","No","None","None","No",1000,10,10,10,NA,NA,NA,TRUE,NA,NA,"Other",NA,"M/F","Oral diet",NA,NA,"1","Years","liver","F","None",1619,"organ weight","F",NA,NA,NA,NA,NA,NA,NA,"No incidence data reported in primary source",NA,NA,NA,NA,NA,NA,NA,NA
"51",371,"Cadmium","7440439","Cd","IRIS","RfD (mg/kg/day)",5e-04,1,1994-02-01,"http://www.epa.gov/iris/subst/0141.htm","2/1/1994","U.S. EPA. 1985. Drinking Water Criteria Document on Cadmium. Office of Drinking Water, Washington, DC. (Final draft)","NOAEL",0.005,"mg/kg/day","NA","proteinuria ( estimated from toxicokinetic model)","No","None","NA","No",10,NA,10,NA,NA,NA,NA,TRUE,NA,NA,"Human",NA,NA,"Oral drinking water",NA,NA,NA,"Duration","kidneys","Both","None",1999,"clinical chemistry","Both","Continuous","proteinuria ( estimated from toxicokinetic model)",NA,NA,NA,NA,NA,"Effect level estimated from toxicokinetic model",NA,NA,NA,NA,NA,NA,NA,NA
"52",371,"Cadmium","7440439","Cd","IRIS","Inhalation Unit Risk (1/μg/m3)",0.0018,NA,1992-06-01,"http://www.epa.gov/iris/subst/0141.htm","6/1/1992","Thun, M.J., T.M. Schnorr, A.B. Smith and W.E. Halperin. 1985. Mortality among a cohort of U.S. cadmium production workers: An update. J. Natl. Cancer Inst. 74(2): 325-333.",NA,NA,NA,"Other","lung, trachea, bronchus cancer deaths","Yes","None","None","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Human",NA,"M",NA,NA,NA,NA,"Duration","lung","Both","None",1448,"other","Both","Continuous","lung, trachea, bronchus cancer deaths",NA,NA,NA,"µg/m3 (ADJ)",NA,"concentrations are the 24-hour equivalent (median observation x lE+3 x 8/24 x 1/365 x 240/365)",NA,NA,168,NA,261,2,NA,NA
"53",371,"Cadmium","7440439","Cd","IRIS","Inhalation Unit Risk (1/μg/m3)",0.0018,NA,1992-06-01,"http://www.epa.gov/iris/subst/0141.htm","6/1/1992","Thun, M.J., T.M. Schnorr, A.B. Smith and W.E. Halperin. 1985. Mortality among a cohort of U.S. cadmium production workers: An update. J. Natl. Cancer Inst. 74(2): 325-333.",NA,NA,NA,"Other","lung, trachea, bronchus cancer deaths","Yes","None","None","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Human",NA,"M",NA,NA,NA,NA,"Duration","lung","Both","None",1448,"other","Both","Continuous","lung, trachea, bronchus cancer deaths",NA,NA,NA,"µg/m3 (ADJ)",NA,"concentrations are the 24-hour equivalent (median observation x lE+3 x 8/24 x 1/365 x 240/365)",NA,NA,2522,NA,261,7,NA,NA
"54",371,"Cadmium","7440439","Cd","IRIS","Inhalation Unit Risk (1/μg/m3)",0.0018,NA,1992-06-01,"http://www.epa.gov/iris/subst/0141.htm","6/1/1992","Thun, M.J., T.M. Schnorr, A.B. Smith and W.E. Halperin. 1985. Mortality among a cohort of U.S. cadmium production workers: An update. J. Natl. Cancer Inst. 74(2): 325-333.",NA,NA,NA,"Other","lung, trachea, bronchus cancer deaths","Yes","None","None","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Human",NA,"M",NA,NA,NA,NA,"Duration","lung","Both","None",1448,"other","Both","Continuous","lung, trachea, bronchus cancer deaths",NA,NA,NA,"µg/m3 (ADJ)",NA,"concentrations are the 24-hour equivalent (median observation x lE+3 x 8/24 x 1/365 x 240/365)",NA,NA,727,NA,261,7,NA,NA
"55",371,"Cadmium","7440439","Cd","IRIS","RfD (mg/kg/day)",0.001,1,1994-02-01,"http://www.epa.gov/iris/subst/0141.htm","2/1/1994","U.S. EPA. 1985. Drinking Water Criteria Document on Cadmium. Office of Drinking Water, Washington, DC. (Final draft)","NOAEL",0.01,"mg/kg/day","NA","Significant proteinuria (food; estimated from toxicokinetic model)","No","None","None","No",10,NA,10,NA,NA,NA,NA,TRUE,NA,NA,"Human",NA,NA,"Oral diet",NA,NA,NA,"Duration","kidneys","Both","None",1447,"clinical chemistry","Both","Continuous",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"56",896,"Chlorpyrifos","2921882",NA,"ATSDR","Chronic Oral MRL (mg/kg/day)",0.001,1,NA,"http://www.atsdr.cdc.gov/ToxProfiles/tp84.pdf","9/1997","McCollister SB, Kociba RJ, Humiston CG. et al. 1974. Studies of the acute and long term oral toxicity of chlorpyrifos (O,O diethyl O (3,5,6 trichloro 2 pyridyl) phosphorothioate) Food Cosmet Toxico1 12(1):(45-61).","NOAEL",0.1,"mg/kg/day","NA","Acetylcholinesterase inhibition","No","None","None","No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Rat","Sherman","M/F","Oral diet",NA,NA,"2","Years","PNS","Both","MOA Determination",4000,"neurotransmitter","Both",NA,NA,NA,NA,NA,NA,NA,"Data presented graphically or without variability measure",NA,NA,NA,NA,NA,NA,NA,NA
"57",896,"Chlorpyrifos","2921882",NA,"OPP","Chronic RfD (mg/kg/day)",3e-04,NA,NA,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,2921-88-2",NA,"Primary sources?","NOAEL",0.03,"mgkg-day",NA,"Significant plasma and RBC cholinesterase inhibition (Weight of Evidence from 5 studies: 2 year dog, 90 day dog, 2 year rat, 90 day rat, developmental neurotoxicity rat study)",NA,NA,NA,"No",100,NA,NA,NA,NA,NA,NA,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"58",158,"Chromium(VI) ion","18540299",NA,"IRIS","RfC (mg/m3)",8e-06,NA,1998-09-03,"http://www.epa.gov/iris/subst/0144.htm","9/3/1998","Lindberg, E; Hedensteirna, G. (1983) Chrome plating: Symptoms, finding in the upper airways and effects on lung function. Arch Environ Health 38:367-374.","LOAEL",0.000714,"mg/m3","NA","Nasal septum atrophy 
(Chromic acid mists and dissolved Cr (VI) aerosols)","Yes","None","None","Yes",90,NA,10,3,3,NA,NA,NA,NA,NA,"Human",NA,"M/F","Inhalation",NA,NA,"4.5","Years","nasal passages","Both","None",2035,"other","Both","Dichotomous","Nasal septum atrophy",NA,NA,NA,NA,NA,"Epi data not compatible with dose-response format.  Incidence: 4/19 workers at mean exposures < 0.002 mg/m3; 8/24 at mean exposures of > 0.002 mg/m3; 0/19 in controls.  0.002 mg/m3 exposure converted to continuous equivalent of 0.000714 as follows:  LOAELc = 0.002 mg/m3 x (Mvho/MVh) x 5 days/7 days",NA,NA,NA,NA,NA,NA,NA,NA
"59",158,"Chromium(VI) ion","18540299",NA,"IRIS","RfC (mg/m3)",1e-04,NA,1998-09-03,"http://www.epa.gov/iris/subst/0144.htm","9/3/1998","Glaser, U; Hochrainer, D; Steinhoff, D. (1990) Investigation of irritating properties of inhaled Cr(VI) with possible influence on its carcinogenic action. In: Environmental Hygiene II. Seemayer, NO; Hadnagy, W, eds. Berlin/New York: Springer-Verlag.

Malsch, PA; Proctor, DM; Finley, BL. (1994) Estimation of a chromium inhalation reference concentration using the benchmark dose method: a case study. Regul Toxicol Pharmacol 20:58-82.","BMC",0.034,"mg/m3","10% ER","Lactate dehydrogenase in bronchioalveolar lavage fluid 
(Cr(VI) particulates)","Yes","None","RDDR","No",300,3,10,10,NA,NA,10,NA,"an additional 10-fold uncertainty factor to account for the less-than-lifetime exposure","sodium dichromate","Rat","Wistar","M","Inhalation",22,7,"30-90","Days","lung","Both","MOA Data",2036,"clinical chemistry","Both",NA,"Lactate dehydrogenase in bronchioalveolar lavage fluid (Cr(VI) particulates)",NA,NA,NA,NA,NA,"Application of the total uncertainty factor of 300 and the RDDR of 2.1576 to the BMC generated by Malsch et al. (1994) based on LDH in BALF (Glaser et al., 1990) results in an RfC of 0.1 μg/m3",NA,NA,NA,NA,NA,NA,NA,NA
"60",158,"Chromium(VI) ion","18540299",NA,"IRIS","RfD (mg/kg/day)",0.003,NA,1998-09-03,"http://www.epa.gov/iris/subst/0144.htm","9/3/1998","MacKenzie, RD; Byerrum, RU; Decker, CF, et al. (1958) Chronic toxicity studies. II. Hexavalent and trivalent chromium administered in drinking water to rats. Am Med Assoc Arch Ind Health 18:232-234.","NOAEL",2.5,"mg/kg/day","NA","None Reported","No","None","None","No",300,10,10,NA,NA,NA,3,TRUE,"additional factor of 3 to compensate for the less-than-lifetime exposure duration of the principal study",NA,"Rat","Sprague-Dawley","M/F","Oral drinking water",NA,NA,"1","Years","none","Both","None",2034,"none","Both",NA,"No effect based on body weight, gross external condition, histopathological analysis, and blood chemistry",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"61",241,"DDT","50293","C14H9Cl5","IRIS","Oral Slope Factor (1/mg/kg-day)",0.34,NA,1991-05-01,"http://www.epa.gov/iris/subst/0147.htm","5/1/1991","Tomatis, L. and V. Turusov. 1975. Studies on the carcinogenicity of DDT. Gann Monograph
Cancer Res. 17: 219-241.",NA,NA,NA,"Other","Liver, benign and malignant (slope factor is the geometric mean of slope factors derived from 4 mouse studies and 2 rat studies)","No","None","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CF-1","M/F","Oral diet",NA,NA,"130","Weeks","liver","Both","None",1220,"neoplasia","M","Dichotomous","benign liver tumors",NA,"ppm",NA,NA,NA,"Dose response data are estimated from Figure 1 of primary report, animal numbers were obtained from Table 2. The slope factor derived from this data set was 1.04 per mg/kg/day.",NA,0,NA,NA,348,104,NA,NA
"62",241,"DDT","50293","C14H9Cl5","IRIS","Oral Slope Factor (1/mg/kg-day)",0.34,NA,1991-05-01,"http://www.epa.gov/iris/subst/0147.htm","5/1/1991","Tomatis, L. and V. Turusov. 1975. Studies on the carcinogenicity of DDT. Gann Monograph
Cancer Res. 17: 219-241.",NA,NA,NA,"Other","Liver, benign and malignant (slope factor is the geometric mean of slope factors derived from 4 mouse studies and 2 rat studies)","No","None","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CF-1","M/F","Oral diet",NA,NA,"130","Weeks","liver","Both","None",2166,"neoplasia","F","Dichotomous","benign liver tumors",NA,"ppm",NA,NA,NA,"Dose response data are estimated from Figure 2 of primary report, animal numbers were obtained from Table 2. The slope factor derived from this data set was 0.49 per mg/kg/day.",NA,0,NA,NA,363,18,NA,NA
"63",241,"DDT","50293","C14H9Cl5","IRIS","Oral Slope Factor (1/mg/kg-day)",0.34,NA,1991-05-01,"http://www.epa.gov/iris/subst/0147.htm","5/1/1991","Turusov, V.S., N.E. Day, L. Tomatis, E. Gati and R.T. Charles. 1973. Tumors in CF-1 mice
exposed for six consecutive generations to DDT. J. Natl. Cancer Inst. 51: 983-998.",NA,NA,NA,"Other","Liver, benign and malignant (slope factor is the geometric mean of slope factors derived from 4 mouse studies and 2 rat studies)","No","None","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CF-1","M/F","Oral diet",NA,NA,"6","Generations","liver","Both","None",1246,"neoplasia","M","Dichotomous","benign liver tumors",NA,"ppm",NA,NA,NA,"Dose response data are from Table 3 of primary report.  The slope factor derived from this data set was 0.80 per mg/kg/day.",NA,0,NA,NA,328,97,NA,NA
"64",241,"DDT","50293","C14H9Cl5","IRIS","Oral Slope Factor (1/mg/kg-day)",0.34,NA,1991-05-01,"http://www.epa.gov/iris/subst/0147.htm","5/1/1991","Turusov, V.S., N.E. Day, L. Tomatis, E. Gati and R.T. Charles. 1973. Tumors in CF-1 mice
exposed for six consecutive generations to DDT. J. Natl. Cancer Inst. 51: 983-998.",NA,NA,NA,"Other","Liver, benign and malignant (slope factor is the geometric mean of slope factors derived from 4 mouse studies and 2 rat studies)","No","None","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CF-1","M/F","Oral diet",NA,NA,"6","Generations","liver","Both","None",2168,"neoplasia","F","Dichotomous","benign liver tumors",NA,"ppm",NA,NA,NA,"Dose response data are from Table 3 of primary report.  The slope factor derived from this data set was 0.42 per mg/kg/day.",NA,0,NA,NA,340,16,NA,NA
"65",241,"DDT","50293","C14H9Cl5","IRIS","Oral Slope Factor (1/mg/kg-day)",0.34,NA,1991-05-01,"http://www.epa.gov/iris/subst/0147.htm","5/1/1991","Terracini, B., M.C. Testa, J.R. Cabral and N. Day. 1973. The effects of long-term feeding of DDT
to BALB/c mice. Int. J. Cancer. 11: 747-764.",NA,NA,NA,"Other","Liver, benign and malignant (slope factor is the geometric mean of slope factors derived from 4 mouse studies and 2 rat studies)","No","None","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","BALB/C","M/F","Oral diet",NA,NA,"2","Generations","liver","Both","None",1226,"neoplasia","M","Dichotomous","benign liver tumors",NA,NA,NA,NA,NA,"Dose response data are from Table 1 of primary report, and represents all animals from F0 and F1 generations.  The slope factor derived from this data set was 0.082 per mg/kg/day.",NA,0,NA,NA,107,2,NA,NA
"66",241,"DDT","50293","C14H9Cl5","IRIS","Oral Slope Factor (1/mg/kg-day)",0.34,NA,1991-05-01,"http://www.epa.gov/iris/subst/0147.htm","5/1/1991","Rossi, L., M. Ravera, G. Repetti and L. Santi. 1977. Long-term administration of DDT or
phenobarbital-Na in Wistar rats. Int. J. Cancer. 19: 179-185.",NA,NA,NA,"Other","Liver, benign and malignant (slope factor is the geometric mean of slope factors derived from 4 mouse studies and 2 rat studies)","No","None","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Rat","Wistar","M/F","Oral diet",NA,NA,"152","Weeks","liver","Both","None",1212,"neoplasia","M","Dichotomous","benign liver tumors",NA,"ppm",NA,NA,NA,"Dose response data are from Table 1 of primary report.  The slope factor derived from this data set was 0.16 per mg/kg/day.",NA,0,NA,NA,35,0,NA,NA
"67",241,"DDT","50293","C14H9Cl5","IRIS","Oral Slope Factor (1/mg/kg-day)",0.34,NA,1991-05-01,"http://www.epa.gov/iris/subst/0147.htm","5/1/1991","Rossi, L., M. Ravera, G. Repetti and L. Santi. 1977. Long-term administration of DDT or
phenobarbital-Na in Wistar rats. Int. J. Cancer. 19: 179-185.",NA,NA,NA,"Other","Liver, benign and malignant (slope factor is the geometric mean of slope factors derived from 4 mouse studies and 2 rat studies)","No","None","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Rat","Wistar","M/F","Oral diet",NA,NA,"152","Weeks","liver","Both","None",2164,"neoplasia","F","Dichotomous","benign liver tumors",NA,"ppm",NA,NA,NA,"Dose response data are from Table 1 of primary report. The slope factor derived from this data set was 0.27 per mg/kg/day.",NA,0,NA,NA,32,0,NA,NA
"68",241,"DDT","50293","C14H9Cl5","IRIS","Oral Slope Factor (1/mg/kg-day)",0.34,NA,1991-05-01,"http://www.epa.gov/iris/subst/0147.htm","5/1/1991","Cabral, J.R.P., R.K. Hall, L. Rossi, S.A. Bronczyk and P. Shubik. 1982. Effects of long-term intake of DDT on rats. Tumorigenesis. 68: 11-17.",NA,NA,NA,"Other","Liver, benign and malignant (slope factor is the geometric mean of slope factors derived from 4 mouse studies and 2 rat studies)","No","None","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Rat","Porton","M/F","Oral diet",NA,NA,"144","Weeks","liver","Both","MOA Data",637,"neoplasia","F","Continuous","liver-cell tumors",NA,"ppm",NA,"mg/kg/day",NA,"Dose conversion and dose-response data are from Tables 1 and 3, respectivley, in primary report.  The slope factor derived from this data set was 0.084 per mg/kg/day.",NA,0,0,NA,38,0,NA,NA
"69",241,"DDT","50293","C14H9Cl5","IRIS","Oral Slope Factor (1/mg/kg-day)",0.34,NA,1991-05-01,"http://www.epa.gov/iris/subst/0147.htm","5/1/1991","Thorpe, E. and A.I.T. Walker. 1973. The toxicology of dieldrin (HEOD). II. Comparative longterm
oral toxicity studies in mice with dieldrin, DDT, phenobarbitone, beta-BHC and gamma-
BHC. Food Cosmet. Toxicol. 11: 433-442.",NA,NA,NA,"Other","Liver, benign and malignant (slope factor is the geometric mean of slope factors derived from 4 mouse studies and 2 rat studies)","No","None","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CF-1","M/F","Oral diet",NA,NA,NA,"Duration","liver","Both","None",2167,"neoplasia","F","Dichotomous","benign and malignant liver tumors",NA,"ppm",NA,NA,NA,"Incidence data were calculated from % affected data presented in Table 2 of primary report.   The slope factor derived from this data set was 0.81 per mg/kg/day.",NA,0,NA,NA,44,10,NA,NA
"70",241,"DDT","50293","C14H9Cl5","IRIS","Oral Slope Factor (1/mg/kg-day)",0.34,NA,1991-05-01,"http://www.epa.gov/iris/subst/0147.htm","5/1/1991","Thorpe, E. and A.I.T. Walker. 1973. The toxicology of dieldrin (HEOD). II. Comparative longterm
oral toxicity studies in mice with dieldrin, DDT, phenobarbitone, beta-BHC and gamma-
BHC. Food Cosmet. Toxicol. 11: 433-442.",NA,NA,NA,"Other","Liver, benign and malignant (slope factor is the geometric mean of slope factors derived from 4 mouse studies and 2 rat studies)","No","None","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CF-1","M/F","Oral diet",NA,NA,NA,"Duration","liver","Both","None",1223,"neoplasia","M","Dichotomous","benign and malignant liver tumors",NA,"ppm",NA,NA,NA,"Incidence data were calculated from % affected data presented in Table 2 of primary report.  The slope factor derived from this data set was 0.52 per mg/kg/day.",NA,0,NA,NA,45,11,NA,NA
"71",241,"DDT","50293","C14H9Cl5","IRIS","Inhalation Unit Risk (1/μg/m3)",9.7e-05,NA,1991-05-01,"http://www.epa.gov/iris/subst/0147.htm","5/1/1991","Cabral, J.R.P., R.K. Hall, L. Rossi, S.A. Bronczyk and P. Shubik. 1982. Effects of long-term intake of DDT on rats. Tumorigenesis. 68: 11-17.",NA,NA,NA,"Other","Liver, benign and malignant (inhalation risk estimates were calculated from the oral data presented in oral slope factor section; route-to-route extrapolation method was not specified)","No","Other","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Rat","Porton","Unspecified","Oral diet",NA,NA,NA,"Duration","liver","Both","MOA Data",1177,"neoplasia","Both","Dichotomous","Benign liver tumors",NA,NA,NA,NA,NA,"inhalation risk estimates were calculated from the oral data presented in oral slope factor section; route-to-route extrapolation method was not specified",NA,NA,NA,NA,NA,NA,NA,NA
"72",241,"DDT","50293","C14H9Cl5","IRIS","Inhalation Unit Risk (1/μg/m3)",9.7e-05,NA,1991-05-01,"http://www.epa.gov/iris/subst/0147.htm","5/1/1991","Turusov, V.S., N.E. Day, L. Tomatis, E. Gati and R.T. Charles. 1973. Tumors in CF-1 mice
exposed for six consecutive generations to DDT. J. Natl. Cancer Inst. 51: 983-998.",NA,NA,NA,"Other","Liver, benign and malignant (inhalation risk estimates were calculated from the oral data presented in oral slope factor section; route-to-route extrapolation method was not specified)","No","Other","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CF-1","M/F","Oral diet",NA,NA,NA,"Duration","liver","Both","None",1245,"neoplasia","Both","Dichotomous","benign liver tumors",NA,NA,NA,NA,NA,"inhalation risk estimates were calculated from the oral data presented in oral slope factor section; route-to-route extrapolation method was not specified",NA,NA,NA,NA,NA,NA,NA,NA
"73",241,"DDT","50293","C14H9Cl5","IRIS","Inhalation Unit Risk (1/μg/m3)",9.7e-05,NA,1991-05-01,"http://www.epa.gov/iris/subst/0147.htm","5/1/1991","Rossi, L., M. Ravera, G. Repetti and L. Santi. 1977. Long-term administration of DDT or
phenobarbital-Na in Wistar rats. Int. J. Cancer. 19: 179-185.",NA,NA,NA,"Other","Liver, benign and malignant (inhalation risk estimates were calculated from the oral data presented in oral slope factor section; route-to-route extrapolation method was not specified)","No","Other","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Rat","Wistar","M/F","Oral diet",NA,NA,NA,"Duration","liver","Both","None",1232,"neoplasia","Both","Dichotomous","benign liver tumors",NA,NA,NA,NA,NA,"inhalation risk estimates were calculated from the oral data presented in oral slope factor section; route-to-route extrapolation method was not specified",NA,NA,NA,NA,NA,NA,NA,NA
"74",241,"DDT","50293","C14H9Cl5","IRIS","Inhalation Unit Risk (1/μg/m3)",9.7e-05,NA,1991-05-01,"http://www.epa.gov/iris/subst/0147.htm","5/1/1991","Tomatis, L. and V. Turusov. 1975. Studies on the carcinogenicity of DDT. Gann Monograph
Cancer Res. 17: 219-241.",NA,NA,NA,"Other","Liver, benign and malignant (inhalation risk estimates were calculated from the oral data presented in oral slope factor section; route-to-route extrapolation method was not specified)","No","Other","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CF-1","M/F","Oral diet",NA,NA,NA,"Duration","liver","Both","None",1235,"neoplasia","Both","Dichotomous","benign liver tumors",NA,NA,NA,NA,NA,"inhalation risk estimates were calculated from the oral data presented in oral slope factor section; route-to-route extrapolation method was not specified",NA,NA,NA,NA,NA,NA,NA,NA
"75",241,"DDT","50293","C14H9Cl5","IRIS","Inhalation Unit Risk (1/μg/m3)",9.7e-05,NA,1991-05-01,"http://www.epa.gov/iris/subst/0147.htm","5/1/1991","term
oral toxicity studies in mice with dieldrin, DDT, phenobarbitone, beta-BHC and gamma-
BHC. Food Cosmet. Toxicol. 11: 433-442.",NA,NA,NA,"Other","Liver, benign and malignant (inhalation risk estimates were calculated from the oral data presented in oral slope factor section; route-to-route extrapolation method was not specified)","No","Other","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CF-1","M/F","Oral diet",NA,NA,NA,"Duration","liver","Both","None",1239,"neoplasia","Both","Dichotomous","benign and malignant liver tumors",NA,NA,NA,NA,NA,"inhalation risk estimates were calculated from the oral data presented in oral slope factor section; route-to-route extrapolation method was not specified",NA,NA,NA,NA,NA,NA,NA,NA
"76",241,"DDT","50293","C14H9Cl5","IRIS","Inhalation Unit Risk (1/μg/m3)",9.7e-05,NA,1991-05-01,"http://www.epa.gov/iris/subst/0147.htm","5/1/1991","Terracini, B., M.C. Testa, J.R. Cabral and N. Day. 1973. The effects of long-term feeding of DDT
to BALB/c mice. Int. J. Cancer. 11: 747-764.",NA,NA,NA,"Other","Liver, benign and malignant (inhalation risk estimates were calculated from the oral data presented in oral slope factor section; route-to-route extrapolation method was not specified)","No","Other","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","BALB/C","Unspecified","Oral diet",NA,NA,NA,"Duration","liver","Both","None",1241,"neoplasia","Both","Dichotomous","benign liver tumors",NA,NA,NA,NA,NA,"inhalation risk estimates were calculated from the oral data presented in oral slope factor section; route-to-route extrapolation method was not specified",NA,NA,NA,NA,NA,NA,NA,NA
"77",241,"DDT","50293","C14H9Cl5","IRIS","Oral Slope Factor (1/mg/kg-day)",0.34,NA,1991-05-01,"http://www.epa.gov/iris/subst/0147.htm","5/1/1991","Cabral, J.R.P., R.K. Hall, L. Rossi, S.A. Bronczyk and P. Shubik. 1982. Effects of long-term intake of DDT on rats. Tumorigenesis. 68: 11-17.",NA,NA,NA,"Other","Liver, benign and malignant (slope factor is the geometric mean of slope factors derived from 4 mouse studies and 2 rat studies)","No","None","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Rat","Porton","M/F","Oral diet",NA,NA,"144","Weeks","liver","Both","MOA Data",637,"neoplasia","F","Dichotomous","liver tumors",NA,NA,NA,NA,NA,"The oral slope factor for female rats was 0.084.",NA,NA,NA,NA,NA,NA,NA,NA
"78",241,"DDT","50293","C14H9Cl5","IRIS","RfD (mg/kg/day)",5e-04,1,1996-02-01,"http://www.epa.gov/iris/subst/0147.htm","2/1/1996","Laug, E.P., A.A. Nelson, O.G. Fitzhugh and F.M. Kunze. 1950. Liver cell alteration and DDT storage in the fat of the rat induced by dietary levels of 1-50 ppm DDT. J. Pharmacol. Exp. Therap. 98: 268-273.","NOEL",0.05,"mg/kg/day","NA","Liver lesions","No","None","None","No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Rat","Unspecified","M/F","Oral diet",NA,NA,"15-27","Weeks","liver","Both","None",634,"nonneoplastic histopathology","Both","Dichotomous","Liver lesions",NA,NA,NA,NA,NA,"Lesions included hepatocellular hypertrophy, especially centrilobularly, increased cytoplasmic oxyphilia, and peripheral basophilic cytoplasmic granules.  Incidence data were not reported in Laug et al (1950).",NA,NA,NA,NA,NA,NA,NA,NA
"79",863,"Diazinon","333415",NA,"ATSDR","Chronic Oral MRL (mg/kg/day)",7e-04,0.93,NA,"http://www.atsdr.cdc.gov/ToxProfiles/tp86.pdf","9/2008","Kirchner FR, McCormick GC, Arthur AT. 1991. One/two year oral toxicity study in rats. Ciba-Geigy Corporation. Submitted to the U.S. Environmental Protection Agency. MRID41942002","NOAEL",0.065,"mg/kg/day","NA","22–28% decreased RBC AChE activity","NA","None","None","No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Rat","Sprague-Dawley","M/F","Oral diet",NA,NA,"98","Weeks","systemic","Both","MOA Determination",4433,"clinical chemistry","Both","Continuous","Decreased RBC acetylcholinesterase",NA,NA,NA,NA,NA,"POD was based on AchE measurements at multiple time points.",NA,NA,NA,NA,NA,NA,NA,NA
"80",863,"Diazinon","333415",NA,"OPP","Chronic RfD (mg/kg/day)",2e-04,1,NA,"http://www.epa.gov/opp00001/chem_search/reg_actions/reregistration/red_PC-057801_31-Jul-06.pdf","7/31/2006","Barnes, T. (1988) Diazinon (MG-8): 90-Day Oral Toxicity Study in Dogs: Project ID 882012. Unpublished study prepared by Ciba-Geigy Corp. 647 p.  MRID 40815004

Rudzki, M.; McCormick, G.; Arthur, A. (1991) Diazinon (MG-8): 52- Week Oral Toxicity Study in Dogs: Lab Project Number: 882014. Unpublished study prepared by Ciga-Geigy. 621 p.  MRID 41942001.

 Chang, J. (1994) DZN Diazinon MG87(percent): Cholinesterase Inhibition in 28 Day Study in Rats: Final Report: Lab Project Number: F/00186. Unpublished study prepared by Ciba Geigy Environmental Health Center. 125 p. MRID 43543901.

MRID 40815003

MRID 43543802

Kirchner, F.; McCormick, G.; Arthur, A. (1991) Diazinon (MG-8): One/Two Year Oral Toxicity Study in Rats: Lab Project Number: 882018. Unpublished study prepared by Ciba-Geigy. 3101 p. MRID 41942002","NOAEL",0.02,"mg/kg/day","NA","no adverse effects on cholinesterase inhibition (based on 7 studies - see accompanying records)","NA","None","None","No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Dog",NA,NA,"Oral diet",NA,NA,"4-52","Weeks","CNS","Both","None",3747,"enzyme activity","Both",NA,NA,NA,NA,NA,NA,NA,"The NOAEL is based on review of results from seven oral feeding studies consistently showing no adverse effects on cholinesterase inhibition at the NOAEL, including three dog studies (4 week, 90 day, 1 year)",NA,NA,NA,NA,NA,NA,NA,NA
"81",863,"Diazinon","333415",NA,"OPP","Chronic RfD (mg/kg/day)",2e-04,1,NA,"http://www.epa.gov/opp00001/chem_search/reg_actions/reregistration/red_PC-057801_31-Jul-06.pdf","7/31/2006","Barnes, T. (1988) Diazinon (MG-8): 90-Day Oral Toxicity Study in Dogs: Project ID 882012. Unpublished study prepared by Ciba-Geigy Corp. 647 p.  MRID 40815004

Rudzki, M.; McCormick, G.; Arthur, A. (1991) Diazinon (MG-8): 52- Week Oral Toxicity Study in Dogs: Lab Project Number: 882014. Unpublished study prepared by Ciga-Geigy. 621 p.  MRID 41942001.

 Chang, J. (1994) DZN Diazinon MG87(percent): Cholinesterase Inhibition in 28 Day Study in Rats: Final Report: Lab Project Number: F/00186. Unpublished study prepared by Ciba Geigy Environmental Health Center. 125 p. MRID 43543901.

MRID 40815003

MRID 43543802

Kirchner, F.; McCormick, G.; Arthur, A. (1991) Diazinon (MG-8): One/Two Year Oral Toxicity Study in Rats: Lab Project Number: 882018. Unpublished study prepared by Ciba-Geigy. 3101 p. MRID 41942002","NOAEL",0.02,"mg/kg/day","NA","no adverse effects on cholinesterase inhibition (based on 7 studies - see accompanying records)","NA","None","None","No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Rat",NA,NA,"Oral diet",NA,NA,"4-104","Weeks","CNS","Both","None",3748,"enzyme activity","Both",NA,NA,NA,NA,NA,NA,NA,"The NOAEL is based on review of results from seven oral feeding studies consistently showing no adverse effects on cholinesterase inhibition at the NOAEL, including four rat studies (4 week, 90 day, 90 day neurotox, 2 year)",NA,NA,NA,NA,NA,NA,NA,NA
"82",863,"Diazinon","333415",NA,"HEAST","RfD (mg/kg/day)",9e-04,1,NA,"http://epa-heast.ornl.gov/heast.php?chemical=Diazinon","1984","Davies D.B. and B.J. Holub. 1980. Toxicological evaluation of dietary Diazinon in the rat. Arch Environ Contam Toxicol. 9(6): 637-650.","NOAEL",0.09,"mg/kg/day","NA","decreased blood cholinesterase activity","No","None","None","No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Rat","Wistar","F","Oral diet",NA,NA,"35-42","Days","blood","Both",NA,3437,"enzyme activity","Both","Continuous","decreased plasma cholinesterase (day 35)","SE","ppm","umole/ml plasma/min",NA,NA,"Dose response data are from Table 6 of primary report",NA,0,NA,NA,10,NA,210,8
"83",863,"Diazinon","333415",NA,"HEAST","RfD (mg/kg/day)",9e-04,1,NA,"http://epa-heast.ornl.gov/heast.php?chemical=Diazinon","1984","Davies D.B. and B.J. Holub. 1980. Toxicological evaluation of dietary Diazinon in the rat. Arch Environ Contam Toxicol. 9(6): 637-650.","NOAEL",0.09,"mg/kg/day","NA","decreased blood cholinesterase activity","No","None","None","No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Rat","Wistar","F","Oral diet",NA,NA,"35-42","Days","blood","Both",NA,4370,"enzyme activity","Both","Continuous","decreased plasma cholinesterase (day 42)","SE","ppm","umole/ml plasma/min",NA,NA,"Dose-response data are form Table 3 in primary report",NA,0,NA,NA,10,NA,0.98,0.1
"84",470,"Dibutyl Phthalate","84742","C16H22O4","IRIS","RfD (mg/kg/day)",0.1,NA,1990-08-01,"http://www.epa.gov/iris/subst/0038.htm","8/1/1990","Smith, C.C. 1953. Toxicity of butyl sterate, dibutyl sebacate, dibutyl phthalate and methoxyethyl oleate. Arch. Hyg. Occup. Med. 7: 310-318.","NOAEL",125,"mg/kg/day","NA","Increased mortality","No","None","None","Yes",1000,10,10,NA,NA,NA,10,TRUE,"additional factor of 10 to account for both the less-than-chronic duration of the study and deficiencies in the study, such as the use of only male animals",NA,"Rat","Sprague-Dawley","M","Oral diet",NA,NA,"1","Years","systemic","Both","None",1493,"mortality/survival","Both","Dichotomous","Increased mortality",NA,"% diet","number of deaths","mg/kg/day",NA,"died during the first week of the study",NA,0,0,NA,10,0,NA,NA
"85",965,"Dicofol","115322",NA,"OPP","Chronic RfD (mg/kg/day)",0.0012,1,NA,"http://www.epa.gov/opp00001/chem_search/reg_actions/reregistration/red_PC-010501_1-Nov-98.pdf","9/30/1998","Tegeris, A. (1988) Dicofol (Kelthane Technical Miticide): One Year Dietary Toxicity Study in Beagle Dogs: Final Report: Report No. 86014. Unpublished study prepared by Tegeris Laboratories, Inc. 2094 p. MRID 40997101","NOAEL",0.12,"mg/kg/day","NA","inhibition of adrenal cortical trophic hormone (ACTH)-stimulated cortical release","No","None","None","No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral diet",NA,NA,"1","Years","adrenal glands","Both","None",4317,"neurotransmitter","Both",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"86",304,"Dieldrin","60571","C12H8Cl6O","ATSDR","Chronic Oral MRL (mg/kg/day)",5e-05,1,NA,"http://www.atsdr.cdc.gov/ToxProfiles/tp1.pdf","9/2002","Walker AIT, Stevenson DE, Robinson J, et al. 1969. The toxicology and pharmacodynamics of dieldrin (HEOD): Two-year oral exposures of rats and dogs. Toxicol Appl Pharmacol 15:345-373.","NOAEL",0.005,"mg/kg/day","NA","increased absolute and relative liver weight","No","None","None","No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Rat","Carworth farm","M/F","Oral diet",NA,NA,"2","Years","liver","Both",NA,4138,"organ weight","F","Continuous","increased relative liver weight","SD","ppm diet","g/100 g BW","mg/kg-day",NA,"Measure of variability was not stated but appears to be standard deviation",NA,0,0,NA,18,NA,4.08,0.147
"87",304,"Dieldrin","60571","C12H8Cl6O","ATSDR","Chronic Oral MRL (mg/kg/day)",5e-05,1,NA,"http://www.atsdr.cdc.gov/ToxProfiles/tp1.pdf","9/2002","Walker AIT, Stevenson DE, Robinson J, et al. 1969. The toxicology and pharmacodynamics of dieldrin (HEOD): Two-year oral exposures of rats and dogs. Toxicol Appl Pharmacol 15:345-373.","NOAEL",0.005,"mg/kg/day","NA","increased absolute and relative liver weight","No","None","None","No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Rat","Carworth farm","M/F","Oral diet",NA,NA,"2","Years","liver","Both",NA,4139,"organ weight","F","Continuous","increased absolute liver weight","SD","ppm diet","g","mg/kg-day",NA,"Measure of variability was not stated but appears to be standard deviation",NA,0,0,NA,18,NA,13.54,0.448
"88",304,"Dieldrin","60571","C12H8Cl6O","IRIS","Oral Slope Factor (1/mg/kg-day)",16,NA,1993-07-01,"http://www.epa.gov/iris/subst/0225.htm","7/1/1993","Meierhenry, E.F., B.H. Reuber, M.E. Gershwin, L.S. Hsieh and S.W. French. 1983. Deildrininduced mallory bodies in hepatic tumors of mice of different strains. Hepatology. 3: 90-95.",NA,NA,NA,"Other","liver carcinoma (oral slope factor is the geometric mean of 13 slope factors calculated from liver carcinoma data in mice)","No","None","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse",NA,"M","Oral diet",NA,NA,"85","Weeks","liver","Both","None",1293,"neoplasia","Both","Dichotomous","liver carcinoma",NA,NA,NA,NA,NA,"(oral slope factor is the geometric mean of 13 slope factors calculated from liver carcinoma data in mice).  slope factors for male C57B1/6J, C3H/He, and B6C3F1 mice were 7.4, 8.5, and 11, respectively.",NA,NA,NA,NA,NA,NA,NA,NA
"89",304,"Dieldrin","60571","C12H8Cl6O","IRIS","Oral Slope Factor (1/mg/kg-day)",16,NA,1993-07-01,"http://www.epa.gov/iris/subst/0225.htm","7/1/1993","Tennekes, H.A., A.S. Wright, K.M. Dix and J.H. Koeman. 1981. Effects of dieldrin, diet, and bedding on enzyme function and tumor incidence in livers of male CF-1 mice. Cancer Res. 41: 3615-3620.",NA,NA,NA,"Other","liver carcinoma (oral slope factor is the geometric mean of 13 slope factors calculated from liver carcinoma data in mice)","No","None","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CF-1","M","Oral diet",NA,NA,"110","Weeks","liver","Both","None",1288,"neoplasia","Both","Dichotomous","liver carcinoma",NA,NA,NA,NA,NA,"(oral slope factor is the geometric mean of 13 slope factors calculated from liver carcinoma data in mice).  Oral slope factor for male mice was 18.",NA,NA,NA,NA,NA,NA,NA,NA
"90",304,"Dieldrin","60571","C12H8Cl6O","IRIS","Oral Slope Factor (1/mg/kg-day)",16,NA,1993-07-01,"http://www.epa.gov/iris/subst/0225.htm","7/1/1993","NCI (National Cancer Institute). 1978a. Bioassays of aldrin and dieldrin for possible carcinogenicity. DHEW Publication No. (NIH) 78-821. National Cancer Institute Carcinogenesis Technical Report Series, No. 21. NCI-CG-TR-21.
NCI (National Cancer Institute). 1978b. Bioassays of aldrin and dieldrin for possible carcinogenicity. DHEW Publication No. (NIH) 78-822. National Cancer Institute Carcinogenesis Technical Report Series, No. 22. NCI-CG-TR-22.",NA,NA,NA,"Other","liver carcinoma (oral slope factor is the geometric mean of 13 slope factors calculated from liver carcinoma data in mice)","No","None","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Oral diet",NA,NA,"80","Weeks","liver","M","None",1292,"neoplasia","M","Dichotomous","liver carcinoma",NA,NA,NA,NA,NA,"(oral slope factor is the geometric mean of 13 slope factors calculated from liver carcinoma data in mice).  Slope factor for male mice was 9.8",NA,NA,NA,NA,NA,NA,NA,NA
"91",304,"Dieldrin","60571","C12H8Cl6O","IRIS","Oral Slope Factor (1/mg/kg-day)",16,NA,1993-07-01,"http://www.epa.gov/iris/subst/0225.htm","7/1/1993","Thorpe, E. and A.I.T. Walker. 1973. The toxicology of dieldrin (HEOD). Part II. Comparative
long-term oral toxicology studies in mice with dieldrin, DDT, phenobarbitone, beta-BHC and
gamma-BHC. Food Cosmet. Toxicol. 11: 433-441.",NA,NA,NA,"Other","liver carcinoma (oral slope factor is the geometric mean of 13 slope factors calculated from liver carcinoma data in mice)","No","None","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CF-1","M/F","Oral diet",NA,NA,"110","Weeks","liver","Both","None",1290,"neoplasia","Both","Dichotomous","liver carcinoma",NA,NA,NA,NA,NA,"(oral slope factor is the geometric mean of 13 slope factors calculated from liver carcinoma data in mice).  Slope factors for males and females were 55 and 26, respectively.",NA,NA,NA,NA,NA,NA,NA,NA
"92",304,"Dieldrin","60571","C12H8Cl6O","IRIS","Oral Slope Factor (1/mg/kg-day)",16,NA,1993-07-01,"http://www.epa.gov/iris/subst/0225.htm","7/1/1993","Walker, A.I.T., E. Thorpe and D.E. Stevenson. 1972. The toxicology of dieldrin (HEOD). I.  Long-term oral toxicity studies in mice. Food Cosmet. Toxicol. 11: 415-432.",NA,NA,NA,"Other","liver carcinoma (oral slope factor is the geometric mean of 13 slope factors calculated from liver carcinoma data in mice)","No","None","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CF-1","M/F","Oral diet",NA,NA,"132-140","Weeks","liver","Both","None",1289,"neoplasia","Both","Dichotomous","liver carcinoma",NA,NA,NA,NA,NA,"(oral slope factor is the geometric mean of 13 slope factors calculated from liver carcinoma data in mice) Slope factors for males were 25 and 15; slope factors for females were 28 and 7.1",NA,NA,NA,NA,NA,NA,NA,NA
"93",304,"Dieldrin","60571","C12H8Cl6O","IRIS","Oral Slope Factor (1/mg/kg-day)",16,NA,1993-07-01,"http://www.epa.gov/iris/subst/0225.htm","7/1/1993","Davis, K.J. 1965. Pathology report on mice fed aldrin, dieldrin, heptachlor or heptachlor epoxide for two years. Internal FDA memorandum to Dr. A.J. Lehman. July 19. (Cited in: U.S. EPA, 1986) 

Reuber, M.D. 1974. Exhibit 42. Testimony at hearings on aldrin/dieldrin. (Cited in: Epstein, 1975a)

Epstein, S.S. 1975a. The carcinogenicity of dieldrin. Part 1. Sci. Total Environ. 4: 1-52.

Epstein, S.S. 1975a. The carcinogenicity of dieldrin. Part 1. Sci. Total Environ. 4: 1-52. 

Meierhenry, E.F., B.H. Reuber, M.E. Gershwin, L.S. Hsieh and S.W. French. 1983. Deildrin-induced mallory bodies in hepatic tumors of mice of different strains. Hepatology. 3: 90-95. 

NCI (National Cancer Institute). 1978a. Bioassays of aldrin and dieldrin for possible carcinogenicity. DHEW Publication No. (NIH) 78-821. National Cancer Institute Carcinogenesis Technical Report Series, No. 21. NCI-CG-TR-21. 

NCI (National Cancer Institute). 1978b. Bioassays of aldrin and dieldrin for possible carcinogenicity. DHEW Publication No. (NIH) 78-822. National Cancer Institute Carcinogenesis Technical Report Series, No. 22. NCI-CG-TR-22. 

Reuber, M.D. 1974. Exhibit 42. Testimony at hearings on aldrin/dieldrin. (Cited in: Epstein, 1975a) 

Tennekes, H.A., A.S. Wright, K.M. Dix and J.H. Koeman. 1981. Effects of dieldrin, diet, and bedding on enzyme function and tumor incidence in livers of male CF-1 mice. Cancer Res. 41: 3615-3620. 

Thorpe, E. and A.I.T. Walker. 1973. The toxicology of dieldrin (HEOD). Part II. Comparative long-term oral toxicology studies in mice with dieldrin, DDT, phenobarbitone, beta-BHC and gamma-BHC. Food Cosmet. Toxicol. 11: 433-441. 

Walker, A.I.T., E. Thorpe and D.E. Stevenson. 1972. The toxicology of dieldrin (HEOD). I. Long-term oral toxicity studies in mice. Food Cosmet. Toxicol. 11: 415-432.",NA,NA,NA,"Other","liver carcinoma (oral slope factor is the geometric mean of 13 slope factors calculated from liver carcinoma data in mice)","No","None","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse",NA,"M/F","Oral diet",NA,NA,NA,NA,"liver","Both","MOA Data",666,"neoplasia","Both","Dichotomous","liver carcinoma",NA,NA,NA,NA,NA,"(oral slope factor is the geometric mean of 13 slope factors calculated from liver carcinoma data in mice)",NA,NA,NA,NA,NA,NA,NA,NA
"94",304,"Dieldrin","60571","C12H8Cl6O","IRIS","RfD (mg/kg/day)",5e-05,1,1990-09-01,"http://www.epa.gov/iris/subst/0225.htm","9/1/1990","Walker, A.I.T., D.E. Stevenson, J. Robinson, R. Thorpe and M. Roberts. 1969. The toxicology and pharmacodynamics of dieldrin (HEOD): Two-year oral exposures of rats and dogs. Toxicol. Appl. Pharmacol. 15: 345-373.","NOAEL",0.005,"mg/kg/day","NA","Liver lesions","No","None","None","No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Rat","CFE","M/F","Oral diet",NA,NA,"2","Years","liver","Both","MOA Data",663,"nonneoplastic histopathology","Both","Dichotomous","Liver lesions",NA,NA,NA,NA,NA,"Lesions were liver parenchymal cell changes including focal proliferation and focal hyperplasia.  Incidences of specific lesions were incompletely reported in the primary reference.",NA,NA,NA,NA,NA,NA,NA,NA
"95",304,"Dieldrin","60571","C12H8Cl6O","IRIS","Inhalation Unit Risk (1/μg/m3)",0.0046,NA,1993-07-01,"http://www.epa.gov/iris/subst/0225.htm","7/1/1993","Tennekes, H.A., A.S. Wright, K.M. Dix and J.H. Koeman. 1981. Effects of dieldrin, diet, and bedding on enzyme function and tumor incidence in livers of male CF-1 mice. Cancer Res. 41: 3615-3620.",NA,NA,NA,"Other","liver carcinomas (inhalation unit risk was calculated from data presented in oral slope factor section; method for route-to-route extrapolation was not specified)","No","Other","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CF-1","M","Oral diet",NA,NA,"110","Weeks","liver","Both","None",1306,"neoplasia","Both","Dichotomous","liver carcinoma",NA,NA,NA,NA,NA,"inhalation unit risk was calculated from data presented in oral slope factor section; method for route-to-route extrapolation was not specified",NA,NA,NA,NA,NA,NA,NA,NA
"96",304,"Dieldrin","60571","C12H8Cl6O","IRIS","Inhalation Unit Risk (1/μg/m3)",0.0046,NA,1993-07-01,"http://www.epa.gov/iris/subst/0225.htm","7/1/1993","Meierhenry, E.F., B.H. Reuber, M.E. Gershwin, L.S. Hsieh and S.W. French. 1983. Deildrininduced
mallory bodies in hepatic tumors of mice of different strains. Hepatology. 3: 90-95.",NA,NA,NA,"Other","liver carcinomas (inhalation unit risk was calculated from data presented in oral slope factor section; method for route-to-route extrapolation was not specified)","No","Other","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse",NA,"M","Oral diet",NA,NA,"85","Weeks","liver","Both","None",1312,"neoplasia","Both","Dichotomous","liver carcinoma",NA,NA,NA,NA,NA,"inhalation unit risk was calculated from data presented in oral slope factor section; method for route-to-route extrapolation was not specified",NA,NA,NA,NA,NA,NA,NA,NA
"97",304,"Dieldrin","60571","C12H8Cl6O","IRIS","Inhalation Unit Risk (1/μg/m3)",0.0046,NA,1993-07-01,"http://www.epa.gov/iris/subst/0225.htm","7/1/1993","Thorpe, E. and A.I.T. Walker. 1973. The toxicology of dieldrin (HEOD). Part II. Comparative
long-term oral toxicology studies in mice with dieldrin, DDT, phenobarbitone, beta-BHC and
gamma-BHC. Food Cosmet. Toxicol. 11: 433-441.",NA,NA,NA,"Other","liver carcinomas (inhalation unit risk was calculated from data presented in oral slope factor section; method for route-to-route extrapolation was not specified)","No","Other","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CF-1","M/F","Oral diet",NA,NA,"110","Weeks","liver","Both","None",1301,"neoplasia","Both","Dichotomous","liver carcinoma",NA,NA,NA,NA,NA,"inhalation unit risk was calculated from data presented in oral slope factor section; method for route-to-route extrapolation was not specified",NA,NA,NA,NA,NA,NA,NA,NA
"98",304,"Dieldrin","60571","C12H8Cl6O","IRIS","Inhalation Unit Risk (1/μg/m3)",0.0046,NA,1993-07-01,"http://www.epa.gov/iris/subst/0225.htm","7/1/1993","NCI (National Cancer Institute). 1978a. Bioassays of aldrin and dieldrin for possible carcinogenicity. DHEW Publication No. (NIH) 78-821. National Cancer Institute Carcinogenesis Technical Report Series, No. 21. NCI-CG-TR-21.
NCI (National Cancer Institute). 1978b. Bioassays of aldrin and dieldrin for possible carcinogenicity. DHEW Publication No. (NIH) 78-822. National Cancer Institute Carcinogenesis Technical Report Series, No. 22. NCI-CG-TR-22.",NA,NA,NA,"Other","liver carcinomas (inhalation unit risk was calculated from data presented in oral slope factor section; method for route-to-route extrapolation was not specified)","No","Other","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Oral diet",NA,NA,"80","Weeks","liver","M","None",1314,"neoplasia","M","Dichotomous","liver carcinoma",NA,NA,NA,NA,NA,"Inhalation unit risk was calculated from data presented in oral slope factor section; method for route-to-route extrapolation was not specified",NA,NA,NA,NA,NA,NA,NA,NA
"99",304,"Dieldrin","60571","C12H8Cl6O","IRIS","Inhalation Unit Risk (1/μg/m3)",0.0046,NA,1993-07-01,"http://www.epa.gov/iris/subst/0225.htm","7/1/1993","Walker, A.I.T., E. Thorpe and D.E. Stevenson. 1972. The toxicology of dieldrin (HEOD). I.  Long-term oral toxicity studies in mice. Food Cosmet. Toxicol. 11: 415-432.",NA,NA,NA,"Other","liver carcinomas (inhalation unit risk was calculated from data presented in oral slope factor section; method for route-to-route extrapolation was not specified)","No","Other","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CF-1","M/F","Oral diet",NA,NA,"132-140","Weeks","liver","Both","None",1298,"neoplasia","Both","Dichotomous","liver carcinoma",NA,NA,NA,NA,NA,"inhalation unit risk was calculated from data presented in oral slope factor section; method for route-to-route extrapolation was not specified",NA,NA,NA,NA,NA,NA,NA,NA
"100",304,"Dieldrin","60571","C12H8Cl6O","IRIS","Inhalation Unit Risk (1/μg/m3)",0.0046,NA,1993-07-01,"http://www.epa.gov/iris/subst/0225.htm","7/1/1993","Davis, K.J. 1965. Pathology report on mice fed aldrin, dieldrin, heptachlor or heptachlor epoxide for two years. Internal FDA memorandum to Dr. A.J. Lehman. July 19. (Cited in: U.S. EPA, 1986) 

Epstein, S.S. 1975a. The carcinogenicity of dieldrin. Part 1. Sci. Total Environ. 4: 1-52. 

Reuber, M.D. 1974. Exhibit 42. Testimony at hearings on aldrin/dieldrin. (Cited in: Epstein, 1975a)",NA,NA,NA,"Other","liver carcinomas (inhalation unit risk was calculated from data presented in oral slope factor section; method for route-to-route extrapolation was not specified)","No","Other","None","No",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse",NA,"M/F","Oral diet",NA,NA,NA,NA,"liver","Both","MOA Data",668,"neoplasia","Both","Dichotomous","liver carcinoma",NA,NA,NA,NA,NA,"inhalation unit risk was calculated from data presented in oral slope factor section; method for route-to-route extrapolation was not specified",NA,NA,NA,NA,NA,NA,NA,NA
"101",206,"Disulfoton","298044","C8H19O2PS3","ATSDR","Chronic Oral MRL (mg/kg/day)",6e-05,1,NA,"http://www.atsdr.cdc.gov/ToxProfiles/tp65.pdf","8/1995","Hayes RH. 1985. Chronic feeding/oncogenicity study of technical disulfoton (Di-Syston) with rats. Study no. 82-271-01. Mobay Chemical Corporation, Corporate Toxicology Department, Stilwell, Kansas.","LOAEL",0.06,"mg/kg/day","NA","erythrocyte and brain cholinesterase inhibition","NA","None","None","No",1000,10,10,NA,10,NA,NA,TRUE,NA,NA,"Rat","Fischer 344","M/F","Oral diet",NA,NA,"2","Years","brain","Both",NA,4437,"clinical chemistry","Both","Continuous","brain cholinesterase inhibition",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"102",206,"Disulfoton","298044","C8H19O2PS3","ATSDR","Chronic Oral MRL (mg/kg/day)",6e-05,1,NA,"http://www.atsdr.cdc.gov/ToxProfiles/tp65.pdf","8/1995","Hayes RH. 1985. Chronic feeding/oncogenicity study of technical disulfoton (Di-Syston) with rats. Study no. 82-271-01. Mobay Chemical Corporation, Corporate Toxicology Department, Stilwell, Kansas.","LOAEL",0.06,"mg/kg/day","NA","erythrocyte and brain cholinesterase inhibition","NA","None","None","No",1000,10,10,NA,10,NA,NA,TRUE,NA,NA,"Rat","Fischer 344","M/F","Oral diet",NA,NA,"2","Years","systemic","F","MOA Determination",3603,"clinical chemistry","F","Continuous","erythrocyte cholinesterase inhibition",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"103",206,"Disulfoton","298044","C8H19O2PS3","OPP","Chronic RfD (mg/kg/day)",0.00013,1,NA,"http://www.epa.gov/opp00001/chem_search/reg_actions/reregistration/red_PC-032501_31-Jul-06.pdf","2006","Jones, R.; Hastings, T. (1997) Technical Grade Disulfoton: A Chronic Toxicity Feeding Study in the Beagle Dog: Lab Project Number: 107499: 8097: 94-276-XZ. Unpublished study prepared by Bayer Corp. 991 p.","NOAEL",0.013,"mg/kg/day","NA","plasma, red blood cell, and corneal cholinesterase inhibition; and brain cholinesterase inhibition in females only",NA,NA,NA,"No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Dog","Beagle",NA,"Oral diet",NA,NA,"1","Years",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"104",206,"Disulfoton","298044","C8H19O2PS3","IRIS","RfD (mg/kg/day)",4e-05,1,1988-03-01,"http://www.epa.gov/iris/subst/0154.htm","3/1/1988","Mobay Chemical Company. 1985. MRID No. 00129456, 00146873, 41115401. Available from EPA. Write to FOI, EPA, Washington, DC 20460.","LEL",0.04,"mg/kg/day","NA","ChE inhibition, optic nerve degeneration","No","None","None","No",1000,10,10,NA,10,NA,NA,TRUE,NA,NA,"Rat","Fischer 344","M/F","Oral diet",NA,NA,"105","Weeks","CNS","Both","None",686,"neurotransmitter","Both","Continuous","ChE inhibition (plasma, erythrocytes, and brain)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"105",206,"Disulfoton","298044","C8H19O2PS3","IRIS","RfD (mg/kg/day)",4e-05,1,1988-03-01,"http://www.epa.gov/iris/subst/0154.htm","3/1/1988","Mobay Chemical Company. 1985. MRID No. 00129456, 00146873, 41115401. Available from EPA. Write to FOI, EPA, Washington, DC 20460.","LEL",0.04,"mg/kg/day","NA","ChE inhibition, optic nerve degeneration","No","None","None","No",1000,10,10,NA,10,NA,NA,TRUE,NA,NA,"Rat","Fischer 344","M/F","Oral diet",NA,NA,"105","Weeks","eyes/ocular","F","None",688,"nonneoplastic histopathology","F","Continuous","optic nerve degeneration",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"106",206,"Disulfoton","298044","C8H19O2PS3","IRIS","RfD (mg/kg/day)",4e-05,1,1988-03-01,"http://www.epa.gov/iris/subst/0154.htm","3/1/1988","Mobay Chemical Company. 1985. MRID No. 00129456, 00146873, 41115401. Available from EPA. Write to FOI, EPA, Washington, DC 20460.","LEL",0.04,"mg/kg/day","NA","ChE inhibition, optic nerve degeneration","No","None","None","No",1000,10,10,NA,10,NA,NA,TRUE,NA,NA,"Rat","Fischer 344","M/F","Oral diet",NA,NA,"105","Weeks","eyes/ocular","F","None",688,"nonneoplastic histopathology","F","Dichotomous","optic nerve degeneration",NA,NA,NA,NA,NA,"incidence data not reported",NA,NA,NA,NA,NA,NA,NA,NA
"107",68,"Endosulfan","115297","C9H6Cl6O3S","ATSDR","Chronic Oral MRL (mg/kg/day)",0.002,0.9,NA,"http://www.atsdr.cdc.gov/ToxProfiles/tp41.pdf","9/2000","Hoechst. 1989c. Endosulfan - substance technical (code HOE 02671 OI ZD96 0002):
Testing for toxicity by repeated oral administration (1-year feeding study) to Beagle dogs. Conducted for
Hoechst Aktiengesellschaft, Frankfurt, Germany. Project no. 87.0643.","NOAEL",0.18,"mg/kg/day","NA","increase in serum alkaline phosphatase activity","No","None","None","No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral diet",NA,NA,"1","Years","liver","Both","None",4441,"clinical chemistry","Both","Continuous","increase in serum alkaline phosphatase activity",NA,NA,NA,NA,NA,"Data reported for individual animals in primary reference; means and SDs not reported.",NA,NA,NA,NA,NA,NA,NA,NA
"108",68,"Endosulfan","115297","C9H6Cl6O3S","OPP","Chronic RfD (mg/kg/day)",0.006,0.95,NA,"http://www.epa.gov/opp00001/chem_search/cleared_reviews/csr_PC-079401_31-Jan-07_a.pdf","11/1/2002","Runkman, S. et al. (1989) Combined chronic toxicity/carcinogencity study - 104 week feeding study in rats.  Huntington Research Centre, Ltd.  Study No. HST 289/881067.  Reviews dataed January 10, and May 18, 1990.  MRID 41099502.","NOAEL",0.57,"mg/kg/day","NA","redueced body weight gain, increased incidences of marked progessive glomerulonephrosis and blood vessel aneurysms in male rats","NA","None","None","No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Rat","Unspecified","M/F","Oral diet",NA,NA,"104","Weeks","kidneys","M",NA,3761,"nonneoplastic histopathology","M",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"109",68,"Endosulfan","115297","C9H6Cl6O3S","OPP","Chronic RfD (mg/kg/day)",0.006,0.95,NA,"http://www.epa.gov/opp00001/chem_search/cleared_reviews/csr_PC-079401_31-Jan-07_a.pdf","11/1/2002","Runkman, S. et al. (1989) Combined chronic toxicity/carcinogencity study - 104 week feeding study in rats.  Huntington Research Centre, Ltd.  Study No. HST 289/881067.  Reviews dataed January 10, and May 18, 1990.  MRID 41099502.","NOAEL",0.57,"mg/kg/day","NA","redueced body weight gain, increased incidences of marked progessive glomerulonephrosis and blood vessel aneurysms in male rats","NA","None","None","No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Rat","Unspecified","M/F","Oral diet",NA,NA,"104","Weeks","vascular system","M",NA,3762,"other","M",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"110",68,"Endosulfan","115297","C9H6Cl6O3S","OPP","Chronic RfD (mg/kg/day)",0.006,0.95,NA,"http://www.epa.gov/opp00001/chem_search/cleared_reviews/csr_PC-079401_31-Jan-07_a.pdf","11/1/2002","Runkman, S. et al. (1989) Combined chronic toxicity/carcinogencity study - 104 week feeding study in rats.  Huntington Research Centre, Ltd.  Study No. HST 289/881067.  Reviews dataed January 10, and May 18, 1990.  MRID 41099502.","NOAEL",0.57,"mg/kg/day","NA","redueced body weight gain, increased incidences of marked progessive glomerulonephrosis and blood vessel aneurysms in male rats","NA","None","None","No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Rat","Unspecified","M/F","Oral diet",NA,NA,"104","Weeks","systemic","M",NA,3760,"body weight","M",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"111",68,"Endosulfan","115297","C9H6Cl6O3S","IRIS","RfD (mg/kg/day)",0.006,1,1994-10-01,"http://www.epa.gov/iris/subst/0235.htm","10/1/1994","Hoechst Celanese Corporation. 1989a. MRID No. 40256502, 41099502. HED Doc. No. 007937. Available from EPA. Write to FOI, EPA, Washington, DC 20460.","NOAEL",0.6,"mg/kg/day","NA","Reduced body weight gain in males and females; increased 
incidence of marked progressive glomerulonephrosis
 and blood vessel aneurysms in males","No","None","None","Yes",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Rat","Sprague-Dawley","M/F","Oral diet",NA,NA,"2","Years","kidneys","M","None",488,"nonneoplastic histopathology","M","Dichotomous","increased incidence of marked progressive glomerulonephrosis",NA,"ppm","incidence","mg/kg/day",NA,"combined across the main and satellite groups",NA,0,0,NA,41,10,NA,NA
"112",68,"Endosulfan","115297","C9H6Cl6O3S","IRIS","RfD (mg/kg/day)",0.006,1,1994-10-01,"http://www.epa.gov/iris/subst/0235.htm","10/1/1994","Hoechst Celanese Corporation. 1989a. MRID No. 40256502, 41099502. HED Doc. No. 007937. Available from EPA. Write to FOI, EPA, Washington, DC 20460.","NOAEL",0.6,"mg/kg/day","NA","Reduced body weight gain in males and females; increased 
incidence of marked progressive glomerulonephrosis
 and blood vessel aneurysms in males","No","None","None","Yes",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Rat","Sprague-Dawley","M/F","Oral diet",NA,NA,"2","Years","vascular system","M","None",490,"other","M","Dichotomous","blood vessel aneurysms",NA,"ppm",NA,"mg/kg/day",NA,"only incidences in control and high-dose males were reported in IRIS summary; incidences combined across main and satellite groups",NA,0,0,NA,70,10,NA,NA
"113",68,"Endosulfan","115297","C9H6Cl6O3S","IRIS","RfD (mg/kg/day)",0.006,1,1994-10-01,"http://www.epa.gov/iris/subst/0235.htm","10/1/1994","Hoechst Celanese Corporation. 1989a. MRID No. 40256502, 41099502. HED Doc. No. 007937. Available from EPA. Write to FOI, EPA, Washington, DC 20460.","NOAEL",0.6,"mg/kg/day","NA","Reduced body weight gain in males and females; increased 
incidence of marked progressive glomerulonephrosis
 and blood vessel aneurysms in males","No","None","None","Yes",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Rat","Sprague-Dawley","M/F","Oral diet",NA,NA,"2","Years","kidneys","M","None",488,"nonneoplastic histopathology","M","Continuous",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"114",68,"Endosulfan","115297","C9H6Cl6O3S","IRIS","RfD (mg/kg/day)",0.006,1,1994-10-01,"http://www.epa.gov/iris/subst/0235.htm","10/1/1994","Hoechst Celanese Corporation. 1989a. MRID No. 40256502, 41099502. HED Doc. No. 007937. Available from EPA. Write to FOI, EPA, Washington, DC 20460.","NOAEL",0.6,"mg/kg/day","NA","Reduced body weight gain in males and females; increased 
incidence of marked progressive glomerulonephrosis
 and blood vessel aneurysms in males","No","None","None","Yes",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Rat","Sprague-Dawley","M/F","Oral diet",NA,NA,"2","Years","vascular system","M","None",490,"other","M","Continuous","blood vessel aneurysms",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"115",68,"Endosulfan","115297","C9H6Cl6O3S","IRIS","RfD (mg/kg/day)",0.006,1,1994-10-01,"http://www.epa.gov/iris/subst/0235.htm","10/1/1994","Hoechst Celanese Corporation. 1989a. MRID No. 40256502, 41099502. HED Doc. No. 007937. Available from EPA. Write to FOI, EPA, Washington, DC 20460.","NOAEL",0.6,"mg/kg/day","NA","Reduced body weight gain in males and females; increased 
incidence of marked progressive glomerulonephrosis
 and blood vessel aneurysms in males","No","None","None","Yes",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Rat","Sprague-Dawley","M/F","Oral diet",NA,NA,"2","Years","systemic","Both","None",491,"body weight","Both","Continuous","Reduced body weight gain",NA,NA,NA,NA,NA,"Overall weight gains (weeks 0-104) were 17% lower than the controls in both males and females receiving 75 ppm and 9% lower in rats receiving 15 ppm. The gains were significantly lower (p<0.01) in both sexes at the 75 ppm dose. No weight gain effects were seen in males and females receiving 3 or 7.5 ppm when compared with controls.  (Numerical data not reported for this endpoint)",NA,NA,NA,NA,NA,NA,NA,NA
"116",348,"Endrin","72208","C12H8Cl6O","ATSDR","Chronic Oral MRL (mg/kg/day)",3e-04,0.83,NA,"http://www.atsdr.cdc.gov/toxprofiles/tp89.pdf","1996","Kettering Laboratory. 1969. Effects exerted upon beagle dogs during a period of two years by the introduction of 1,2,3,4,10, 10-hexachloro- 6,7,- epoxy-1,4,4a,5,6,7,8,8a-octahydro -1,4-endo, endo-5,8dimethanonaphthalene into their daily diets. Cincinnati, OH. Report to Velsicol Chemical Corporation.","NOAEL",0.025,"mg/kg-day","NA","convulsions","NA","None","None","No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral diet",NA,NA,"2","Years","CNS","F","MOA Data",3598,"clinical signs","F","Dichotomous","convulsions",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"117",348,"Endrin","72208","C12H8Cl6O","IRIS","RfD (mg/kg/day)",3e-04,0.83,1991-04-01,"http://www.epa.gov/iris/subst/0363.htm","4/1/1991","Velsicol Chemical Corporation. 1969. MRID. No. 00030198. Available from EPA. Write FOI, EPA, Washington, DC. 20460.","NOAEL",0.025,"mg/kg/day","NA","Mild histological lesions in liver, occasional convulsions","No","None","None","No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Dog",NA,"M/F","Oral diet",NA,NA,"2","Years","CNS","Both","None",693,"clinical signs","Both","Dichotomous","occasional convulsions",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"118",348,"Endrin","72208","C12H8Cl6O","IRIS","RfD (mg/kg/day)",3e-04,0.83,1991-04-01,"http://www.epa.gov/iris/subst/0363.htm","4/1/1991","Velsicol Chemical Corporation. 1969. MRID. No. 00030198. Available from EPA. Write FOI, EPA, Washington, DC. 20460.","NOAEL",0.025,"mg/kg/day","NA","Mild histological lesions in liver, occasional convulsions","No","None","None","No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Dog",NA,"M/F","Oral diet",NA,NA,"2","Years","liver","Both","None",694,"nonneoplastic histopathology","Both","Dichotomous","mild histological lesions",NA,NA,NA,NA,NA,"slight vacuolization of hepatic cells",NA,NA,NA,NA,NA,NA,NA,NA
"119",274,"Ethion","563122","C9H22O4P2S4","ATSDR","Chronic Oral MRL (mg/kg/day)",4e-04,NA,NA,"http://www.atsdr.cdc.gov/toxprofiles/tp152.pdf","2000","Bailey DE. 1988. 90-Day subchronic toxicity study of ethion technical in dogs (A86-1990). Unpublished revised final report dated June 21, 1988 by Hazelton Laboratories America, Inc., Vienna,
Va for FMC Corp., Princeton, NJ. EPA MRID No. 40773301.","NOAEL",0.06,"mg/kg-day","NA","inhibition of brain acetylcholinesterase","NA","None","None","No",30,3,10,NA,NA,NA,5,FALSE,"an additional modifying factor of 5 was applied to protect against
possible long-term effects, seen in structurally-related cholinesterase inhibitors, which might be the
result of mechanisms other than cholinesterase inhibition, and to protect against possible susceptibility in
children.",NA,"Dog","Beagle","M/F","Oral diet",NA,NA,"90","Days","brain","Both","MOA Determination",3599,"enzyme activity","Both","Continuous","inhibition of brain acetylcholinesterase",NA,NA,NA,NA,NA,"Data reported as percent change from control",NA,NA,NA,NA,NA,NA,NA,NA
"120",274,"Ethion","563122","C9H22O4P2S4","OPP","Chronic RfD (mg/kg/day)",5e-04,1,NA,"http://www.epa.gov/opp00001/chem_search/reg_actions/reregistration/red_PC-058401_27-Apr-01.pdf","4/27/2001","MRID 41188401","NOAEL",0.05,"mg/kg/day","NA","plasma, rbc, brain cholinesterase activity","NA","None","None","No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral diet",NA,NA,"1","Years","CNS","Both",NA,3779,"enzyme activity","Both",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"121",274,"Ethion","563122","C9H22O4P2S4","IRIS","RfD (mg/kg/day)",5e-04,1.2,1989-09-01,"http://www.epa.gov/iris/subst/0156.htm","9/1/1989","FMC Corporation. 1988. MRID No. 40773301. Available from EPA. Write to FOI, EPA, Washington DC 20460.","NOEL",0.06,"mg/kg-day","NA","Inhibition of brain cholinesterase","No","None","None","No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral diet",NA,NA,"90","Days","brain","Both",NA,699,"neurotransmitter","Both",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"122",274,"Ethion","563122","C9H22O4P2S4","IRIS","RfD (mg/kg/day)",5e-04,NA,1989-09-01,"http://www.epa.gov/iris/subst/0156.htm","9/1/1989","FMC Corporation. 1970. MRID No. 00073157. FMC Corporation. 1988. MRID No. 40773301. Available from EPA. Write to FOI, EPA, Washington, DC 20460.

FMC Corporation. 1988. MRID No. 40773301. Available from EPA. Write to FOI, EPA, Washington DC 20460.","NOEL",0.05,"mg/kg/day","NA","Plasma cholinesterase inhibition","No","None","None","No",100,NA,10,NA,NA,NA,10,TRUE,"An additional UF of 10 was used to account for the brain cholinesterase inhibition observed at 25 ppm (0.71 mg/kg/day) in a subchronic dog study (FMC, 1988).",NA,"Human",NA,"Unspecified","Other",NA,NA,"66","Days","CNS","Both","None",695,"neurotransmitter","Both","Continuous","Plasma cholinesterase inhibition",NA,NA,NA,NA,NA,"The test period was divided into four sequential dosing regimens and a recovery period as follows: 1) 0.05 mg/kg/day - 21 days; 2) 0.075 mg/kg/day - 21 days; 3) 0.10 mg/kg/day - 21 days; 4) 0.15 mg/kg/day - 3 days; and 4) Recovery - 19 days. Test material was administered in corn oil solutions at dosages. Dosages were adjusted to body weight on a weekly basis. Control subjects received capsules containing corn oil.",NA,NA,NA,NA,NA,NA,NA,NA
"123",177,"Fluoranthene","206440","C16H10","IRIS","RfD (mg/kg/day)",0.04,NA,1993-07-01,"http://www.epa.gov/iris/subst/0444.htm","7/1/1993","U.S. EPA. 1988. 13-Week mouse oral subchronic toxicity study. Prepared by Toxicity Research Laboratories, Ltd., Muskegon, MI for the Office of Solid Waste, Washington, DC.","NOAEL",125,"mg/kg/day","NA","Nephropathy, increased liver weights, hematological alterations, and clinical effects","No","None","None","No",3000,10,10,NA,NA,NA,30,TRUE,"UF (subchronic to chronic extrapolation) and UF(database incomplete) were reported collectively as 30.",NA,"Mouse","CD-1","M/F","Oral gavage",NA,NA,"13","Weeks","kidneys","Both","None",2193,"nonneoplastic histopathology","F","Dichotomous","nephropathy",NA,"mg/kg/day",NA,NA,NA,"Incidence data are from Table 9 in primary report",NA,0,NA,NA,20,1,NA,NA
"124",177,"Fluoranthene","206440","C16H10","IRIS","RfD (mg/kg/day)",0.04,NA,1993-07-01,"http://www.epa.gov/iris/subst/0444.htm","7/1/1993","U.S. EPA. 1988. 13-Week mouse oral subchronic toxicity study. Prepared by Toxicity Research Laboratories, Ltd., Muskegon, MI for the Office of Solid Waste, Washington, DC.","NOAEL",125,"mg/kg/day","NA","Nephropathy, increased liver weights, hematological alterations, and clinical effects","No","None","None","No",3000,10,10,NA,NA,NA,30,TRUE,"UF (subchronic to chronic extrapolation) and UF(database incomplete) were reported collectively as 30.",NA,"Mouse","CD-1","M/F","Oral gavage",NA,NA,"13","Weeks","kidneys","Both","None",1043,"nonneoplastic histopathology","M","Dichotomous","Nephropathy",NA,"mg/kg/day",NA,NA,NA,"Incidence data are from Table 9 in primary report",NA,0,NA,NA,20,1,NA,NA
"125",177,"Fluoranthene","206440","C16H10","IRIS","RfD (mg/kg/day)",0.04,NA,1993-07-01,"http://www.epa.gov/iris/subst/0444.htm","7/1/1993","U.S. EPA. 1988. 13-Week mouse oral subchronic toxicity study. Prepared by Toxicity Research Laboratories, Ltd., Muskegon, MI for the Office of Solid Waste, Washington, DC.","NOAEL",125,"mg/kg/day","NA","Nephropathy, increased liver weights, hematological alterations, and clinical effects","No","None","None","No",3000,10,10,NA,NA,NA,30,TRUE,"UF (subchronic to chronic extrapolation) and UF(database incomplete) were reported collectively as 30.",NA,"Mouse","CD-1","M/F","Oral gavage",NA,NA,"13","Weeks","liver","Both","None",2191,"clinical chemistry","M","Continuous","increased SGPT levels","SD","mg/kg/day","U/l",NA,NA,"Dose-response data are from Table 6 in primary report.",NA,0,NA,NA,10,NA,21.9,5.79
"126",177,"Fluoranthene","206440","C16H10","IRIS","RfD (mg/kg/day)",0.04,NA,1993-07-01,"http://www.epa.gov/iris/subst/0444.htm","7/1/1993","U.S. EPA. 1988. 13-Week mouse oral subchronic toxicity study. Prepared by Toxicity Research Laboratories, Ltd., Muskegon, MI for the Office of Solid Waste, Washington, DC.","NOAEL",125,"mg/kg/day","NA","Nephropathy, increased liver weights, hematological alterations, and clinical effects","No","None","None","No",3000,10,10,NA,NA,NA,30,TRUE,"UF (subchronic to chronic extrapolation) and UF(database incomplete) were reported collectively as 30.",NA,"Mouse","CD-1","M/F","Oral gavage",NA,NA,"13","Weeks","liver","Both","None",1928,"organ weight","F","Continuous","increased absolute liver weights","SD","mg/kg/day","g",NA,NA,"Dose-response data are from Appendix I of primary report",NA,0,NA,NA,20,NA,1.443,0.102
"127",177,"Fluoranthene","206440","C16H10","IRIS","RfD (mg/kg/day)",0.04,NA,1993-07-01,"http://www.epa.gov/iris/subst/0444.htm","7/1/1993","U.S. EPA. 1988. 13-Week mouse oral subchronic toxicity study. Prepared by Toxicity Research Laboratories, Ltd., Muskegon, MI for the Office of Solid Waste, Washington, DC.","NOAEL",125,"mg/kg/day","NA","Nephropathy, increased liver weights, hematological alterations, and clinical effects","No","None","None","No",3000,10,10,NA,NA,NA,30,TRUE,"UF (subchronic to chronic extrapolation) and UF(database incomplete) were reported collectively as 30.",NA,"Mouse","CD-1","M/F","Oral gavage",NA,NA,"13","Weeks","liver","Both","None",1044,"organ weight","M","Continuous","increased absolute liver weights","SD","mg/kg/day","g",NA,NA,"Dose-response data are from Appendix I of primary report",NA,0,NA,NA,20,NA,1.742,0.235
"128",177,"Fluoranthene","206440","C16H10","IRIS","RfD (mg/kg/day)",0.04,NA,1993-07-01,"http://www.epa.gov/iris/subst/0444.htm","7/1/1993","U.S. EPA. 1988. 13-Week mouse oral subchronic toxicity study. Prepared by Toxicity Research Laboratories, Ltd., Muskegon, MI for the Office of Solid Waste, Washington, DC.","NOAEL",125,"mg/kg/day","NA","Nephropathy, increased liver weights, hematological alterations, and clinical effects","No","None","None","No",3000,10,10,NA,NA,NA,30,TRUE,"UF (subchronic to chronic extrapolation) and UF(database incomplete) were reported collectively as 30.",NA,"Mouse","CD-1","M/F","Oral gavage",NA,NA,"13","Weeks","liver","Both","None",2192,"clinical chemistry","F","Continuous","increased SGPT levels","SD","mg/kg/day","U/l",NA,NA,"Dose-response data are from Table 6 in primary report.",NA,0,NA,NA,10,NA,20.2,4.62
"129",177,"Fluoranthene","206440","C16H10","IRIS","RfD (mg/kg/day)",0.04,NA,1993-07-01,"http://www.epa.gov/iris/subst/0444.htm","7/1/1993","U.S. EPA. 1988. 13-Week mouse oral subchronic toxicity study. Prepared by Toxicity Research Laboratories, Ltd., Muskegon, MI for the Office of Solid Waste, Washington, DC.","NOAEL",125,"mg/kg/day","NA","Nephropathy, increased liver weights, hematological alterations, and clinical effects","No","None","None","No",3000,10,10,NA,NA,NA,30,TRUE,"UF (subchronic to chronic extrapolation) and UF(database incomplete) were reported collectively as 30.",NA,"Mouse","CD-1","M/F","Oral gavage",NA,NA,"13","Weeks","systemic","Both","None",1046,"clinical signs","Both","Dichotomous","clinical effects (salivation)",NA,NA,NA,NA,NA,"According to Table 1 of primary report, increased salivation was observed at several timepoints during the study in animals in the two highest dose group.  Increased salivation in the low dose group was only observed in 2/20 males at week 1.",NA,NA,NA,NA,NA,NA,NA,NA
"130",289,"Gamma-Hexachlorocyclohexane","58899","C6H6Cl6","HEAST","Oral Slope Factor (1/mg/kg-day)",1.3,NA,NA,"http://epa-heast.ornl.gov/heast.php?chemical=Hexachlorocyclohexane, Gamma-",NA,"Thorpe, E. and A.I.T. Walker. 1973. The toxicology of Dieldrin (HEOD). II. Comparative long-term oral toxicity studies in mice with Dieldrin, DDT, Phenobarbitone, beta-BHC and gamma-BHC. Food Cosmet Toxicol. 11: 433-442.",NA,NA,NA,NA,"liver tumors",NA,"None",NA,"Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CF-1","M","Oral diet",NA,NA,"110","Weeks","liver","Both",NA,3644,"neoplasia","Both","Dichotomous","liver tumors",NA,"mg/kg-day",NA,NA,NA,"combined incidence of hyperplastic nodules and hepatocellular carcinomas",NA,0,NA,NA,NA,45,11,NA
"131",289,"Gamma-Hexachlorocyclohexane","58899","C6H6Cl6","CalEPA","Oral Slope Factor (mg/kg-day)-1",1.1,NA,NA,"http://www.oehha.ca.gov/air/hot_spots/2009/AppendixB.pdf","1988","Thorpe E and Walker AIT. 1973. The toxicology of dieldrin (HEOD). II. Comparative long-term oral toxicity studies in mice with dieldrin, DDT, phenobarbitone, -BHC and -BHC. Food Cosmet Toxicol 11:433-442.

U.S. Environmental Protection Agency (US EPA). 1987. Health Assessment Document for Beryllium. Office of Health and Environmental Assessment, Washington DC.7-84.

U.S. Environmental Protection Agency (US EPA). 1988. Drinking Water Criteria Document for Lindane. Environmental Criteria and Assessment Office, Office of Health and Environmental Assessment, U.S. Environmental Protection Agency, Cincinnati, OH.",NA,NA,NA,"NA","liver tumors","NA","None","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CF-1","M","Oral diet",NA,NA,"110","Weeks","liver","Both",NA,2892,"neoplasia","Both","Dichotomous","liver tumors",NA,"ppm diet",NA,"mg/kg-day",NA,NA,NA,0,0,NA,45,11,NA,NA
"132",289,"Gamma-Hexachlorocyclohexane","58899","C6H6Cl6","OPP","Chronic RfD (mg/kg/day)",0.0047,1,NA,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,58-89-9",NA,"MRID: 42871201. Lindane: combined oncogenicity and toxicity study in dietary administration to Wistar rats for 104 weeks.","NOAEL",0.47,"mg/kg-day",NA,"Periacinar hepatocyte hypertrophy, increased liver/spleen weight, decreased platelets",NA,NA,NA,"No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Rat",NA,NA,NA,NA,NA,NA,"Duration",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"133",289,"Gamma-Hexachlorocyclohexane","58899","C6H6Cl6","IRIS","RfD (mg/kg/day)",3e-04,1.1,1988-03-01,"http://www.epa.gov/iris/subst/0065.htm","3/1/1988","Zoecon Corporation. 1983. MRID No. 00128356. Available from EPA. Write to FOI, EPA, Washington D.C. 20460.","NOAEL",0.33,"mg/kg/day","NA","Liver and kidney toxicity","No","None","None","No",1000,10,10,10,NA,NA,NA,TRUE,NA,NA,"Rat","Wistar","M/F","Oral diet",NA,NA,"12","Weeks","liver","Both","None",738,"nonneoplastic histopathology","Both","Dichotomous","Liver toxicity",NA,NA,NA,NA,NA,"liver hypertrophy",NA,NA,NA,NA,NA,NA,NA,NA
"134",289,"Gamma-Hexachlorocyclohexane","58899","C6H6Cl6","IRIS","RfD (mg/kg/day)",3e-04,1.1,1988-03-01,"http://www.epa.gov/iris/subst/0065.htm","3/1/1988","Zoecon Corporation. 1983. MRID No. 00128356. Available from EPA. Write to FOI, EPA, Washington D.C. 20460.","NOAEL",0.33,"mg/kg/day","NA","Liver and kidney toxicity","No","None","None","No",1000,10,10,10,NA,NA,NA,TRUE,NA,NA,"Rat","Wistar","M/F","Oral diet",NA,NA,"12","Weeks","kidneys","Both","None",739,"nonneoplastic histopathology","Both","Dichotomous","kidney toxicity",NA,NA,NA,NA,NA,"Rats were observed to have greater-than-control incidence of the following: tubular degeneration, hyaline droplets, tubular distension, interstitial nephritis, and basophilic
tubules.",NA,NA,NA,NA,NA,NA,NA,NA
"135",289,"Gamma-Hexachlorocyclohexane","58899","C6H6Cl6","CalEPA","Inhalation Unit Risk (1/μg/m3)",0.00031,NA,NA,"http://www.oehha.ca.gov/air/hot_spots/2009/AppendixB.pdf","1988","Thorpe E and Walker AIT. 1973. The toxicology of dieldrin (HEOD). II. Comparative long-term oral toxicity studies in mice with dieldrin, DDT, phenobarbitone, -BHC and -BHC. Food Cosmet Toxicol 11:433-442.

U.S. Environmental Protection Agency (US EPA). 1987. Health Assessment Document for Beryllium. Office of Health and Environmental Assessment, Washington DC.7-84.

U.S. Environmental Protection Agency (US EPA). 1988. Drinking Water Criteria Document for Lindane. Environmental Criteria and Assessment Office, Office of Health and Environmental Assessment, U.S. Environmental Protection Agency, Cincinnati, OH.",NA,NA,NA,"NA","liver tumors","NA","Simple","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CF-1","M","Oral diet",NA,NA,"110","Weeks","liver","Both",NA,2893,"neoplasia","Both","Dichotomous","liver tumors",NA,NA,NA,NA,NA,"IUR was calculated from the cancer slope factor (see accompanying record) using a reference human body weight of 70 kg and an inspiration rate of 20 m3/day.",NA,NA,NA,NA,NA,NA,NA,NA
"136",897,"Guthion (Azinphos-Methyl)","86500",NA,"ATSDR","Chronic Oral MRL (mg/kg/day)",0.003,1,NA,"http://www.atsdr.cdc.gov/ToxProfiles/tp188.pdf","9/2008","Allen TR, Janiak T, Frei T, et al. 1990. 52-Week oral toxicity (feeding) study with azinphosmethyl
(E 1582) in the dog. Mobay Corporation. Submitted to the U.S. Environmental Protection
Agency. MRID41804801.","BMDL",0.3,"mg/kg/day","Other","inhibition of erythrocyte AChE activity in male dogs","NA","None","None","Yes",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral diet",NA,7,"52","Weeks","systemic","Both","MOA Determination",3605,"enzyme activity","M","Continuous","inhibition of erythrocyte AChE activity","SD","mg/kg-day","umol/mL/min",NA,NA,"BMR was 20% reduction in AChE activity",NA,0,NA,NA,4,NA,2.87,0.36
"137",897,"Guthion (Azinphos-Methyl)","86500",NA,"ATSDR","Chronic Inhalation MRL (mg/m3)",0.01,NA,NA,"http://www.atsdr.cdc.gov/ToxProfiles/tp188.pdf","9/2008","Kimmerle G. 1976. Subchronic inhalation toxicity of azinphos-methyl in rats. Arch Toxicol
35:83-89.","NOAEL",1.24,"mg/m3","NA","decreased erythrocyte AChE activity","Yes","None","RDDR","No",30,3,10,NA,NA,NA,NA,NA,NA,NA,"Rat","Wistar","M/F","Inhalation",6,5,"12","Weeks","PNS","Both","MOA Determination",4001,"neurotransmitter","Both",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"138",897,"Guthion (Azinphos-Methyl)","86500",NA,"OPP","Chronic RfD (mg/kg/day)",0.0015,0.99,NA,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,86-50-0","07/31/2006","MRID 41804801: Allen T. 1990. 52-week oral toxicity (feeding) study with Azinphos-methyl (E 1582) in the dogL Lab project number: R5064: 100644. (Unpublished study prepared by Bayer AG).","NOAEL",0.149,"mg/kg-day",NA,"significant decreases in red blood cell cholinesterase activity in both sexes and an increased incidence of diarrhea in males.",NA,NA,NA,"No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral diet",NA,NA,"1","Years",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"139",408,"Heptachlor","76448","C10H5Cl7","CalEPA","Oral Slope Factor (mg/kg-day)-1",4.1,NA,NA,"http://oehha.ca.gov/risk/ChemicalDB/index.asp","02/1999","Davis, H.J. 1965. Pathology report on mice fed aldrin, dieldrin, heptachlor or heptachlor epoxide
for two years. Internal FDA memorandum to Dr. A.J. Lehman, July 19. (Cited in Epstein, 1976).",NA,NA,NA,"10% ER","liver tumors",NA,NA,"BW3/4","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","C3H","M/F",NA,NA,NA,"2","Years","liver","Both","None",3236,"neoplasia","M",NA,"liver tumors",NA,"ppm diet",NA,NA,"mg/kg/day","The CSF is the geometric mean of male and female C3H mice and male B6C3F1 mice",NA,0,NA,0,73,22,NA,NA
"140",408,"Heptachlor","76448","C10H5Cl7","CalEPA","Oral Slope Factor (mg/kg-day)-1",4.1,NA,NA,"http://oehha.ca.gov/risk/ChemicalDB/index.asp","02/1999","Davis, H.J. 1965. Pathology report on mice fed aldrin, dieldrin, heptachlor or heptachlor epoxide
for two years. Internal FDA memorandum to Dr. A.J. Lehman, July 19. (Cited in Epstein, 1976).",NA,NA,NA,"10% ER","liver tumors",NA,NA,"BW3/4","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","C3H","M/F",NA,NA,NA,"2","Years","liver","Both","None",4390,"neoplasia","F",NA,"liver tumors",NA,"ppm diet",NA,NA,"mg/kg/day",NA,NA,0,NA,0,53,2,NA,NA
"141",408,"Heptachlor","76448","C10H5Cl7","CalEPA","Oral Slope Factor (mg/kg-day)-1",4.1,NA,NA,"http://oehha.ca.gov/risk/ChemicalDB/index.asp","02/1999","NCI. 1977. Bioassay of Heptachlor for Possible Carcinogenicity. NCI Carcinogenesis Tech.
Rep. Ser. No. 9 111 p. [Also publ. as DHEW Publication No. (NIH) 77-809], National Cancer
Institute, Washington, DC.",NA,NA,NA,"10% ER","liver tumors- carcinomas",NA,NA,"BW3/4","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","B6C3F1","M/F",NA,NA,NA,"80","Weeks","liver","Both","None",3222,"neoplasia","M","Dichotomous","liver tumors carcinomas",NA,"ppm diet",NA,NA,"mg/kg/day","The CSF is the geometric mean of male and female C3H mice and male B6C3F1 mice",NA,0,NA,0,19,9,NA,NA
"142",408,"Heptachlor","76448","C10H5Cl7","IRIS","Oral Slope Factor (1/mg/kg-day)",4.5,NA,1993-07-01,"http://www.epa.gov/iris/subst/0243.htm","7/1/1993","NCI (National Cancer Institute). 1977. Bioassay of Heptachlor for Possible Carcinogenicity. NCI Carcinogenesis Tech. Rep. Ser. No. 9. (Also published as DHEW Publication No. [NIH] 77-809).",NA,NA,NA,NA,"hepatocellular carcinomas","No","None","Other","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Oral diet",NA,NA,"80","Weeks","liver","Both","None",1597,"neoplasia","F","Dichotomous","hepatocellular carcinomas",NA,"ppm","incidence",NA,"mg/kg/day","The OSF is the geometric mean of the slope factors from male and female C3H (Davis, 1965) and male and female B6C3F1 mice (NCI, 1977).  Method for animal to human extrapolation was not reported.",NA,0,NA,0,10,2,NA,NA
"143",408,"Heptachlor","76448","C10H5Cl7","IRIS","Oral Slope Factor (1/mg/kg-day)",4.5,NA,1993-07-01,"http://www.epa.gov/iris/subst/0243.htm","7/1/1993","NCI (National Cancer Institute). 1977. Bioassay of Heptachlor for Possible Carcinogenicity. NCI Carcinogenesis Tech. Rep. Ser. No. 9. (Also published as DHEW Publication No. [NIH] 77-809).",NA,NA,NA,NA,"hepatocellular carcinomas","No","None","Other","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Oral diet",NA,NA,"80","Weeks","liver","Both","None",1596,"neoplasia","M","Dichotomous","hepatocellular carcinomas",NA,"ppm",NA,NA,"mg/kg/day","The OSF is the geometric mean of the slope factors from male and female C3H (Davis, 1965) and male and female B6C3F1 mice (NCI, 1977).  Method for animal to human extrapolation was not reported.",NA,0,NA,0,19,5,NA,NA
"144",408,"Heptachlor","76448","C10H5Cl7","IRIS","Oral Slope Factor (1/mg/kg-day)",4.5,NA,1993-07-01,"http://www.epa.gov/iris/subst/0243.htm","7/1/1993","Davis, K. 1965. Pathology Report on Mice Fed Aldrin, Dieldrin, Heptachlor and Heptachlor Epoxide for Two Years. Internal FDA memorandum to Dr. A.J. Lehman, July 19.

Reuber, M.D. 1977. Histopathology of Carcinomas of the Liver in Mice Ingesting Heptachlor or Heptachlor Epoxide. Exp. Cell Biol. 45: 147-157.

Epstein, S.S. 1976. Carcinogenicity of heptachlor and chlordane. Sci. Total Environ. 6: 103-154.",NA,NA,NA,"Other","hepatocellular carcinomas","No","None","None","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","C3H","M/F","Oral diet",NA,NA,"2","Years","liver","Both","None",1593,"neoplasia","M","Dichotomous","hepatocellular carcinomas",NA,"ppm","incidence",NA,"mg/kg/day","The OSF is the geometric mean of the slope factors from male and female C3H (Davis, 1965) and male and female B6C3F1 mice (NCI, 1977).  Method for animal to human extrapolation was not reported.",NA,0,NA,0,73,22,NA,NA
"145",408,"Heptachlor","76448","C10H5Cl7","IRIS","Oral Slope Factor (1/mg/kg-day)",4.5,NA,1993-07-01,"http://www.epa.gov/iris/subst/0243.htm","7/1/1993","Davis, K. 1965. Pathology Report on Mice Fed Aldrin, Dieldrin, Heptachlor and Heptachlor Epoxide for Two Years. Internal FDA memorandum to Dr. A.J. Lehman, July 19.

Reuber, M.D. 1977. Histopathology of Carcinomas of the Liver in Mice Ingesting Heptachlor or Heptachlor Epoxide. Exp. Cell Biol. 45: 147-157.

Epstein, S.S. 1976. Carcinogenicity of heptachlor and chlordane. Sci. Total Environ. 6: 103-154.",NA,NA,NA,"Other","hepatocellular carcinomas","No","None","None","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","C3H","M/F","Oral diet",NA,NA,"2","Years","liver","Both","None",1594,"neoplasia","F","Dichotomous","hepatocellular carcinomas",NA,"ppm","incidence",NA,"mg/kg/day","The OSF is the geometric mean of the slope factors from male and female C3H (Davis, 1965) and male and female B6C3F1 mice (NCI, 1977).  Method for animal to human extrapolation was not reported.",NA,0,NA,0,53,2,NA,NA
"146",408,"Heptachlor","76448","C10H5Cl7","IRIS","Inhalation Unit Risk (1/μg/m3)",0.0013,NA,1993-07-01,"http://www.epa.gov/iris/subst/0243.htm","7/1/1993","Davis, K. 1965. Pathology Report on Mice Fed Aldrin, Dieldrin, Heptachlor and Heptachlor Epoxide for Two Years. Internal FDA memorandum to Dr. A.J. Lehman, July 19.

Reuber, M.D. 1977. Histopathology of Carcinomas of the Liver in Mice Ingesting Heptachlor or Heptachlor Epoxide. Exp. Cell Biol. 45: 147-157.

Epstein, S.S. 1976. Carcinogenicity of heptachlor and chlordane. Sci. Total Environ. 6: 103-154.

NCI (National Cancer Institute). 1977. Bioassay of Heptachlor for Possible Carcinogenicity. NCI Carcinogenesis Tech. Rep. Ser. No. 9. (Also published as DHEW Publication No. [NIH] 77-809).",NA,NA,NA,"Other","hepatocellular carcinomas (from oral data presented with OSF; method for route-to-route extrapolation not reported)","Yes","Other","Other","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"147",408,"Heptachlor","76448","C10H5Cl7","IRIS","RfD (mg/kg/day)",5e-04,1,1991-03-01,"http://www.epa.gov/iris/subst/0243.htm","3/1/1991","Velsicol Chemical Corporation. 1955a. MRID No. 00062599. Available from EPA. Write to FOI, EPA, Washington, DC 20460.","NOEL",0.15,"mg/kg/day","NA","liver weight increases in males","No","None","None","No",300,10,10,NA,NA,3,NA,TRUE,NA,NA,"Rat","Carworth farm","M/F","Oral diet",NA,NA,"2","Years","liver","Both","None",1589,"organ weight","M",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"148",12,"Heptachlor Epoxide","1024573","C10H5Cl7O","IRIS","Oral Slope Factor (1/mg/kg-day)",9.1,NA,1993-07-01,"http://www.epa.gov/iris/subst/0160.htm","7/1/1993","Davis, K.J. 1965. Pathology Report on Mice Fed Aldrin, Dieldrin, Heptachlor and Heptachlor Epoxide for Two Years. Internal FDA memorandum to Dr. A.J. Lehman, July 19.
Epstein, S.S. 1976. Carcinogenicity of heptachlor and chlordane. Sci. Total Environ. 6: 103-154.
Reuber, M.D. 1977. Histopathology of carcinomas of the liver in mice ingesting heptachlor or heptachlor epoxide. Exp. Cell Biol. 45: 147-157.",NA,NA,NA,"Other","hepatocellular carcinomas",NA,NA,"Other","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","C3H","M/F","Oral diet",NA,NA,"2","Years","liver","Both","MOA Data",236,"neoplasia","F","Dichotomous","hepatocellular carcinomas",NA,"ppm","incidence",NA,"mg/kg/day","The oral slope factor is a geometric mean of the slope factors derived from both sexes from both studies.  (For this study: F = 36.2 per mg/kg/day)",NA,0,NA,0,53,2,NA,NA
"149",12,"Heptachlor Epoxide","1024573","C10H5Cl7O","IRIS","Oral Slope Factor (1/mg/kg-day)",9.1,NA,1993-07-01,"http://www.epa.gov/iris/subst/0160.htm","7/1/1993","Davis, K.J. 1965. Pathology Report on Mice Fed Aldrin, Dieldrin, Heptachlor and Heptachlor Epoxide for Two Years. Internal FDA memorandum to Dr. A.J. Lehman, July 19.
Epstein, S.S. 1976. Carcinogenicity of heptachlor and chlordane. Sci. Total Environ. 6: 103-154.
Reuber, M.D. 1977. Histopathology of carcinomas of the liver in mice ingesting heptachlor or heptachlor epoxide. Exp. Cell Biol. 45: 147-157.",NA,NA,NA,"Other","hepatocellular carcinomas",NA,NA,"Other","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","C3H","M/F","Oral diet",NA,NA,"2","Years","liver","Both","MOA Data",235,"neoplasia","M","Dichotomous","hepatocellular carcinomas",NA,"ppm","incidence",NA,"mg/kg/day","The oral slope factor is a geometric mean of the slope factors derived from both sexes from both studies.  (For this study: M = 27.7 per mg/kg/day)",NA,0,NA,0,73,22,NA,NA
"150",12,"Heptachlor Epoxide","1024573","C10H5Cl7O","IRIS","Oral Slope Factor (1/mg/kg-day)",9.1,NA,1993-07-01,"http://www.epa.gov/iris/subst/0160.htm","7/1/1993","Velsicol Chemical Corporation. 1973. MRID No. 00062678. Available from EPA. Write to FOI, EPA, Washington, D.C. 20460.
Reuber, M.D. 1977. Histopathology of carcinomas of the liver in mice ingesting heptachlor or heptachlor epoxide. Exp. Cell Biol. 45: 147-157.",NA,NA,NA,"Other","hepatocellular carcinomas",NA,NA,"Other","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CD-1","M/F","Oral diet",NA,NA,"18","Months","liver","Both","MOA Data",249,"neoplasia","F","Dichotomous","hepatocelluar carcinomas (mg/kg/day)",NA,"ppm","incidence",NA,"mg/kg/day","he oral slope factor is a geometric mean of the slope factors derived from both sexes from both studies.  (For this study F = 1.04 per mg/kg/day)",NA,0,NA,0,76,6,NA,NA
"151",12,"Heptachlor Epoxide","1024573","C10H5Cl7O","IRIS","Oral Slope Factor (1/mg/kg-day)",9.1,NA,1993-07-01,"http://www.epa.gov/iris/subst/0160.htm","7/1/1993","Velsicol Chemical Corporation. 1973. MRID No. 00062678. Available from EPA. Write to FOI, EPA, Washington, D.C. 20460.
Reuber, M.D. 1977. Histopathology of carcinomas of the liver in mice ingesting heptachlor or heptachlor epoxide. Exp. Cell Biol. 45: 147-157.",NA,NA,NA,"Other","hepatocellular carcinomas",NA,NA,"Other","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CD-1","M/F","Oral diet",NA,NA,"18","Months","liver","Both","MOA Data",248,"neoplasia","M","Dichotomous","hepatocelluar carcinomas (incidence)",NA,"ppm","incidence",NA,"mg/kg/day","The oral slope factor is a geometric mean of the slope factors derived from both sexes from both studies.  (For this study M = 6.48 per mg/kg/day)",NA,0,NA,0,62,0,NA,NA
"152",12,"Heptachlor Epoxide","1024573","C10H5Cl7O","CalEPA","Oral Slope Factor (mg/kg-day)-1",5.5,NA,NA,"http://oehha.ca.gov/risk/ChemicalDB/index.asp","2-1999","Davis, H.J. 1965. Pathology report on mice fed aldrin, dieldrin, heptachlor or heptachlor epoxide
for two years. Internal FDA memorandum to Dr. A.J. Lehman, July 19. (Cited in Epstein, 1976).",NA,NA,NA,"10% ER","liver tumors",NA,NA,"BW3/4","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","C3H","M/F","Oral diet",NA,NA,"2","Years","liver","Both","None",4391,"neoplasia","F",NA,"hepatocellular carcinomas",NA,"ppm diet",NA,NA,"mg/kg/day",NA,NA,0,NA,0,53,2,NA,NA
"153",12,"Heptachlor Epoxide","1024573","C10H5Cl7O","CalEPA","Oral Slope Factor (mg/kg-day)-1",5.5,NA,NA,"http://oehha.ca.gov/risk/ChemicalDB/index.asp","2-1999","Davis, H.J. 1965. Pathology report on mice fed aldrin, dieldrin, heptachlor or heptachlor epoxide
for two years. Internal FDA memorandum to Dr. A.J. Lehman, July 19. (Cited in Epstein, 1976).",NA,NA,NA,"10% ER","liver tumors",NA,NA,"BW3/4","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","C3H","M/F","Oral diet",NA,NA,"2","Years","liver","Both","None",3237,"neoplasia","M",NA,"hepatocellular carcinomas",NA,"ppm diet",NA,NA,"mg/kg/day","The CSF is the geometric mean of the male and female studies in C3H and CD1 mice",NA,0,NA,0,73,22,NA,NA
"154",12,"Heptachlor Epoxide","1024573","C10H5Cl7O","CalEPA","Oral Slope Factor (mg/kg-day)-1",5.5,NA,NA,"http://oehha.ca.gov/risk/ChemicalDB/index.asp","2-1999","IRDC. 1973. Unpublished report to Velsicol Chemical corporation, Eighteen Month Oral Carcinogenic Study in Mice, December 14. (Cited in Epstein, 1976), International Research and Development Corporation, Mattawan, MI.",NA,NA,NA,"10% ER","liver tumors",NA,NA,"BW3/4","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CD-1","M/F","Oral diet",NA,NA,"18","Months","liver","Both","None",3238,"neoplasia","M","Dichotomous","liver tumors",NA,"ppm diet",NA,NA,"mg/kg/day","The CSF is the geometric mean of the male and female studies in C3H and CD1 mice",NA,0,NA,0,62,0,NA,NA
"155",12,"Heptachlor Epoxide","1024573","C10H5Cl7O","CalEPA","Oral Slope Factor (mg/kg-day)-1",5.5,NA,NA,"http://oehha.ca.gov/risk/ChemicalDB/index.asp","2-1999","IRDC. 1973. Unpublished report to Velsicol Chemical corporation, Eighteen Month Oral Carcinogenic Study in Mice, December 14. (Cited in Epstein, 1976), International Research and Development Corporation, Mattawan, MI.",NA,NA,NA,"10% ER","liver tumors",NA,NA,"BW3/4","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CD-1","M/F","Oral diet",NA,NA,"18","Months","liver","Both","None",3239,"neoplasia","F","Dichotomous","liver tumors",NA,"ppm diet",NA,NA,"mg/kg/day",NA,NA,0,NA,0,76,6,NA,NA
"156",12,"Heptachlor Epoxide","1024573","C10H5Cl7O","IRIS","RfD (mg/kg/day)",1.3e-05,0.96,1991-03-01,"http://www.epa.gov/iris/subst/0160.htm","3/1/1991","Dow Chemical Company. 1958. MRID No. 00061912. Available from EPA. Write to FOI, EPA,
Washington, DC 20460.","LEL",0.0125,"mg/kg/day","NA","Increased liver-to-body weight ratio in both males and females","No","None","None","No",1000,10,10,NA,10,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral diet",NA,NA,"60","Weeks","liver","Both","None",268,"organ weight","Both",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"157",12,"Heptachlor Epoxide","1024573","C10H5Cl7O","IRIS","Oral Slope Factor (1/mg/kg-day)",9.1,NA,1993-07-01,"http://www.epa.gov/iris/subst/0160.htm","7/1/1993","Davis, K.J. 1965. Pathology Report on Mice Fed Aldrin, Dieldrin, Heptachlor and Heptachlor Epoxide for Two Years. Internal FDA memorandum to Dr. A.J. Lehman, July 19.
Epstein, S.S. 1976. Carcinogenicity of heptachlor and chlordane. Sci. Total Environ. 6: 103-154.
Reuber, M.D. 1977. Histopathology of carcinomas of the liver in mice ingesting heptachlor or heptachlor epoxide. Exp. Cell Biol. 45: 147-157.",NA,NA,NA,"Other","hepatocellular carcinomas",NA,NA,"Other","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","C3H","M/F","Oral diet",NA,NA,"2","Years","liver","Both","MOA Data",235,"neoplasia","M","Continuous",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"158",12,"Heptachlor Epoxide","1024573","C10H5Cl7O","IRIS","Oral Slope Factor (1/mg/kg-day)",9.1,NA,1993-07-01,"http://www.epa.gov/iris/subst/0160.htm","7/1/1993","Velsicol Chemical Corporation. 1973. MRID No. 00062678. Available from EPA. Write to FOI, EPA, Washington, D.C. 20460.
Reuber, M.D. 1977. Histopathology of carcinomas of the liver in mice ingesting heptachlor or heptachlor epoxide. Exp. Cell Biol. 45: 147-157.",NA,NA,NA,"Other","hepatocellular carcinomas",NA,NA,"Other","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CD-1","M/F","Oral diet",NA,NA,"18","Months","liver","Both","MOA Data",248,"neoplasia","M","Continuous",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"159",12,"Heptachlor Epoxide","1024573","C10H5Cl7O","IRIS","Inhalation Unit Risk (1/μg/m3)",0.0026,NA,1993-07-01,"http://www.epa.gov/iris/subst/0160.htm","7/1/1993","Davis, K.J. 1965. Pathology Report on Mice Fed Aldrin, Dieldrin, Heptachlor and Heptachlor Epoxide for Two Years. Internal FDA memorandum to Dr. A.J. Lehman, July 19.
Epstein, S.S. 1976. Carcinogenicity of heptachlor and chlordane. Sci. Total Environ. 6: 103-154.
Reuber, M.D. 1977. Histopathology of carcinomas of the liver in mice ingesting heptachlor or heptachlor epoxide. Exp. Cell Biol. 45: 147-157.
Velsicol Chemical Corporation. 1973. MRID No. 00062678. Available from EPA. Write to FOI, EPA, Washington, D.C. 20460.",NA,NA,NA,"Other","hepatocelluar carcinomas (data from oral studies was used to derive inhalation risk estimates; route-to-route extrapolation method was not defined)",NA,"Other","Other","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"160",357,"Lead","7439921","Pb",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"161",381,"Mercury(II) chloride","7487947","HgCl2","IRIS","RfD (mg/kg/day)",3e-04,1.06,1995-05-01,"http://www.epa.gov/iris/subst/0692.htm","5/1/1995","U.S. EPA. 1987. Peer Review Workshop on Mercury Issues. Summary Report. Environmental Criteria and Assessment Office, Cincinnati, OH. October 26-27.","LOAEL",0.317,"mg/kg-d",NA,"Autoimmune effects (i.e., glomerulonephritis)","Yes",NA,NA,"No",1000,10,10,NA,10,NA,NA,TRUE,NA,NA,"Rat",NA,NA,NA,NA,NA,NA,"Duration","kidneys","Both","MOA Data",2095,"nonneoplastic histopathology","Both",NA,"Autoimmune effects (i.e., glomerulonephritis)",NA,NA,NA,NA,NA,"The LOAEL exposure levels, utilized in the three studies selected as the basis of the recommended DWEL, are from Druet et al. (1978), Bernaudin et al. (1981) and Andres (1984), respectively.This RfD is based on the back calculations from a Drinking Water Equivalent Level (DWEL), recommended to and subsequently adopted by the Agency, of 0.010 mg/L: (RfD = 0.010 mg/L x 2 L/day/70 kg bw = 0.0003 mg/kg bw/day).",NA,NA,NA,NA,NA,NA,NA,NA
"162",349,"Methoxychlor","72435","C16H15Cl3O2","IRIS","RfD (mg/kg/day)",0.005,1,1991-08-01,"http://www.epa.gov/iris/subst/0369.htm","8/1/1991","Kincaid Enterprises, Inc. 1986. MRID No. 0015992. Available from EPA. Write to FOI, EPA, Washington, DC 20460.","NOEL",5.01,"mg/kg/day","NA","Excessive loss of litters","No","None","None","No",1000,10,10,NA,NA,10,NA,TRUE,NA,NA,"Rabbit","New Zealand","F","Oral gavage",NA,NA,"7-19","GD","female repro","Both","MOA Determination",786,"reproduction","Both","Dichotomous","Excessive loss of litters",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"163",488,"Naphthalene","91203","C10H8","CalEPA","Inhalation Unit Risk (1/μg/m3)",3.4e-05,NA,NA,"http://www.oehha.ca.gov/air/hot_spots/2009/AppendixB.pdf","2004","National Toxicology Program (NTP). 2000. Toxicology and Carcinogenesis Studies of Naphthalene (CAS No. 91-20-3) in F344/N Rats (Inhalation Studies). Technical Report Series No. 500. NIH Publication No. 00-4434. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health. NTP, Research Triangle Park, NC.",NA,NA,NA,"NA","nasal respiratory epithelial adenoma and nasal olfactory epithelial neuroblastoma in male rats","Yes","None","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Rat","Fischer 344","M/F","Inhalation",6,5,"105","Weeks","nasal passages","M","MOA Data",4459,"neoplasia","M","Dichotomous","nasal olfactory epithelial neuroblastoma",NA,"ppm air",NA,"mg/m3 (ADJ)",NA,NA,NA,0,0,NA,49,0,NA,NA
"164",488,"Naphthalene","91203","C10H8","CalEPA","Inhalation Unit Risk (1/μg/m3)",3.4e-05,NA,NA,"http://www.oehha.ca.gov/air/hot_spots/2009/AppendixB.pdf","2004","National Toxicology Program (NTP). 2000. Toxicology and Carcinogenesis Studies of Naphthalene (CAS No. 91-20-3) in F344/N Rats (Inhalation Studies). Technical Report Series No. 500. NIH Publication No. 00-4434. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health. NTP, Research Triangle Park, NC.",NA,NA,NA,"NA","nasal respiratory epithelial adenoma and nasal olfactory epithelial neuroblastoma in male rats","Yes","None","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Rat","Fischer 344","M/F","Inhalation",6,5,"105","Weeks","nasal passages","M","MOA Data",3021,"neoplasia","M","Dichotomous","nasal respiratory epithelial adenoma",NA,"ppm air",NA,"mg/m3 (ADJ)",NA,NA,NA,0,0,NA,44,0,NA,NA
"165",488,"Naphthalene","91203","C10H8","IRIS","RfC (mg/m3)",0.003,NA,1998-09-17,"http://www.epa.gov/iris/subst/0436.htm","9/17/1998","National Toxicology Program (NTP). (1992a) Toxicology and carcinogenesis studies of naphthalene in B6C3F1 mice (inhalation studies). Technical Report Series No. 410. NIH Publication No. 92-3141.","LOAEL",9.3,"mg/m3","NA","Nasal effects: hyperplasia and metaplasia in respiratory and olfactory epithelium, respectively","Yes","None","Blood:gas partitioning","Yes",3000,10,10,NA,10,3,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Inhalation",6,5,"103","Weeks","nasal passages","Both","MOA Evaluation",3666,"nonneoplastic histopathology","M","Dichotomous","Nasal effects: hyperplasia in respiratory  epithelium",NA,"mg/m3",NA,"mg/m3 (ADJ)","mg/m3",NA,NA,0,0,0,70,0,NA,NA
"166",488,"Naphthalene","91203","C10H8","IRIS","RfC (mg/m3)",0.003,NA,1998-09-17,"http://www.epa.gov/iris/subst/0436.htm","9/17/1998","National Toxicology Program (NTP). (1992a) Toxicology and carcinogenesis studies of naphthalene in B6C3F1 mice (inhalation studies). Technical Report Series No. 410. NIH Publication No. 92-3141.","LOAEL",9.3,"mg/m3","NA","Nasal effects: hyperplasia and metaplasia in respiratory and olfactory epithelium, respectively","Yes","None","Blood:gas partitioning","Yes",3000,10,10,NA,10,3,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Inhalation",6,5,"103","Weeks","nasal passages","Both","MOA Evaluation",1762,"nonneoplastic histopathology","F","Dichotomous","Nasal effects: hyperplasia in respiratory  epithelium",NA,"mg/m3",NA,"mg/m3 (ADJ)","mg/m3",NA,NA,0,0,0,69,0,NA,NA
"167",488,"Naphthalene","91203","C10H8","IRIS","RfC (mg/m3)",0.003,NA,1998-09-17,"http://www.epa.gov/iris/subst/0436.htm","9/17/1998","National Toxicology Program (NTP). (1992a) Toxicology and carcinogenesis studies of naphthalene in B6C3F1 mice (inhalation studies). Technical Report Series No. 410. NIH Publication No. 92-3141.","LOAEL",9.3,"mg/m3","NA","Nasal effects: hyperplasia and metaplasia in respiratory and olfactory epithelium, respectively","Yes","None","Blood:gas partitioning","Yes",3000,10,10,NA,10,3,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Inhalation",6,5,"103","Weeks","nasal passages","Both","MOA Evaluation",3667,"nonneoplastic histopathology","M","Dichotomous","Nasal effects: metaplasia  in olfactory epithelium",NA,"mg/m3",NA,"mg/m3 (ADJ)","mg/m3",NA,NA,0,0,0,70,0,NA,NA
"168",488,"Naphthalene","91203","C10H8","IRIS","RfC (mg/m3)",0.003,NA,1998-09-17,"http://www.epa.gov/iris/subst/0436.htm","9/17/1998","National Toxicology Program (NTP). (1992a) Toxicology and carcinogenesis studies of naphthalene in B6C3F1 mice (inhalation studies). Technical Report Series No. 410. NIH Publication No. 92-3141.","LOAEL",9.3,"mg/m3","NA","Nasal effects: hyperplasia and metaplasia in respiratory and olfactory epithelium, respectively","Yes","None","Blood:gas partitioning","Yes",3000,10,10,NA,10,3,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Inhalation",6,5,"103","Weeks","nasal passages","Both","MOA Evaluation",3023,"nonneoplastic histopathology","F","Dichotomous","Nasal effects: metaplasia  in olfactory epithelium",NA,"mg/m3",NA,"mg/m3 (ADJ)","mg/m3",NA,NA,0,0,0,69,0,NA,NA
"169",488,"Naphthalene","91203","C10H8","CalEPA","Oral Slope Factor (1/mg/kg-day)",0.12,NA,NA,"http://www.oehha.ca.gov/air/hot_spots/2009/AppendixB.pdf","2004","National Toxicology Program (NTP). 2000. Toxicology and Carcinogenesis Studies of Naphthalene (CAS No. 91-20-3) in F344/N Rats (Inhalation Studies). Technical Report Series No. 500. NIH Publication No. 00-4434. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health. NTP, Research Triangle Park, NC.",NA,NA,NA,"NA","nasal respiratory epithelial adenoma and nasal olfactory epithelial neuroblastoma in male rats","Yes","Simple","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Rat","Fischer 344","M/F","Inhalation",6,5,"105","Weeks","nasal passages","Both","MOA Data",3019,"neoplasia","M","Dichotomous","nasal respiratory epithelial adenoma and nasal olfactory epithelial neuroblastoma in male rats",NA,NA,NA,NA,NA,"Based on inhalation study (see IUR record). Breathing rates were calculated to be 0.262 m3/day for male rats.  Lifetime average doses were determined by multiplying the average concentrations during the dosing period by the appropriate animal breathing rate divided by the corresponding animal body weight.   The slope factor for this dataset was 0.10 per mg/kg/day.",NA,NA,NA,NA,NA,NA,NA,NA
"170",488,"Naphthalene","91203","C10H8","OPP","RfD (mg/kg/day)",0.1,1,NA,"http://www.epa.gov/opp00001/chem_search/reg_actions/reregistration/red_PC-055801_12-Sep-08.pdf","9/12/2008","National Toxicology Program (NTP) 1980. Unpublished subchronic toxicity study: Naphthalene (C52904), Fischer 344 rats.","NOAEL",100,"mg/kg/day","NA","significant decreases in body weights/body weight gains","No","None","None","No",1000,10,10,10,NA,NA,NA,TRUE,NA,NA,"Rat","Fischer 344","M/F","Oral gavage",NA,5,"90","Days","systemic","Both",NA,3863,"body weight","Both",NA,NA,NA,NA,NA,NA,NA,"Primary study does not report varibility measures.",NA,NA,NA,NA,NA,NA,NA,NA
"171",488,"Naphthalene","91203","C10H8","ATSDR","Chronic Inhalation MRL (ppm)",7e-04,NA,NA,"http://www.atsdr.cdc.gov/toxprofiles/tp67.pdf","2005","NTP. 1992a. Toxicology and carcinogenesis studies of naphthalene (CAS No. 91-20-3) in B6C3F1 mice (inhalation studies). Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health. National Toxicology Program. NIH Publication No. 92-3141. Technical report series no. 410.

NTP. 2000. Toxicology and carcinogenesis studies of naphthalene (CAS No. 91-20-3) in F344/N rats (inhalation studies). National Toxicology Program. NTP TR 500, NIH Publ. No. 01-4434.

Abdo et al. 2001; NTP 2000: Groups of 49 male and 49 female F344/N rats were exposed to naphthalene at concentrations of 0, 10, 30, or 60 ppm for 6 hours/day, 5 days/week for 105 weeks.","LOAEL",0.2,"ppm","NA","nonneoplastic lesions in nasal olfactory epithelium (metaplasia, hyperplasia, atrophy, and chronic inflammation)","Yes","None","RGDR","Yes",300,3,10,NA,10,NA,NA,NA,NA,NA,"Rat","Fischer 344","M/F","Inhalation",6,5,"105","Weeks","nasal passages","Both","MOA Evaluation",3612,"nonneoplastic histopathology","M","Dichotomous","nonneoplastic lesions in nasal olfactory epithelium (metaplasia, hyperplasia, atrophy, and chronic inflammation).",NA,NA,NA,NA,NA,"Benchmark dose analyses were not conducted on the incidence data for nonneoplastic nasal lesions, because the data provided insufficient information on the shape of the dose-response relationship.  The lowest exposure level in the principal study induced nasal lesions in essentially all of the rats.",NA,NA,NA,NA,NA,NA,NA,NA
"172",488,"Naphthalene","91203","C10H8","IRIS","RfD (mg/kg/day)",0.02,1.18,1998-09-17,"http://www.epa.gov/iris/subst/0436.htm","9/17/1998","Battelle's Columbus Laboratories (BCL). (1980a) Unpublished subchronic toxicity study: Naphthalene (C52904), Fischer 344 rats. Prepared by Battelle Laboratories under NTP Subcontract No. 76-34-106002.","NOAEL",71,"mg/kg/day","NA","Decreased mean terminal body weight in males","Yes","None","None","No",3000,10,10,10,NA,3,NA,TRUE,NA,NA,"Rat","Fischer 344","M/F","Oral gavage",NA,5,"13","Weeks","systemic","M","None",1758,"body weight","M","Continuous","Decreased mean terminal body weight in males",NA,NA,NA,NA,NA,"Body weight data presented without variability measure.  (Individual animal data are available)",NA,NA,NA,NA,NA,NA,NA,NA
"173",362,"Nickel","7440020","Ni","IRIS","RfD (mg/kg/day)",0.02,0.83,1996-12-01,"http://www.epa.gov/iris/subst/0271.htm","12/1/1996","Ambrose, A.M., D.S. Larson, J.R. Borzelleca and G.R. Hennigar, Jr. 1976. Long-term toxicologic assessment of nickel in rats and dogs. J. Food Sci. Technol. 13: 181-187.","NOAEL",5,"mg/kg/day","NA","Decreased body and organ weights","No","None","None","No",300,10,10,NA,NA,3,NA,TRUE,NA,NA,"Rat","Wistar","M/F","Oral diet",NA,NA,"2","Years","liver","F","None",1412,"organ weight","F","Continuous","decreased organ weight (lower liver-to-body weight ratio)","SD","ppm","g/kg bw","mg/kg/day",NA,"Data are from Table 3 in primary report.",NA,0,0,NA,4,NA,36.6,5.2
"174",362,"Nickel","7440020","Ni","IRIS","RfD (mg/kg/day)",0.02,0.83,1996-12-01,"http://www.epa.gov/iris/subst/0271.htm","12/1/1996","Ambrose, A.M., D.S. Larson, J.R. Borzelleca and G.R. Hennigar, Jr. 1976. Long-term toxicologic assessment of nickel in rats and dogs. J. Food Sci. Technol. 13: 181-187.","NOAEL",5,"mg/kg/day","NA","Decreased body and organ weights","No","None","None","No",300,10,10,NA,NA,3,NA,TRUE,NA,NA,"Rat","Wistar","M/F","Oral diet",NA,NA,"2","Years","heart","F","None",1409,"organ weight","F","Continuous","organ weights (higher heart-to-body weight ratio)","SD","ppm","g/kg bw","mg/kg/day",NA,"Data are from Table 3 in primary report.",NA,0,0,NA,4,NA,2.5,0.3
"175",362,"Nickel","7440020","Ni","IRIS","RfD (mg/kg/day)",0.02,0.83,1996-12-01,"http://www.epa.gov/iris/subst/0271.htm","12/1/1996","Ambrose, A.M., D.S. Larson, J.R. Borzelleca and G.R. Hennigar, Jr. 1976. Long-term toxicologic assessment of nickel in rats and dogs. J. Food Sci. Technol. 13: 181-187.","NOAEL",5,"mg/kg/day","NA","Decreased body and organ weights","No","None","None","No",300,10,10,NA,NA,3,NA,TRUE,NA,NA,"Rat","Wistar","M/F","Oral diet",NA,NA,"2","Years","systemic","Both","None",802,"body weight","F","Continuous","Decreased body weights","SD","ppm","g","mg/kg/day",NA,"Terminal body weight data are from Table 1 in primary report.  Body weight was significantly decreased at the LOAEL from wks 26-104.",NA,0,0,NA,4,NA,496,84
"176",350,"p,p'-DDD","72548","C14H10Cl4","CalEPA","Oral Slope Factor (mg/kg-day)-1",0.24,NA,NA,NA,"1997","Tomatis, L., V. Turusov, R.T. Charles and M. Boicchi. 1974. Effect of long- term exposure to 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene, to 1,1- dichloro-2,2-bis(p-chlorophenyl)-ethane, and to the two chemicals combined on CF-1 mice. J. Natl. Cancer Inst. 52(3): 883-891.",NA,NA,NA,"Other","liver tumors","No","None","Other","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CF-1","M/F","Oral diet",NA,NA,"130","Weeks","liver","M","None",4393,"neoplasia","M","Dichotomous","liver tumors",NA,"ppm diet",NA,NA,"mg/kg-day","references US EPA IRIS documentation",NA,0,NA,0,98,33,NA,NA
"177",350,"p,p'-DDD","72548","C14H10Cl4","IRIS","Oral Slope Factor (1/mg/kg-day)",0.24,NA,1988-08-22,"http://www.epa.gov/iris/subst/0347.htm","8/22/1988","Tomatis, L., V. Turusov, R.T. Charles and M. Boicchi. 1974. Effect of long- term exposure to 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene, to 1,1- dichloro-2,2-bis(p-chlorophenyl)-ethane, and to the two chemicals combined on CF-1 mice. J. Natl. Cancer Inst. 52(3): 883-891.",NA,NA,NA,"Other","liver tumors","No","None","Other","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CF-1","M/F","Oral diet",NA,NA,"130","Weeks","liver","M","None",841,"neoplasia","M","Dichotomous","liver tumors",NA,"ppm","incidence",NA,"mg/kg/day",NA,NA,0,NA,0,98,33,NA,NA
"178",350,"p,p'-DDD","72548","C14H10Cl4","CalEPA","Inhalation Unit Risk (1/μg/m3)",6.9e-05,NA,NA,"http://studioweeren.net/tox-db/print/chemicals/dichlorodiphenyldichloroethane","1997","Tomatis, L., V. Turusov, R.T. Charles and M. Boicchi. 1974. Effect of long- term exposure to 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene, to 1,1- dichloro-2,2-bis(p-chlorophenyl)-ethane, and to the two chemicals combined on CF-1 mice. J. Natl. Cancer Inst. 52(3): 883-891.",NA,NA,NA,"Other","liver tumors","Yes","Simple","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","CF-1","M/F","Oral diet",NA,NA,"130","Weeks","liver","M","None",3385,"neoplasia","M",NA,"liver tumor",NA,NA,NA,NA,NA,"The IUR was calculated from the IRIS OSF value of 0.24 per mg/kg/day using a reference human body weight of 70 kg and an inspiration rate of 20 m3/day.",NA,NA,NA,NA,NA,NA,NA,NA
"179",277,"Parathion","56382","C10H14NO5PS","OPP","Chronic RfD (mg/kg/day)",3.3e-05,NA,NA,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,56-38-2",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"180",277,"Parathion","56382","C10H14NO5PS","HEAST","RfD (mg/kg/day)",0.006,1.07,NA,"http://epa-heast.ornl.gov/heast.php?chemical=Parathion","1987","U.S. EPA. 1987. Health effects assessment for Parathion. Prepared by the Office of Health and
Environmental Assessment, Environmental Criteria and Assessment Office, Cincinnati, OH for the Office
of Emergency and Remedial Response, Washington, DC","NOAEL",0.064,"mg/kg-day",NA,"Decreased cholinesterase activity",NA,NA,NA,"No",10,NA,10,NA,NA,NA,NA,TRUE,NA,NA,"Human",NA,NA,"Oral - other",NA,NA,NA,"Duration","CNS","Both",NA,3461,"enzyme activity","Both",NA,"Decreased cholinesterase activity",NA,NA,NA,NA,NA,"It was not specified how chemical was orally administered or how long the exposure was.  A primary reference was not cited in HEAST.",NA,NA,NA,NA,NA,NA,NA,NA
"181",22,"p-Cresol","106445","C7H8O","HEAST","RfD (mg/kg/day)",0.005,1,NA,"http://epa-heast.ornl.gov/heast.php?chemical=Cresol, p- / (4-Methylphenol)","1990","CMA (Chemical Manufacturers' Association). 1988. Developmental toxicity evaluation of o-, m- or p-Cresol administered by gavage to New Zealand white rabbits. Final project report 51-508. Fiche No. 0TS0517695.","NOAEL",5,"mg/kg/day","NA","CNS signs and respiratory distress; maternal mortality","NA","None","None","No",1000,10,10,10,NA,NA,NA,TRUE,NA,NA,"Rabbit","New Zealand","F","Oral gavage",NA,NA,"6-18","GD","CNS","Both",NA,3464,"clinical signs","Both","Dichotomous","CNS signs (hypoactivity)",NA,"mg/kg/day",NA,NA,NA,"Dose response data (GD 6-18) are from Table 10 in the primary report",NA,0,NA,NA,24,0,NA,NA
"182",22,"p-Cresol","106445","C7H8O","HEAST","RfD (mg/kg/day)",0.005,1,NA,"http://epa-heast.ornl.gov/heast.php?chemical=Cresol, p- / (4-Methylphenol)","1990","CMA (Chemical Manufacturers' Association). 1988. Developmental toxicity evaluation of o-, m- or p-Cresol administered by gavage to New Zealand white rabbits. Final project report 51-508. Fiche No. 0TS0517695.","NOAEL",5,"mg/kg/day","NA","CNS signs and respiratory distress; maternal mortality","NA","None","None","No",1000,10,10,10,NA,NA,NA,TRUE,NA,NA,"Rabbit","New Zealand","F","Oral gavage",NA,NA,"6-18","GD","systemic","Both",NA,3465,"body weight","Both","Dichotomous","maternal mortality",NA,"mg/kg/day",NA,NA,NA,"Dose-response data are from Table 10 in the primary report.",NA,0,NA,NA,24,0,NA,NA
"183",22,"p-Cresol","106445","C7H8O","HEAST","RfD (mg/kg/day)",0.005,1,NA,"http://epa-heast.ornl.gov/heast.php?chemical=Cresol, p- / (4-Methylphenol)","1990","CMA (Chemical Manufacturers' Association). 1988. Developmental toxicity evaluation of o-, m- or p-Cresol administered by gavage to New Zealand white rabbits. Final project report 51-508. Fiche No. 0TS0517695.","NOAEL",5,"mg/kg/day","NA","CNS signs and respiratory distress; maternal mortality","NA","None","None","No",1000,10,10,10,NA,NA,NA,TRUE,NA,NA,"Rabbit","New Zealand","F","Oral gavage",NA,NA,"6-18","GD","respiratory system","Both",NA,3725,"clinical signs","Both","Dichotomous","respiratory distress (labored respiration)",NA,"mg/kg/day",NA,NA,NA,"Dose response data (GD 6-18) are from Table 10 in the primary report",NA,0,NA,NA,24,0,NA,NA
"184",481,"Pentachlorophenol","87865","C6HCl5O","CalEPA","Oral Slope Factor (mg/kg-day)-1",0.018,NA,NA,"http://studioweeren.net/tox-db/print/chemicals/pentachlorophenol","1991","National Toxicology Program (NTP) 1989. Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures in B6C3F1 Mice. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.",NA,NA,NA,"10% ER","liver and adrenal medullary tumors in male and female mice, and hemangiosarcomas in the females","No","None","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Oral diet",NA,NA,"2","Years","adrenal glands","Both","None",3085,"neoplasia","F","Dichotomous","Adrenal gland/medullary tumor incidence (benign and malignant pheochromocytomas)",NA,"ppm diet",NA,"mg/kg-day diet",NA,"Grade of PeCP - EC-7",NA,0,0,NA,35,0,NA,NA
"185",481,"Pentachlorophenol","87865","C6HCl5O","CalEPA","Oral Slope Factor (mg/kg-day)-1",0.018,NA,NA,"http://studioweeren.net/tox-db/print/chemicals/pentachlorophenol","1991","National Toxicology Program (NTP) 1989. Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures in B6C3F1 Mice. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.",NA,NA,NA,"10% ER","liver and adrenal medullary tumors in male and female mice, and hemangiosarcomas in the females","No","None","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Oral diet",NA,NA,"2","Years","adrenal glands","Both","None",3084,"neoplasia","M","Dichotomous","Adrenal gland/medullary tumor incidence (benign and malignant pheochromocytomas)",NA,"ppm diet",NA,"mg/kg-day diet",NA,"Grade of PeCP - EC-7",NA,0,0,NA,34,1,NA,NA
"186",481,"Pentachlorophenol","87865","C6HCl5O","CalEPA","Oral Slope Factor (mg/kg-day)-1",0.018,NA,NA,"http://studioweeren.net/tox-db/print/chemicals/pentachlorophenol","1991","National Toxicology Program (NTP) 1989. Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures in B6C3F1 Mice. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.",NA,NA,NA,"10% ER","liver and adrenal medullary tumors in male and female mice, and hemangiosarcomas in the females","No","None","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Oral diet",NA,NA,"2","Years","liver","Both","None",4401,"neoplasia","F",NA,"hemangiosarcomas",NA,"ppm diet",NA,"mg/kg-day diet",NA,NA,NA,0,0,NA,35,0,NA,NA
"187",481,"Pentachlorophenol","87865","C6HCl5O","CalEPA","Oral Slope Factor (mg/kg-day)-1",0.018,NA,NA,"http://studioweeren.net/tox-db/print/chemicals/pentachlorophenol","1991","National Toxicology Program (NTP) 1989. Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures in B6C3F1 Mice. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.",NA,NA,NA,"10% ER","liver and adrenal medullary tumors in male and female mice, and hemangiosarcomas in the females","No","None","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Oral diet",NA,NA,"2","Years","liver","Both","None",4400,"neoplasia","M","Dichotomous","hepatocellular adenomas and carcinomas",NA,"ppm diet",NA,"mg/kg-day diet",NA,"Grade of PeCP - EC-7",NA,0,0,NA,35,6,NA,NA
"188",481,"Pentachlorophenol","87865","C6HCl5O","CalEPA","Oral Slope Factor (mg/kg-day)-1",0.018,NA,NA,"http://studioweeren.net/tox-db/print/chemicals/pentachlorophenol","1991","National Toxicology Program (NTP) 1989. Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures in B6C3F1 Mice. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.",NA,NA,NA,"10% ER","liver and adrenal medullary tumors in male and female mice, and hemangiosarcomas in the females","No","None","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Oral diet",NA,NA,"2","Years","liver","Both","None",3083,"neoplasia","F","Dichotomous","hepatocellular adenomas and carcinomas",NA,"ppm diet",NA,"mg/kg-day",NA,"Grade of PeCP - EC-7",NA,0,0,NA,34,1,NA,NA
"189",481,"Pentachlorophenol","87865","C6HCl5O","IRIS","Oral Slope Factor (1/mg/kg-day)",0.4,NA,2010-09-30,"http://www.epa.gov/iris/subst/0086.htm","9/30/2010","NTP (National Toxicology Program). (1989) NTP toxicology and carcinogenesis studies of two pentachlorophenol technical-grade mixtures (CAS No. 87-86-5) in B6C3F1 mice (feed studies).  Public Health Service, U.S. Department of Health and Human Services; NTP TR 349. Available from the National Institute of Environmental Health Sciences, Research Triangle Park, NC.",NA,NA,NA,"10% ER","Hepatocellular adenomas or carcinomas and adrenal benign or malignant pheochromocytomas","NA","None","BW3/4","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Oral diet",NA,NA,"2","Years","liver","Both","MOA Evaluation",1798,"neoplasia","M","Dichotomous","Hepatocellular adenomas or carcinomas",NA,"ppm","incidence","mg/kg/day",NA,"A bootstrap analysis (Efron and Tibshirani, 1993) was used to derive the distribution of the benchmark dose (BMD) for the combined risk of liver and adrenal gland tumors.  A simulated incidence level was generated for each exposure group using a binomial distribution with probability of success estimated by a Bayesian estimate of probability.  Each simulated data set was modeled using the multistage model in the same manner as was done for the individual risks associated with the liver and adrenal gland tumors.  The 5th percentile from the distribution of combined BMDs was used to estimate the BMDL corresponding to an extra risk of 1% for any of the two tumor sites.",NA,0,0,NA,32,7,NA,NA
"190",481,"Pentachlorophenol","87865","C6HCl5O","IRIS","Oral Slope Factor (1/mg/kg-day)",0.4,NA,2010-09-30,"http://www.epa.gov/iris/subst/0086.htm","9/30/2010","NTP (National Toxicology Program). (1989) NTP toxicology and carcinogenesis studies of two pentachlorophenol technical-grade mixtures (CAS No. 87-86-5) in B6C3F1 mice (feed studies).  Public Health Service, U.S. Department of Health and Human Services; NTP TR 349. Available from the National Institute of Environmental Health Sciences, Research Triangle Park, NC.",NA,NA,NA,"10% ER","Hepatocellular adenomas or carcinomas and adrenal benign or malignant pheochromocytomas","NA","None","BW3/4","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Oral diet",NA,NA,"2","Years","adrenal glands","Both","MOA Evaluation",1799,"neoplasia","M","Dichotomous","Adrenal benign or malignant pheochromocytomas",NA,"ppm","incidence","mg/kg/day",NA,"A bootstrap analysis (Efron and Tibshirani, 1993) was used to derive the distribution of the benchmark dose (BMD) for the combined risk of liver and adrenal gland tumors.  A simulated incidence level was generated for each exposure group using a binomial distribution with probability of success estimated by a Bayesian estimate of probability.  Each simulated data set was modeled using the multistage model in the same manner as was done for the individual risks associated with the liver and adrenal gland tumors.  The 5th percentile from the distribution of combined BMDs was used to estimate the BMDL corresponding to an extra risk of 1% for any of the two tumor sites.",NA,0,0,NA,31,0,NA,NA
"191",481,"Pentachlorophenol","87865","C6HCl5O","ATSDR","Chronic Oral MRL (mg/kg/day)",0.001,1,NA,"http://www.atsdr.cdc.gov/ToxProfiles/tp51.pdf","9/2001","Beard AP, Rawlings NC. 1998. Reproductive effects in mink (mustela vison) exposed to the pesticides lindane, carbofuran and pentachlorophenol in a multigeneration study. J Reprod Fertil 113:95-104.","LOAEL",1,"mg/kg/day","NA","decreased serum thyroxine concentrations and decreased relative thyroid weight in mink","NA","None","None","No",1000,10,10,NA,10,NA,NA,TRUE,NA,NA,"Other",NA,"M/F","Oral diet",NA,NA,"3","Generations","thyroid","F","MOA Evaluation",3626,"organ weight","F","Continuous","decreased relative thyroid weight in mink (F2 females)",NA,NA,NA,NA,NA,"F0 females were treated 3 weeks prior to mating (to untreated males) through weaning of F1 generation.   F1 females were mated to untreated males to produce F2 generation.  F1 and F2 generations (males and females) received the same dietary concentration after weaning. Dose-response data were presented graphically in primary report.",NA,NA,NA,NA,NA,NA,NA,NA
"192",481,"Pentachlorophenol","87865","C6HCl5O","ATSDR","Chronic Oral MRL (mg/kg/day)",0.001,1,NA,"http://www.atsdr.cdc.gov/ToxProfiles/tp51.pdf","9/2001","Beard AP, Rawlings NC. 1998. Reproductive effects in mink (mustela vison) exposed to the pesticides lindane, carbofuran and pentachlorophenol in a multigeneration study. J Reprod Fertil 113:95-104.","LOAEL",1,"mg/kg/day","NA","decreased serum thyroxine concentrations and decreased relative thyroid weight in mink","NA","None","None","No",1000,10,10,NA,10,NA,NA,TRUE,NA,NA,"Other",NA,"M/F","Oral diet",NA,NA,"3","Generations","thyroid","Both","MOA Evaluation",3625,"clinical chemistry","Both","Continuous","decreased serum thyroxine concentrations (F1 males, F2 males and females)",NA,NA,NA,NA,NA,"F0 females were treated 3 weeks prior to mating (to untreated males) through weaning of F1 generation.   F1 females were mated to untreated males to produce F2 generation.  F1 and F2 generations (males and females) received the same dietary concentration after weaning.  Dose-response data were presented graphically in primary report.",NA,NA,NA,NA,NA,NA,NA,NA
"193",481,"Pentachlorophenol","87865","C6HCl5O","OPP","Chronic RfD (mg/kg/day)",0.005,NA,NA,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:3:0::NO:1,3,31,7,12,25:P3_XCHEMICAL_ID:3237",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"194",481,"Pentachlorophenol","87865","C6HCl5O","IRIS","RfD (mg/kg/day)",0.005,1,2010-09-30,"http://www.epa.gov/iris/subst/0086.htm","9/30/2010","Mecler, F. (1996) Fifty-two week repeated dose chronic oral study of pentachlorophenol administered via capsule to dogs.  Study conducted by TSI Mason Laboratories, Worcester, MA; TSI Report #ML-PTF-J31-95-94. Submitted to the Pentachlorophenol Task Force, c/o SRA International, Inc., Washington, DC. U.S. Environmental Protection Agency, Washington, DC; MRID 439827-01.  Unpublished report.","LOAEL",1.5,"mg/kg/day","Other","Hepatotoxicity","No","None","None","Yes",300,10,10,NA,3,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral - other",NA,NA,"52","Weeks","liver","Both","MOA Evaluation",1787,"nonneoplastic histopathology","M","Dichotomous","liver pigmentation",NA,"mg/kg/day","incidence",NA,NA,NA,NA,0,NA,NA,4,0,NA,NA
"195",481,"Pentachlorophenol","87865","C6HCl5O","IRIS","RfD (mg/kg/day)",0.005,1,2010-09-30,"http://www.epa.gov/iris/subst/0086.htm","9/30/2010","Mecler, F. (1996) Fifty-two week repeated dose chronic oral study of pentachlorophenol administered via capsule to dogs.  Study conducted by TSI Mason Laboratories, Worcester, MA; TSI Report #ML-PTF-J31-95-94. Submitted to the Pentachlorophenol Task Force, c/o SRA International, Inc., Washington, DC. U.S. Environmental Protection Agency, Washington, DC; MRID 439827-01.  Unpublished report.","LOAEL",1.5,"mg/kg/day","Other","Hepatotoxicity","No","None","None","Yes",300,10,10,NA,3,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral - other",NA,NA,"52","Weeks","liver","Both","MOA Evaluation",1791,"nonneoplastic histopathology","M","Dichotomous","chronic inflammation",NA,"mg/kg/day","incidence",NA,NA,NA,NA,0,NA,NA,4,0,NA,NA
"196",481,"Pentachlorophenol","87865","C6HCl5O","IRIS","RfD (mg/kg/day)",0.005,1,2010-09-30,"http://www.epa.gov/iris/subst/0086.htm","9/30/2010","Mecler, F. (1996) Fifty-two week repeated dose chronic oral study of pentachlorophenol administered via capsule to dogs.  Study conducted by TSI Mason Laboratories, Worcester, MA; TSI Report #ML-PTF-J31-95-94. Submitted to the Pentachlorophenol Task Force, c/o SRA International, Inc., Washington, DC. U.S. Environmental Protection Agency, Washington, DC; MRID 439827-01.  Unpublished report.","LOAEL",1.5,"mg/kg/day","Other","Hepatotoxicity","No","None","None","Yes",300,10,10,NA,3,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral - other",NA,NA,"52","Weeks","liver","Both","MOA Evaluation",1793,"nonneoplastic histopathology","F","Dichotomous","chronic inflammation",NA,"mg/kg/day","incidence",NA,NA,NA,NA,0,NA,NA,4,2,NA,NA
"197",481,"Pentachlorophenol","87865","C6HCl5O","CalEPA","Inhalation Unit Risk (1/μg/m3)",4.6e-06,NA,NA,"http://studioweeren.net/tox-db/print/chemicals/pentachlorophenol","2009","National Toxicology Program (NTP) 1989. Toxicology and Carcinogenesis Studies of Two Pentachlorophenol Technical-Grade Mixtures in B6C3F1 Mice. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.",NA,NA,NA,"10% ER","liver and adrenal medullary tumors in male and female mice, and hemangiosarcomas in the females [see accompanying records]","No","Simple","BW2/3","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Mouse","B6C3F1","M/F","Oral diet",NA,NA,"2","Years","liver","Both","None",3065,"neoplasia","Both",NA,NA,NA,NA,NA,NA,NA,"An airborne unit risk factor of 4.6E-6 (μg/m3)-1 was calculated from the qhuman value by OEHHA/ATES using the default parameters of 70 kg human body weight and 20 m3/day breathing rate.",NA,NA,NA,NA,NA,NA,NA,NA
"198",481,"Pentachlorophenol","87865","C6HCl5O","IRIS","RfD (mg/kg/day)",0.005,1,2010-09-30,"http://www.epa.gov/iris/subst/0086.htm","9/30/2010","Mecler, F. (1996) Fifty-two week repeated dose chronic oral study of pentachlorophenol administered via capsule to dogs.  Study conducted by TSI Mason Laboratories, Worcester, MA; TSI Report #ML-PTF-J31-95-94. Submitted to the Pentachlorophenol Task Force, c/o SRA International, Inc., Washington, DC. U.S. Environmental Protection Agency, Washington, DC; MRID 439827-01.  Unpublished report.","LOAEL",1.5,"mg/kg/day","Other","Hepatotoxicity","No","None","None","Yes",300,10,10,NA,3,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral - other",NA,NA,"52","Weeks","liver","Both","MOA Evaluation",1790,"nonneoplastic histopathology","M","Dichotomous","cytoplasmic vacuolization",NA,"mg/kg/day","incidence",NA,NA,NA,NA,0,NA,NA,4,1,NA,NA
"199",481,"Pentachlorophenol","87865","C6HCl5O","IRIS","RfD (mg/kg/day)",0.005,1,2010-09-30,"http://www.epa.gov/iris/subst/0086.htm","9/30/2010","Mecler, F. (1996) Fifty-two week repeated dose chronic oral study of pentachlorophenol administered via capsule to dogs.  Study conducted by TSI Mason Laboratories, Worcester, MA; TSI Report #ML-PTF-J31-95-94. Submitted to the Pentachlorophenol Task Force, c/o SRA International, Inc., Washington, DC. U.S. Environmental Protection Agency, Washington, DC; MRID 439827-01.  Unpublished report.","LOAEL",1.5,"mg/kg/day","Other","Hepatotoxicity","No","None","None","Yes",300,10,10,NA,3,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral - other",NA,NA,"52","Weeks","liver","Both","MOA Evaluation",1789,"nonneoplastic histopathology","F","Dichotomous","liver pigmentation",NA,"mg/kg/day","incidence",NA,NA,NA,NA,0,NA,NA,4,0,NA,NA
"200",481,"Pentachlorophenol","87865","C6HCl5O","IRIS","RfD (mg/kg/day)",0.005,1,2010-09-30,"http://www.epa.gov/iris/subst/0086.htm","9/30/2010","Mecler, F. (1996) Fifty-two week repeated dose chronic oral study of pentachlorophenol administered via capsule to dogs.  Study conducted by TSI Mason Laboratories, Worcester, MA; TSI Report #ML-PTF-J31-95-94. Submitted to the Pentachlorophenol Task Force, c/o SRA International, Inc., Washington, DC. U.S. Environmental Protection Agency, Washington, DC; MRID 439827-01.  Unpublished report.","LOAEL",1.5,"mg/kg/day","Other","Hepatotoxicity","No","None","None","Yes",300,10,10,NA,3,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral - other",NA,NA,"52","Weeks","liver","Both","MOA Evaluation",1783,"organ weight","Both","Continuous","increases in relative and absolute (females only) weight",NA,NA,NA,NA,NA,"Dose response data not reported for this endpoint",NA,NA,NA,NA,NA,NA,NA,NA
"201",481,"Pentachlorophenol","87865","C6HCl5O","IRIS","RfD (mg/kg/day)",0.005,1,2010-09-30,"http://www.epa.gov/iris/subst/0086.htm","9/30/2010","Mecler, F. (1996) Fifty-two week repeated dose chronic oral study of pentachlorophenol administered via capsule to dogs.  Study conducted by TSI Mason Laboratories, Worcester, MA; TSI Report #ML-PTF-J31-95-94. Submitted to the Pentachlorophenol Task Force, c/o SRA International, Inc., Washington, DC. U.S. Environmental Protection Agency, Washington, DC; MRID 439827-01.  Unpublished report.","LOAEL",1.5,"mg/kg/day","Other","Hepatotoxicity","No","None","None","Yes",300,10,10,NA,3,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral - other",NA,NA,"52","Weeks","liver","Both","MOA Evaluation",1782,"clinical chemistry","Both","Continuous","Increased serum enzyme activity",NA,NA,NA,NA,NA,"Chemical was administered orally in gelatin capsules. Dose response data not reported for this endpoint.",NA,NA,NA,NA,NA,NA,NA,NA
"202",143,"Trifluralin","1582098","C13H16F3N3O4","IRIS","Oral Slope Factor (1/mg/kg-day)",0.0077,NA,1993-10-01,"http://www.epa.gov/iris/subst/0268.htm","10/1/1993","Emmerson, J.L., E.C. Pierce, J.P. McGrath, et al. 1980. The chronic toxicity of compound 36352 (trifluralin) given as a compound of the diet to the Fischer 344 rats for two years. Studies R-87 and R-97 (unpublished study received September 18, 1980 under 1471-35; submitted by Elanco Products Co., Division of Eli Lilly and Co., Indianapolis, IN).",NA,NA,NA,"Other","combined renal pelvis carcinomas, urinary bladder papillomas and/or thyroid adenomas and carcinomas","No","None","Other","Yes",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Rat","Fischer 344","M/F","Oral diet",NA,NA,"2","Years","combined","Both","None",1285,"neoplasia","M","Dichotomous","combined renal pelvis carcinomas, urinary bladder papillomas and/or thyroid adenomas and carcinomas",NA,"ppm","incidence",NA,"mg/kg/day","method for animal to human extrapolation was not reported",NA,0,NA,0,60,5,NA,NA
"203",143,"Trifluralin","1582098","C13H16F3N3O4","OPP","Chronic RfD (mg/kg/day)",0.024,1,NA,"http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2012-0417-0004","6/7/2012","Adams, E.; Bernhard, N.; Jordon, W. (1992) A Chronic Toxicity Study of Trifluralin (Compound 036352) Administered Orally to Beagle Dogs for One Year Supp.): Lab Project Number: D07190. Unpublished study prepared by Lilly Research Labs. 470 p.  MRID 42447001","NOEL",2.4,"mg/kg/day","NA","increased frequency of abnormal stool, decreased body weights and body weight gains, and decreased erythrocytes and hemoglobin and increased thrombocytes (males)","NA","None","None","Yes",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral - other",NA,NA,"1","Years","systemic","F",NA,3984,"body weight","F","Continuous","decreased body weights","SD","mg/kg/day","kg",NA,NA,"Dose response data are from Table 2 in the Data Evaluation Record (average body weight over 52 week treatment period).",NA,0,NA,NA,4,NA,9.57,1.55
"204",143,"Trifluralin","1582098","C13H16F3N3O4","OPP","Chronic RfD (mg/kg/day)",0.024,1,NA,"http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2012-0417-0004","6/7/2012","Adams, E.; Bernhard, N.; Jordon, W. (1992) A Chronic Toxicity Study of Trifluralin (Compound 036352) Administered Orally to Beagle Dogs for One Year Supp.): Lab Project Number: D07190. Unpublished study prepared by Lilly Research Labs. 470 p.  MRID 42447001","NOEL",2.4,"mg/kg/day","NA","increased frequency of abnormal stool, decreased body weights and body weight gains, and decreased erythrocytes and hemoglobin and increased thrombocytes (males)","NA","None","None","Yes",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral - other",NA,NA,"1","Years","gastrointestinal","Both",NA,3983,"clinical signs","Both",NA,NA,NA,NA,NA,NA,NA,"Compound was administered via capsules.",NA,NA,NA,NA,NA,NA,NA,NA
"205",143,"Trifluralin","1582098","C13H16F3N3O4","OPP","Chronic RfD (mg/kg/day)",0.024,1,NA,"http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2012-0417-0004","6/7/2012","Adams, E.; Bernhard, N.; Jordon, W. (1992) A Chronic Toxicity Study of Trifluralin (Compound 036352) Administered Orally to Beagle Dogs for One Year Supp.): Lab Project Number: D07190. Unpublished study prepared by Lilly Research Labs. 470 p.  MRID 42447001","NOEL",2.4,"mg/kg/day","NA","increased frequency of abnormal stool, decreased body weights and body weight gains, and decreased erythrocytes and hemoglobin and increased thrombocytes (males)","NA","None","None","Yes",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral - other",NA,NA,"1","Years","blood","M",NA,3985,"hematology","M",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"206",143,"Trifluralin","1582098","C13H16F3N3O4","IRIS","RfD (mg/kg/day)",0.0075,1,1989-07-01,"http://www.epa.gov/iris/subst/0268.htm","7/1/1989","Hoechst Aktiengesellschaft. 1984a. MRID No. 00151908. Available from EPA. Write to FOI, EPA, Washington, DC 20460.","NOEL",0.75,"mg/kg/day","NA","Increased liver weights; increase in methemoglobin","No","None","None","No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral diet",NA,NA,"12","Months","liver","Both","None",1280,"organ weight","M",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"207",143,"Trifluralin","1582098","C13H16F3N3O4","IRIS","RfD (mg/kg/day)",0.0075,1,1989-07-01,"http://www.epa.gov/iris/subst/0268.htm","7/1/1989","Hoechst Aktiengesellschaft. 1984a. MRID No. 00151908. Available from EPA. Write to FOI, EPA, Washington, DC 20460.","NOEL",0.75,"mg/kg/day","NA","Increased liver weights; increase in methemoglobin","No","None","None","No",100,10,10,NA,NA,NA,NA,TRUE,NA,NA,"Dog","Beagle","M/F","Oral diet",NA,NA,"12","Months","blood","Both","None",1281,"hematology","Both",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"208",374,"Zinc","7440666","Zn","IRIS","RfD (mg/kg/day)",0.3,1.01,2005-08-03,"http://www.epa.gov/iris/subst/0426.htm","8/3/2005","Milne, DB; Davis, CD; Nielsen, FH. (2001) Low dietary zinc alters indices of copper function and status in postmenopausal women. Nutrition 17:701-708.

Davis, CD; Milne, DB; Nielsen, FH. (2000) Changes in dietary zinc and copper affect zinc-status indicators of postmenopausal women, notably, extracellular superoxide dismutase and amyloid precursor proteins. Am J Clin Nutr 71:781-788.

Yadrick, MK; Kenney, MA; Winterfeldt, EA. (1989) Iron, copper, and zinc status: response to supplementation with zinc or zinc and iron in adult females. Am J Clin Nutr 49:145-150.

Fischer, PW; Giroux, A; L'Abbe, MR. (1984) Effect of zinc supplementation on copper status in adult man. Am J Clin Nutr 40:743-746.","LOAEL",0.91,"mg/kg/day","NA","Decreases in erythrocyte Cu, Zn-superoxide dismutase (ESOD) activity in healthy adult male and female volunteers","NA","None","NA","No",3,NA,3,NA,NA,NA,NA,TRUE,NA,NA,"Human",NA,"M/F","Oral diet",NA,NA,"42-200","Days","systemic","Both","MOA Evaluation",1866,"clinical chemistry","Both","Continuous","Decreases in erythrocyte Cu, Zn-superoxide dismutase (ESOD) activity in healthy adult male and female volunteers",NA,NA,NA,NA,NA,"As the four studies identified physiological changes on similar, sensitive endpoints (indicators of body copper status) at similar dose levels (0.81-0.99 mg Zn/kg-day) in a variety of human subject groups (postmenopausal females, adult females, and adult males), the studies of Yadrick et al. (1989), Fischer et al. (1984), Davis et al. (2000) and Milne et al. (2001) were selected as co-principal studies.
RfD based on human therapeutic dose no DR data available",NA,NA,NA,NA,NA,NA,NA,NA
"209",374,"Zinc","7440666","Zn","IRIS","RfD (mg/kg/day)",0.3,1.01,2005-08-03,"http://www.epa.gov/iris/subst/0426.htm","8/3/2005","Milne, DB; Davis, CD; Nielsen, FH. (2001) Low dietary zinc alters indices of copper function and status in postmenopausal women. Nutrition 17:701-708.

Davis, CD; Milne, DB; Nielsen, FH. (2000) Changes in dietary zinc and copper affect zinc-status indicators of postmenopausal women, notably, extracellular superoxide dismutase and amyloid precursor proteins. Am J Clin Nutr 71:781-788.

Yadrick, MK; Kenney, MA; Winterfeldt, EA. (1989) Iron, copper, and zinc status: response to supplementation with zinc or zinc and iron in adult females. Am J Clin Nutr 49:145-150.

Fischer, PW; Giroux, A; L'Abbe, MR. (1984) Effect of zinc supplementation on copper status in adult man. Am J Clin Nutr 40:743-746.","LOAEL",0.91,"mg/kg/day","NA","Decreases in erythrocyte Cu, Zn-superoxide dismutase (ESOD) activity in healthy adult male and female volunteers","NA","None","NA","No",3,NA,3,NA,NA,NA,NA,TRUE,NA,NA,"Human",NA,"M/F","Oral diet",NA,NA,"42-200","Days","systemic","Both","MOA Evaluation",1867,"enzyme activity","Both",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
